10.6858
10005
10005
120
135
6
1
False
False
Chapter5a: Amphetamines |
Prevalence |
|
Unadjusted prevalence by gender and age groups |
|
16-17 |
18-24 |
25-34 |
35-44 |
45-54 |
55-64 |
Total |
Ever used amphetamines for recreational purposes in lifetime (among total population) |
Men |
0.5 ( 0.1 - 1.7) |
12.3 ( 8.1 - 16.5) |
15.9 ( 11.8 - 20) |
8.5 ( 5.5 - 11.6) |
7.2 ( 4 - 10.4) |
3.8 ( 1.7 - 7.1) |
9 ( 7.5 - 10.5) |
Women |
3.8 ( 0.6 - 11.9) |
7.9 ( 5 - 10.9) |
10.6 ( 8 - 13.2) |
5.3 ( 3.8 - 6.8) |
2.8 ( 1.5 - 4.8) |
1.1 ( 0.2 - 3.3) |
5.5 ( 4.5 - 6.4) |
Total |
2.2 ( 0.5 - 6) |
10.1 ( 7.4 - 12.7) |
13.1 ( 10.5 - 15.6) |
6.8 ( 5.2 - 8.5) |
5 ( 3.2 - 6.7) |
2.4 ( 1.3 - 4.2) |
7.2 ( 6.2 - 8.1) |
Age of first use of amphetamines for recreational purposes: 14 years or younger (among people who had ever used amphetamines) |
Men |
N/A |
1.4 ( 0 - 8.1) |
1.4 ( 0 - 7.6) |
7.8 ( 0.5 - 30.7) |
0 ( 0 - 9.3) |
N/A |
2.4 ( 0.5 - 7.2) |
Women |
N/A |
7.4 ( 0.6 - 26.7) |
1.4 ( 0.1 - 5.4) |
2.1 ( 0.3 - 6.6) |
N/A |
N/A |
2.6 ( 0.8 - 6.3) |
Total |
N/A |
3.8 ( 0.7 - 11.1) |
1.4 ( 0.1 - 6.3) |
5.4 ( 0.7 - 18.2) |
0 ( 0 - 5.6) |
N/A |
2.5 ( 0.9 - 5.4) |
Age of first use of amphetamines for recreational purposes: 15–17 years (among people who had ever used amphetamines) |
Men |
N/A |
23.7 ( 9 - 45.2) |
15 ( 6.3 - 28.5) |
5.2 ( 1.1 - 14.4) |
8.8 ( 1.6 - 25.1) |
N/A |
13.5 ( 8.1 - 18.9) |
Women |
N/A |
23.9 ( 9.4 - 44.9) |
22.5 ( 10.6 - 39.1) |
16.5 ( 7.3 - 30.2) |
N/A |
N/A |
22.6 ( 15 - 30.2) |
Total |
N/A |
23.8 ( 12.9 - 37.9) |
18.3 ( 11.6 - 26.7) |
9.9 ( 5.2 - 16.7) |
10.4 ( 3.7 - 22) |
N/A |
17.1 ( 13.1 - 21.1) |
Age of first use of amphetamines for recreational purposes: 18–20 years (among people who had ever used amphetamines) |
Men |
N/A |
64.1 ( 44.1 - 81.1) |
38.3 ( 25.7 - 51) |
24.3 ( 10.1 - 44.3) |
42.9 ( 19.5 - 68.9) |
N/A |
42.1 ( 33.4 - 50.9) |
Women |
N/A |
59.9 ( 37.7 - 79.5) |
32.2 ( 18.7 - 48.4) |
18.8 ( 8.2 - 34.2) |
N/A |
N/A |
36.2 ( 27 - 45.4) |
Total |
N/A |
62.4 ( 49.7 - 75.1) |
35.7 ( 26.9 - 44.5) |
22 ( 12.6 - 34.1) |
42.7 ( 24.4 - 62.7) |
N/A |
39.7 ( 33 - 46.5) |
Age of first use of amphetamines for recreational purposes: 21 years or older (among people who had ever used amphetamines) |
Men |
N/A |
10.8 ( 2 - 30) |
45.3 ( 33.1 - 57.4) |
62.8 ( 44.9 - 80.6) |
48.2 ( 25.1 - 71.9) |
N/A |
42 ( 33.1 - 50.9) |
Women |
N/A |
8.8 ( 1.6 - 24.8) |
43.8 ( 30.6 - 57) |
62.7 ( 47.1 - 78.2) |
N/A |
N/A |
38.6 ( 32.2 - 45.1) |
Total |
N/A |
10 ( 3.5 - 21.3) |
44.6 ( 35.8 - 53.4) |
62.7 ( 50.4 - 75) |
46.9 ( 30.2 - 63.5) |
N/A |
40.6 ( 34.9 - 46.4) |
Median age of first using amphetamines (among people who had ever used amphetamines) |
Men |
16 |
18 |
20 |
23 |
19 |
20 |
20 |
Women |
17 |
18 |
20 |
25 |
20 |
18 |
20 |
Total |
17 |
18 |
20 |
23 |
20 |
20 |
20 |
Used amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
0 ( 0 - 3.7) |
8.4 ( 5.1 - 12.8) |
4.1 ( 2.2 - 6.8) |
2.8 ( 1.4 - 5.1) |
0.9 ( 0.2 - 2.7) |
0 ( 0 - 0.9) |
2.9 ( 2 - 3.7) |
Women |
2.8 ( 0.1 - 12.4) |
3.4 ( 1.5 - 6.5) |
2.5 ( 1.3 - 3.6) |
0.8 ( 0.3 - 1.8) |
0.3 ( 0.1 - 1) |
0 ( 0 - 0.5) |
1.4 ( 0.9 - 1.8) |
Total |
1.4 ( 0.1 - 6.2) |
5.8 ( 3.7 - 8) |
3.2 ( 2.1 - 4.3) |
1.8 ( 1 - 2.9) |
0.6 ( 0.2 - 1.4) |
0 ( 0 - 0.3) |
2.1 ( 1.6 - 2.5) |
Used speed for recreational purposes in the past 12 months (among total population) |
Men |
0 ( 0 - 3.7) |
4.9 ( 2.6 - 8.4) |
2.5 ( 1 - 4.9) |
1.6 ( 0.7 - 3.1) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
1.6 ( 1 - 2.1) |
Women |
0.4 ( 0 - 2.2) |
2 ( 0.6 - 4.6) |
1.2 ( 0.5 - 2.3) |
0.2 ( 0.1 - 0.5) |
0.2 ( 0 - 1) |
0 ( 0 - 0.5) |
0.6 ( 0.3 - 0.9) |
Total |
0.2 ( 0 - 1.1) |
3.4 ( 2 - 5.5) |
1.8 ( 1 - 2.9) |
0.9 ( 0.4 - 1.6) |
0.1 ( 0 - 0.5) |
0 ( 0 - 0.3) |
1.1 ( 0.8 - 1.4) |
Used P for recreational purposes in the past 12 months (among total population) |
Men |
0 ( 0 - 3.7) |
4 ( 1.9 - 7.2) |
1.2 ( 0.6 - 2.3) |
1.1 ( 0.4 - 2.4) |
0.6 ( 0.1 - 2.3) |
0 ( 0 - 0.9) |
1.2 ( 0.7 - 1.7) |
Women |
2.4 ( 0.1 - 12.8) |
1.7 ( 0.3 - 5) |
1.6 ( 0.9 - 2.8) |
0.7 ( 0.2 - 1.7) |
0.2 ( 0 - 1) |
0 ( 0 - 0.5) |
0.9 ( 0.5 - 1.3) |
Total |
1.2 ( 0 - 6.4) |
2.8 ( 1.5 - 4.8) |
1.4 ( 0.9 - 2) |
0.9 ( 0.4 - 1.6) |
0.4 ( 0.1 - 1.2) |
0 ( 0 - 0.3) |
1 ( 0.7 - 1.3) |
Used ice for recreational purposes in the past 12 months (among total population) |
Men |
0 ( 0 - 3.7) |
2.6 ( 1.1 - 5.1) |
1.7 ( 0.6 - 3.9) |
1.3 ( 0.5 - 2.9) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
1 ( 0.6 - 1.5) |
Women |
0 ( 0 - 2.9) |
0.1 ( 0 - 0.4) |
0.8 ( 0.3 - 1.9) |
0.3 ( 0.1 - 0.8) |
0.1 ( 0 - 0.5) |
0 ( 0 - 0.5) |
0.3 ( 0.2 - 0.5) |
Total |
0 ( 0 - 1.6) |
1.3 ( 0.6 - 2.6) |
1.3 ( 0.6 - 2.2) |
0.8 ( 0.4 - 1.5) |
0.1 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0.6 ( 0.4 - 0.9) |
Used other types of amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
0 ( 0 - 3.7) |
0.8 ( 0.1 - 3) |
0.7 ( 0.1 - 2) |
0.5 ( 0 - 2.1) |
0.3 ( 0 - 1.6) |
0 ( 0 - 0.9) |
0.4 ( 0.2 - 0.9) |
Women |
0 ( 0 - 2.9) |
0.6 ( 0.1 - 1.8) |
0.6 ( 0.1 - 1.9) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.1) |
0 ( 0 - 0.5) |
0.2 ( 0.1 - 0.5) |
Total |
0 ( 0 - 1.6) |
0.7 ( 0.2 - 1.7) |
0.7 ( 0.2 - 1.4) |
0.3 ( 0.1 - 1) |
0.1 ( 0 - 0.7) |
0 ( 0 - 0.3) |
0.3 ( 0.2 - 0.6) |
Used speed for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
61.4 ( 46.2 - 76.6) |
Women |
N/A |
N/A |
49.3 ( 20.2 - 78.8) |
N/A |
N/A |
N/A |
52 ( 34.2 - 69.8) |
Total |
N/A |
68.2 ( 46 - 85.7) |
56.9 ( 35.5 - 76.6) |
N/A |
N/A |
N/A |
58.2 ( 46.9 - 69.5) |
Used P for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
46.8 ( 31.9 - 61.6) |
Women |
N/A |
N/A |
66.4 ( 32.4 - 91.1) |
N/A |
N/A |
N/A |
67.9 ( 51.4 - 84.5) |
Total |
N/A |
55.8 ( 30.6 - 78.9) |
45.6 ( 28.4 - 62.8) |
N/A |
N/A |
N/A |
54.1 ( 42.7 - 65.5) |
Used ice for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
40.4 ( 26.2 - 54.7) |
Women |
N/A |
N/A |
34.2 ( 10.7 - 65.4) |
N/A |
N/A |
N/A |
23.7 ( 11.4 - 40.3) |
Total |
N/A |
26.9 ( 10.7 - 49.4) |
40 ( 21.1 - 61.4) |
N/A |
N/A |
N/A |
34.7 ( 23.7 - 45.6) |
Used other types of amphetamines for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
16.8 ( 6.9 - 31.9) |
Women |
N/A |
N/A |
25.6 ( 3.8 - 64.1) |
N/A |
N/A |
N/A |
20.2 ( 6.8 - 41.3) |
Total |
N/A |
13.6 ( 3.1 - 34) |
20.6 ( 7.3 - 41.1) |
N/A |
N/A |
N/A |
18 ( 9.5 - 29.4) |
Used amphetamines at home in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
50.6 ( 35.9 - 65.4) |
Women |
N/A |
N/A |
68.8 ( 41.2 - 89.1) |
N/A |
N/A |
N/A |
48.8 ( 29.3 - 68.2) |
Total |
N/A |
29.6 ( 15 - 48) |
64.1 ( 45.7 - 82.6) |
N/A |
N/A |
N/A |
50 ( 38.8 - 61.2) |
Used amphetamines at someone elses home in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
51.8 ( 36.4 - 67.3) |
Women |
N/A |
N/A |
52.7 ( 22.8 - 81.2) |
N/A |
N/A |
N/A |
67.4 ( 52.8 - 82.1) |
Total |
N/A |
64.4 ( 40.5 - 84) |
49.8 ( 29.6 - 70) |
N/A |
N/A |
N/A |
57.3 ( 45.2 - 69.3) |
Used amphetamines at pubs, hotels, restaurants or cafes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
10.4 ( 4 - 21.1) |
Women |
N/A |
N/A |
11 ( 0.9 - 38.9) |
N/A |
N/A |
N/A |
7.1 ( 1.5 - 19.1) |
Total |
N/A |
10 ( 2.8 - 23.9) |
11.3 ( 2.9 - 27.4) |
N/A |
N/A |
N/A |
9.3 ( 4.5 - 16.6) |
Used amphetamines at special events in the past 12 months (among past year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
21.5 ( 10.1 - 37.2) |
Women |
N/A |
N/A |
5.1 ( 0.5 - 18.5) |
N/A |
N/A |
N/A |
13.4 ( 5.4 - 26) |
Total |
N/A |
23.9 ( 11.3 - 41.1) |
13.5 ( 1.9 - 39.2) |
N/A |
N/A |
N/A |
18.6 ( 10.8 - 28.9) |
Used amphetamines at groups, workplaces or meetings in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
3.4 ( 0.5 - 11.1) |
Women |
N/A |
N/A |
5.9 ( 0.3 - 25.4) |
N/A |
N/A |
N/A |
3.3 ( 0.5 - 10.9) |
Total |
N/A |
2.6 ( 0 - 14.9) |
2.4 ( 0.2 - 10.3) |
N/A |
N/A |
N/A |
3.4 ( 1 - 8.2) |
Used amphetamines in outdoor public places in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
4.3 ( 0.5 - 14.5) |
Women |
N/A |
N/A |
10.3 ( 1.1 - 33.6) |
N/A |
N/A |
N/A |
4.5 ( 0.8 - 13.4) |
Total |
N/A |
0.4 ( 0 - 2.5) |
12.8 ( 3.1 - 31.2) |
N/A |
N/A |
N/A |
4.3 ( 1.2 - 10.5) |
Used amphetamines at nightclubs or bars in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
32.5 ( 21.4 - 45.2) |
Women |
N/A |
N/A |
11.5 ( 2.1 - 31.9) |
N/A |
N/A |
N/A |
16.7 ( 7 - 31.3) |
Total |
N/A |
41.4 ( 24 - 60.6) |
20.8 ( 8.5 - 38.8) |
N/A |
N/A |
N/A |
27 ( 19 - 35) |
Used amphetamines at sports clubs or events in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
5.7 ( 1.1 - 16.2) |
Women |
N/A |
N/A |
14.1 ( 0.1 - 64.7) |
N/A |
N/A |
N/A |
5.4 ( 0.1 - 28.3) |
Total |
N/A |
2.1 ( 0 - 12.2) |
9.8 ( 1 - 32.9) |
N/A |
N/A |
N/A |
5.6 ( 1.5 - 14) |
Used amphetamines in theatres or cinemas in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 5.1) |
Women |
N/A |
N/A |
0 ( 0 - 11.2) |
N/A |
N/A |
N/A |
0 ( 0 - 5.6) |
Total |
N/A |
0 ( 0 - 8.4) |
0 ( 0 - 6.3) |
N/A |
N/A |
N/A |
0 ( 0 - 2.7) |
Used amphetamines in private motor vehicles in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
6.9 ( 1.8 - 17.1) |
Women |
N/A |
N/A |
1.2 ( 0 - 7) |
N/A |
N/A |
N/A |
1.7 ( 0.3 - 5.2) |
Total |
N/A |
3 ( 0.4 - 10.3) |
8.6 ( 1.1 - 27.6) |
N/A |
N/A |
N/A |
5.1 ( 1.7 - 11.6) |
Used amphetamines in school, university or polytechnic in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 5.1) |
Women |
N/A |
N/A |
0 ( 0 - 11.2) |
N/A |
N/A |
N/A |
0 ( 0 - 5.6) |
Total |
N/A |
0 ( 0 - 8.4) |
0 ( 0 - 6.3) |
N/A |
N/A |
N/A |
0 ( 0 - 2.7) |
Unadjusted prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Ever used amphetamines for recreational purposes in lifetime (among total population) |
Men |
9.8 ( 8.1 - 11.6) |
12.8 ( 9.3 - 16.2) |
5.3 ( 3.2 - 8.2) |
3.6 ( 1 - 9) |
9 ( 7.5 - 10.5) |
Women |
6.1 ( 4.9 - 7.3) |
7.3 ( 5.7 - 9) |
2.3 ( 0.7 - 5.3) |
0 ( 0 - 1.4) |
5.5 ( 4.5 - 6.4) |
Total |
7.9 ( 6.8 - 9) |
9.8 ( 8 - 11.6) |
3.7 ( 2 - 5.4) |
1.8 ( 0.5 - 4.4) |
7.2 ( 6.2 - 8.1) |
Age of first use of amphetamines for recreational purposes: 14 years or younger (among people who had ever used amphetamines) |
Men |
2.4 ( 0.3 - 8.2) |
2.1 ( 0 - 11.9) |
N/A |
N/A |
2.4 ( 0.5 - 7.2) |
Women |
2.8 ( 0.7 - 7) |
2.5 ( 0.4 - 8.2) |
N/A |
N/A |
2.6 ( 0.8 - 6.3) |
Total |
2.5 ( 0.8 - 5.9) |
2.3 ( 0.4 - 7.3) |
0 ( 0 - 11.2) |
N/A |
2.5 ( 0.9 - 5.4) |
Age of first use of amphetamines for recreational purposes: 15–17 years (among people who had ever used amphetamines) |
Men |
14.1 ( 8.4 - 21.7) |
12.7 ( 6 - 22.6) |
N/A |
N/A |
13.5 ( 8.1 - 18.9) |
Women |
22.8 ( 14.1 - 31.5) |
27.3 ( 17.6 - 38.9) |
N/A |
N/A |
22.6 ( 15 - 30.2) |
Total |
17.6 ( 12.9 - 22.3) |
18.6 ( 12.3 - 25) |
0 ( 0 - 11.2) |
N/A |
17.1 ( 13.1 - 21.1) |
Age of first use of amphetamines for recreational purposes: 18–20 years (among people who had ever used amphetamines) |
Men |
40.9 ( 31.3 - 50.5) |
43.3 ( 30.1 - 57.2) |
N/A |
N/A |
42.1 ( 33.4 - 50.9) |
Women |
38 ( 27.7 - 48.2) |
20.4 ( 12.8 - 30) |
N/A |
N/A |
36.2 ( 27 - 45.4) |
Total |
39.7 ( 32.2 - 47.2) |
34 ( 25 - 43.1) |
60.5 ( 34.2 - 83) |
N/A |
39.7 ( 33 - 46.5) |
Age of first use of amphetamines for recreational purposes: 21 years or older (among people who had ever used amphetamines) |
Men |
42.6 ( 32.6 - 52.7) |
41.9 ( 30.9 - 52.9) |
N/A |
N/A |
42 ( 33.1 - 50.9) |
Women |
36.5 ( 29.5 - 43.5) |
49.7 ( 37.9 - 61.5) |
N/A |
N/A |
38.6 ( 32.2 - 45.1) |
Total |
40.2 ( 33.5 - 46.8) |
45 ( 36.4 - 53.7) |
39.5 ( 17 - 65.8) |
N/A |
40.6 ( 34.9 - 46.4) |
Median age of first using amphetamines (among people who had ever used amphetamines) |
Men |
20 |
20 |
20 |
19 |
20 |
Women |
20 |
20 |
20 |
N/A |
20 |
Total |
20 |
20 |
20 |
19 |
20 |
Used amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
3.2 ( 2.1 - 4.2) |
4.5 ( 2.5 - 7.3) |
1.5 ( 0.5 - 3.4) |
0.9 ( 0 - 5.3) |
2.9 ( 2 - 3.7) |
Women |
1.5 ( 0.9 - 2) |
2.1 ( 1.4 - 3.1) |
0.1 ( 0 - 0.3) |
0 ( 0 - 1.4) |
1.4 ( 0.9 - 1.8) |
Total |
2.3 ( 1.7 - 2.9) |
3.2 ( 2.1 - 4.3) |
0.8 ( 0.3 - 1.6) |
0.5 ( 0 - 2.6) |
2.1 ( 1.6 - 2.5) |
Used speed for recreational purposes in the past 12 months (among total population) |
Men |
1.8 ( 1.1 - 2.5) |
2.6 ( 1.2 - 5) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
1.6 ( 1 - 2.1) |
Women |
0.7 ( 0.3 - 1.2) |
1.1 ( 0.6 - 1.9) |
0.1 ( 0 - 0.3) |
0 ( 0 - 1.4) |
0.6 ( 0.3 - 0.9) |
Total |
1.2 ( 0.8 - 1.6) |
1.8 ( 1.1 - 2.9) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
1.1 ( 0.8 - 1.4) |
Used P for recreational purposes in the past 12 months (among total population) |
Men |
1.2 ( 0.7 - 1.9) |
3 ( 1.5 - 5.3) |
1 ( 0.3 - 2.6) |
0 ( 0 - 2.1) |
1.2 ( 0.7 - 1.7) |
Women |
1 ( 0.5 - 1.4) |
1.5 ( 0.9 - 2.4) |
0.1 ( 0 - 0.3) |
0 ( 0 - 1.4) |
0.9 ( 0.5 - 1.3) |
Total |
1.1 ( 0.7 - 1.4) |
2.2 ( 1.3 - 3.1) |
0.5 ( 0.1 - 1.3) |
0 ( 0 - 0.8) |
1 ( 0.7 - 1.3) |
Used ice for recreational purposes in the past 12 months (among total population) |
Men |
1.1 ( 0.7 - 1.8) |
1.7 ( 0.8 - 3.4) |
0.6 ( 0.2 - 1.5) |
0 ( 0 - 2.1) |
1 ( 0.6 - 1.5) |
Women |
0.2 ( 0.1 - 0.5) |
1.1 ( 0.5 - 1.9) |
0.1 ( 0 - 0.3) |
0 ( 0 - 1.4) |
0.3 ( 0.2 - 0.5) |
Total |
0.7 ( 0.4 - 0.9) |
1.4 ( 0.8 - 2.1) |
0.3 ( 0.1 - 0.7) |
0 ( 0 - 0.8) |
0.6 ( 0.4 - 0.9) |
Used other types of amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
0.5 ( 0.2 - 1.1) |
0.6 ( 0.1 - 2) |
0 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0.4 ( 0.2 - 0.9) |
Women |
0.3 ( 0.1 - 0.6) |
0.6 ( 0.2 - 1.3) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.2 ( 0.1 - 0.5) |
Total |
0.4 ( 0.2 - 0.7) |
0.6 ( 0.2 - 1.2) |
0 ( 0 - 0.5) |
0 ( 0 - 0.8) |
0.3 ( 0.2 - 0.6) |
Used speed for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
63.4 ( 46.8 - 80) |
N/A |
N/A |
N/A |
61.4 ( 46.2 - 76.6) |
Women |
50.7 ( 27.6 - 73.5) |
N/A |
N/A |
N/A |
52 ( 34.2 - 69.8) |
Total |
59.1 ( 46.2 - 72) |
57.5 ( 40.2 - 73.5) |
N/A |
N/A |
58.2 ( 46.9 - 69.5) |
Used P for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
42.7 ( 25.9 - 60.8) |
N/A |
N/A |
N/A |
46.8 ( 31.9 - 61.6) |
Women |
67.7 ( 44.7 - 85.7) |
N/A |
N/A |
N/A |
67.9 ( 51.4 - 84.5) |
Total |
51 ( 38.2 - 63.9) |
69.9 ( 50.6 - 89.2) |
N/A |
N/A |
54.1 ( 42.7 - 65.5) |
Used ice for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
39.8 ( 23.8 - 57.5) |
N/A |
N/A |
N/A |
40.4 ( 26.2 - 54.7) |
Women |
18.7 ( 6.3 - 38.6) |
N/A |
N/A |
N/A |
23.7 ( 11.4 - 40.3) |
Total |
32.7 ( 20.4 - 45) |
43.8 ( 27.7 - 60.9) |
N/A |
N/A |
34.7 ( 23.7 - 45.6) |
Used other types of amphetamines for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
17.6 ( 6.5 - 35) |
N/A |
N/A |
N/A |
16.8 ( 6.9 - 31.9) |
Women |
20 ( 5.5 - 44.3) |
N/A |
N/A |
N/A |
20.2 ( 6.8 - 41.3) |
Total |
18.4 ( 9.1 - 31.5) |
17.9 ( 6.2 - 36.7) |
N/A |
N/A |
18 ( 9.5 - 29.4) |
Used amphetamines at home in the past 12 months (among past-year amphetamines users) |
Men |
50 ( 32.8 - 67.1) |
N/A |
N/A |
N/A |
50.6 ( 35.9 - 65.4) |
Women |
47.8 ( 24.5 - 71.9) |
N/A |
N/A |
N/A |
48.8 ( 29.3 - 68.2) |
Total |
49.2 ( 36.7 - 61.8) |
48.8 ( 30.3 - 67.2) |
N/A |
N/A |
50 ( 38.8 - 61.2) |
Used amphetamines at someone elses home in the past 12 months (among past-year amphetamines users) |
Men |
46.7 ( 29.2 - 64.9) |
N/A |
N/A |
N/A |
51.8 ( 36.4 - 67.3) |
Women |
67.3 ( 46.9 - 83.8) |
N/A |
N/A |
N/A |
67.4 ( 52.8 - 82.1) |
Total |
53.8 ( 40.2 - 67.3) |
66 ( 47.8 - 84.3) |
N/A |
N/A |
57.3 ( 45.2 - 69.3) |
Used amphetamines at pubs, hotels, restaurants or cafes in the past 12 months (among past-year amphetamines users) |
Men |
9.5 ( 2.9 - 21.8) |
N/A |
N/A |
N/A |
10.4 ( 4 - 21.1) |
Women |
6.3 ( 0.9 - 20) |
N/A |
N/A |
N/A |
7.1 ( 1.5 - 19.1) |
Total |
8.4 ( 3.4 - 16.6) |
8.2 ( 1.3 - 24.3) |
N/A |
N/A |
9.3 ( 4.5 - 16.6) |
Used amphetamines at special events in the past 12 months (among past year amphetamines users) |
Men |
24.4 ( 11.5 - 41.9) |
N/A |
N/A |
N/A |
21.5 ( 10.1 - 37.2) |
Women |
13.4 ( 4.5 - 28.4) |
N/A |
N/A |
N/A |
13.4 ( 5.4 - 26) |
Total |
20.6 ( 11.7 - 32.3) |
4.9 ( 1.1 - 13.2) |
N/A |
N/A |
18.6 ( 10.8 - 28.9) |
Used amphetamines at groups, workplaces or meetings in the past 12 months (among past-year amphetamines users) |
Men |
1.9 ( 0 - 11) |
N/A |
N/A |
N/A |
3.4 ( 0.5 - 11.1) |
Women |
1.9 ( 0.1 - 7.6) |
N/A |
N/A |
N/A |
3.3 ( 0.5 - 10.9) |
Total |
1.9 ( 0.2 - 7) |
8.4 ( 1.4 - 24.7) |
N/A |
N/A |
3.4 ( 1 - 8.2) |
Used amphetamines in outdoor public places in the past 12 months (among past-year amphetamines users) |
Men |
4.8 ( 0.6 - 16.4) |
N/A |
N/A |
N/A |
4.3 ( 0.5 - 14.5) |
Women |
5.2 ( 0.9 - 15.8) |
N/A |
N/A |
N/A |
4.5 ( 0.8 - 13.4) |
Total |
5 ( 1.4 - 12) |
3.5 ( 0.8 - 9.1) |
N/A |
N/A |
4.3 ( 1.2 - 10.5) |
Used amphetamines at nightclubs or bars in the past 12 months (among past-year amphetamines users) |
Men |
32.8 ( 20.4 - 47.4) |
N/A |
N/A |
N/A |
32.5 ( 21.4 - 45.2) |
Women |
16.1 ( 5.7 - 32.7) |
N/A |
N/A |
N/A |
16.7 ( 7 - 31.3) |
Total |
27.1 ( 18.5 - 37.2) |
31.6 ( 15.5 - 51.7) |
N/A |
N/A |
27 ( 19 - 35) |
Used amphetamines at sports clubs or events in the past 12 months (among past-year amphetamines users) |
Men |
6.4 ( 1.2 - 18.5) |
N/A |
N/A |
N/A |
5.7 ( 1.1 - 16.2) |
Women |
6.3 ( 0.1 - 33.3) |
N/A |
N/A |
N/A |
5.4 ( 0.1 - 28.3) |
Total |
6.4 ( 1.6 - 16.1) |
0 ( 0 - 6.5) |
N/A |
N/A |
5.6 ( 1.5 - 14) |
Used amphetamines in theatres or cinemas in the past 12 months (among past-year amphetamines users) |
Men |
0 ( 0 - 7.1) |
N/A |
N/A |
N/A |
0 ( 0 - 5.1) |
Women |
0 ( 0 - 8) |
N/A |
N/A |
N/A |
0 ( 0 - 5.6) |
Total |
0 ( 0 - 3.8) |
0 ( 0 - 6.5) |
N/A |
N/A |
0 ( 0 - 2.7) |
Used amphetamines in private motor vehicles in the past 12 months (among past-year amphetamines users) |
Men |
5.8 ( 1 - 17.6) |
N/A |
N/A |
N/A |
6.9 ( 1.8 - 17.1) |
Women |
1.5 ( 0.1 - 5.7) |
N/A |
N/A |
N/A |
1.7 ( 0.3 - 5.2) |
Total |
4.3 ( 1 - 11.8) |
8 ( 1.4 - 22.9) |
N/A |
N/A |
5.1 ( 1.7 - 11.6) |
Used amphetamines in school, university or polytechnic in the past 12 months (among past-year amphetamines users) |
Men |
0 ( 0 - 7.1) |
N/A |
N/A |
N/A |
0 ( 0 - 5.1) |
Women |
0 ( 0 - 8) |
N/A |
N/A |
N/A |
0 ( 0 - 5.6) |
Total |
0 ( 0 - 3.8) |
0 ( 0 - 6.5) |
N/A |
N/A |
0 ( 0 - 2.7) |
Age-standardised prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Ever used amphetamines for recreational purposes in lifetime (among total population) |
Men |
11.4 ( 9.3 - 13.5) |
13.4 ( 9.8 - 17) |
5.3 ( 3.1 - 8.3) |
3.2 ( 0.9 - 7.9) |
10 ( 8.3 - 11.7) |
Women |
7.5 ( 6 - 9) |
7.5 ( 5.8 - 9.2) |
2.2 ( 0.7 - 5.2) |
0 ( 0 - 1.4) |
6.3 ( 5.2 - 7.4) |
Total |
9.4 ( 8 - 10.7) |
10.2 ( 8.4 - 12) |
3.7 ( 2 - 5.4) |
1.6 ( 0.5 - 3.9) |
8.1 ( 7 - 9.1) |
Age of first use of amphetamines for recreational purposes: 14 years or younger (among people who had ever used amphetamines) |
Men |
2.4 ( 0.4 - 7.4) |
2 ( 0 - 11) |
N/A |
N/A |
2.4 ( 0.5 - 6.7) |
Women |
3.2 ( 0.8 - 8.7) |
2.5 ( 0.4 - 8.1) |
N/A |
N/A |
3 ( 0.8 - 7.5) |
Total |
2.7 ( 1 - 6) |
2.2 ( 0.4 - 6.9) |
0 ( 0 - 11.2) |
N/A |
2.6 ( 1 - 5.5) |
Age of first use of amphetamines for recreational purposes: 15–17 years (among people who had ever used amphetamines) |
Men |
16 ( 9.4 - 24.7) |
12.3 ( 6 - 21.6) |
N/A |
N/A |
14.6 ( 8.6 - 20.6) |
Women |
24.4 ( 14.7 - 34.1) |
27.5 ( 17.7 - 39.2) |
N/A |
N/A |
23.9 ( 15.5 - 32.2) |
Total |
19.5 ( 14.1 - 24.8) |
18.4 ( 12.3 - 24.5) |
0 ( 0 - 11.2) |
N/A |
18.4 ( 13.9 - 22.8) |
Age of first use of amphetamines for recreational purposes: 18–20 years (among people who had ever used amphetamines) |
Men |
41.8 ( 32.3 - 51.4) |
43.8 ( 30.5 - 57.8) |
N/A |
N/A |
42.9 ( 34.4 - 51.4) |
Women |
38.6 ( 27.5 - 49.7) |
20.5 ( 12.8 - 30.3) |
N/A |
N/A |
36.9 ( 27.1 - 46.6) |
Total |
40.5 ( 32.8 - 48.2) |
34.4 ( 25.3 - 43.6) |
60.7 ( 34.5 - 83) |
N/A |
40.4 ( 33.7 - 47.2) |
Age of first use of amphetamines for recreational purposes: 21 years or older (among people who had ever used amphetamines) |
Men |
39.8 ( 29.8 - 49.8) |
41.9 ( 30.7 - 53.2) |
N/A |
N/A |
40.1 ( 31.3 - 48.9) |
Women |
33.7 ( 26.6 - 40.8) |
49.4 ( 37.5 - 61.4) |
N/A |
N/A |
36.2 ( 29.7 - 42.8) |
Total |
37.3 ( 30.7 - 43.8) |
44.9 ( 36.1 - 53.7) |
39.3 ( 17 - 65.5) |
N/A |
38.6 ( 32.9 - 44.2) |
Median age of first using amphetamines (among people who had ever used amphetamines) |
Men |
20 |
20 |
20 |
19 |
20 |
Women |
19 |
20 |
20 |
N/A |
20 |
Total |
20 |
20 |
20 |
19 |
20 |
Used amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
4.2 ( 2.8 - 5.7) |
4.6 ( 2.6 - 7.5) |
1.5 ( 0.5 - 3.5) |
0.8 ( 0 - 4.4) |
3.5 ( 2.4 - 4.6) |
Women |
2 ( 1.2 - 2.9) |
2.2 ( 1.4 - 3.2) |
0.1 ( 0 - 0.3) |
0 ( 0 - 1.4) |
1.7 ( 1.1 - 2.4) |
Total |
3.1 ( 2.3 - 3.9) |
3.3 ( 2.2 - 4.4) |
0.8 ( 0.3 - 1.7) |
0.4 ( 0 - 2.2) |
2.6 ( 2 - 3.2) |
Used speed for recreational purposes in the past 12 months (among total population) |
Men |
2.5 ( 1.5 - 3.5) |
2.7 ( 1.2 - 5) |
0.1 ( 0 - 0.8) |
0 ( 0 - 2.1) |
2 ( 1.2 - 2.7) |
Women |
0.9 ( 0.5 - 1.7) |
1.1 ( 0.6 - 1.9) |
0.1 ( 0 - 0.3) |
0 ( 0 - 1.4) |
0.8 ( 0.4 - 1.2) |
Total |
1.7 ( 1.1 - 2.3) |
1.8 ( 1.1 - 2.9) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
1.4 ( 0.9 - 1.8) |
Used P for recreational purposes in the past 12 months (among total population) |
Men |
1.6 ( 0.9 - 2.5) |
3.1 ( 1.6 - 5.5) |
1 ( 0.2 - 2.7) |
0 ( 0 - 2.1) |
1.4 ( 0.9 - 2) |
Women |
1.3 ( 0.6 - 2) |
1.5 ( 0.9 - 2.4) |
0.1 ( 0 - 0.3) |
0 ( 0 - 1.4) |
1.1 ( 0.6 - 1.7) |
Total |
1.4 ( 0.9 - 1.9) |
2.3 ( 1.4 - 3.2) |
0.5 ( 0.1 - 1.3) |
0 ( 0 - 0.8) |
1.3 ( 0.9 - 1.6) |
Used ice for recreational purposes in the past 12 months (among total population) |
Men |
1.5 ( 0.9 - 2.4) |
1.8 ( 0.8 - 3.5) |
0.6 ( 0.1 - 1.5) |
0 ( 0 - 2.1) |
1.3 ( 0.7 - 1.8) |
Women |
0.3 ( 0.1 - 0.6) |
1.1 ( 0.6 - 1.9) |
0.1 ( 0 - 0.3) |
0 ( 0 - 1.4) |
0.3 ( 0.2 - 0.6) |
Total |
0.9 ( 0.5 - 1.2) |
1.4 ( 0.9 - 2.2) |
0.3 ( 0.1 - 0.8) |
0 ( 0 - 0.8) |
0.8 ( 0.5 - 1.1) |
Used other types of amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
0.6 ( 0.2 - 1.3) |
0.5 ( 0.1 - 1.9) |
0 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0.5 ( 0.2 - 1) |
Women |
0.4 ( 0.1 - 0.9) |
0.6 ( 0.2 - 1.3) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.3 ( 0.1 - 0.7) |
Total |
0.5 ( 0.2 - 0.9) |
0.6 ( 0.2 - 1.2) |
0 ( 0 - 0.5) |
0 ( 0 - 0.8) |
0.4 ( 0.2 - 0.7) |
Used speed for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
66.3 ( 49.9 - 82.7) |
N/A |
N/A |
N/A |
62.9 ( 47.7 - 78) |
Women |
51.2 ( 26.6 - 75.4) |
N/A |
N/A |
N/A |
52.4 ( 33.6 - 71.3) |
Total |
61.1 ( 48 - 74.1) |
57.1 ( 40.2 - 73) |
N/A |
N/A |
59.2 ( 47.7 - 70.6) |
Used P for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
41.8 ( 24.8 - 60.4) |
N/A |
N/A |
N/A |
46.4 ( 31.4 - 61.5) |
Women |
66.3 ( 41.7 - 85.7) |
N/A |
N/A |
N/A |
67.1 ( 49.4 - 84.9) |
Total |
50.3 ( 36.9 - 63.7) |
70.4 ( 51.7 - 89.2) |
N/A |
N/A |
53.7 ( 42 - 65.5) |
Used ice for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
40 ( 23.4 - 58.4) |
N/A |
N/A |
N/A |
40.5 ( 26 - 55.1) |
Women |
15.7 ( 4.6 - 34.8) |
N/A |
N/A |
N/A |
21.1 ( 9.6 - 37.5) |
Total |
31.5 ( 19.1 - 43.9) |
44 ( 28.1 - 60.7) |
N/A |
N/A |
33.7 ( 22.6 - 44.7) |
Used other types of amphetamines for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
16.6 ( 6.1 - 33.2) |
N/A |
N/A |
N/A |
15.9 ( 6.5 - 30.3) |
Women |
20.2 ( 5.2 - 45.6) |
N/A |
N/A |
N/A |
20.1 ( 6.5 - 41.8) |
Total |
17.8 ( 8.7 - 30.7) |
17.5 ( 6.3 - 35.4) |
N/A |
N/A |
17.3 ( 9.2 - 28.6) |
Used amphetamines at home in the past 12 months (among past-year amphetamines users) |
Men |
47.2 ( 30 - 64.8) |
N/A |
N/A |
N/A |
48.4 ( 33.4 - 63.4) |
Women |
44.4 ( 20.8 - 70) |
N/A |
N/A |
N/A |
46 ( 25.8 - 66.2) |
Total |
46.2 ( 33.2 - 59.2) |
49.1 ( 30.7 - 67.5) |
N/A |
N/A |
47.6 ( 36 - 59.2) |
Used amphetamines at someone elses home in the past 12 months (among past-year amphetamines users) |
Men |
48.7 ( 30.6 - 67.1) |
N/A |
N/A |
N/A |
53.2 ( 37.6 - 68.8) |
Women |
67.2 ( 45.8 - 84.4) |
N/A |
N/A |
N/A |
67.3 ( 52.1 - 82.6) |
Total |
55.2 ( 41.5 - 68.8) |
65.9 ( 47.9 - 83.9) |
N/A |
N/A |
58.2 ( 46.1 - 70.3) |
Used amphetamines at pubs, hotels, restaurants or cafes in the past 12 months (among past-year amphetamines users) |
Men |
10.4 ( 3.2 - 23.8) |
N/A |
N/A |
N/A |
10.8 ( 4 - 22.1) |
Women |
6.2 ( 0.8 - 20.8) |
N/A |
N/A |
N/A |
7.1 ( 1.4 - 19.5) |
Total |
9 ( 3.6 - 17.8) |
7.9 ( 1.4 - 22.9) |
N/A |
N/A |
9.5 ( 4.5 - 17.1) |
Used amphetamines at special events in the past 12 months (among past year amphetamines users) |
Men |
25 ( 11.9 - 42.6) |
N/A |
N/A |
N/A |
22 ( 10.4 - 37.9) |
Women |
13.1 ( 4.3 - 28) |
N/A |
N/A |
N/A |
13.3 ( 5.3 - 26.1) |
Total |
20.8 ( 11.9 - 32.4) |
4.8 ( 1.1 - 13) |
N/A |
N/A |
18.9 ( 11 - 29.2) |
Used amphetamines at groups, workplaces or meetings in the past 12 months (among past-year amphetamines users) |
Men |
2.2 ( 0 - 12.3) |
N/A |
N/A |
N/A |
3.2 ( 0.4 - 11.1) |
Women |
1.4 ( 0.1 - 5.6) |
N/A |
N/A |
N/A |
3 ( 0.4 - 10.1) |
Total |
1.9 ( 0.2 - 7.6) |
8 ( 1.4 - 23.4) |
N/A |
N/A |
3.1 ( 0.8 - 7.9) |
Used amphetamines in outdoor public places in the past 12 months (among past-year amphetamines users) |
Men |
5.1 ( 0.6 - 17.3) |
N/A |
N/A |
N/A |
4.5 ( 0.6 - 15.2) |
Women |
5.2 ( 0.9 - 15.8) |
N/A |
N/A |
N/A |
4.4 ( 0.8 - 13.2) |
Total |
5.2 ( 1.5 - 12.4) |
3.4 ( 0.8 - 9) |
N/A |
N/A |
4.5 ( 1.3 - 10.8) |
Used amphetamines at nightclubs or bars in the past 12 months (among past-year amphetamines users) |
Men |
35.7 ( 22.4 - 50.9) |
N/A |
N/A |
N/A |
34.2 ( 22.5 - 47.4) |
Women |
17.5 ( 5.9 - 36.3) |
N/A |
N/A |
N/A |
17.9 ( 7.2 - 34.1) |
Total |
29.3 ( 19.9 - 40.1) |
31.3 ( 15.6 - 50.8) |
N/A |
N/A |
28.4 ( 19.9 - 36.9) |
Used amphetamines at sports clubs or events in the past 12 months (among past-year amphetamines users) |
Men |
6 ( 1.1 - 17.5) |
N/A |
N/A |
N/A |
5.4 ( 1.1 - 15.5) |
Women |
6.2 ( 0.1 - 32.8) |
N/A |
N/A |
N/A |
5.2 ( 0.1 - 27.7) |
Total |
6.1 ( 1.5 - 15.6) |
0 ( 0 - 6.5) |
N/A |
N/A |
5.3 ( 1.4 - 13.5) |
Used amphetamines in theatres or cinemas in the past 12 months (among past-year amphetamines users) |
Men |
0 ( 0 - 7.1) |
N/A |
N/A |
N/A |
0 ( 0 - 5.1) |
Women |
0 ( 0 - 8) |
N/A |
N/A |
N/A |
0 ( 0 - 5.6) |
Total |
0 ( 0 - 3.8) |
0 ( 0 - 6.5) |
N/A |
N/A |
0 ( 0 - 2.7) |
Used amphetamines in private motor vehicles in the past 12 months (among past-year amphetamines users) |
Men |
6.2 ( 1 - 18.7) |
N/A |
N/A |
N/A |
7 ( 1.8 - 17.5) |
Women |
1.2 ( 0.1 - 4.7) |
N/A |
N/A |
N/A |
1.5 ( 0.3 - 4.7) |
Total |
4.5 ( 1 - 12.3) |
7.7 ( 1.4 - 22) |
N/A |
N/A |
5.1 ( 1.6 - 11.7) |
Used amphetamines in school, university or polytechnic in the past 12 months (among past-year amphetamines users) |
Men |
0 ( 0 - 7.1) |
N/A |
N/A |
N/A |
0 ( 0 - 5.1) |
Women |
0 ( 0 - 8) |
N/A |
N/A |
N/A |
0 ( 0 - 5.6) |
Total |
0 ( 0 - 3.8) |
0 ( 0 - 6.5) |
N/A |
N/A |
0 ( 0 - 2.7) |
Standardised rate ratios by gender for each ethnic group compared to males and females in the total population |
|
European/Other |
Māori |
Pacific |
Asian |
Ever used amphetamines for recreational purposes in lifetime (among total population) |
Men |
1.14 ( 1.07 - 1.21) |
1.34 ( 1 - 1.68) |
0.53 ( 0.28 - 0.78) |
0.32 ( 0.02 - 0.62) |
Women |
1.19 ( 1.13 - 1.24) |
1.19 ( 0.87 - 1.51) |
0.35 ( 0.04 - 0.67) |
0 ( 0 - 0) |
Total |
1.16 ( 1.11 - 1.2) |
1.26 ( 1.03 - 1.5) |
0.46 ( 0.24 - 0.67) |
0.2 ( 0.01 - 0.38) |
Age of first use of amphetamines for recreational purposes: 14 years or younger (among people who had ever used amphetamines) |
Men |
1 ( 0.61 - 1.39) |
0.83 ( 0 - 3.19) |
N/A |
N/A |
Women |
1.07 ( 0.89 - 1.25) |
0.84 ( 0 - 2.44) |
N/A |
N/A |
Total |
1.04 ( 0.84 - 1.24) |
0.83 ( 0 - 2.07) |
0 ( 0 - 0) |
N/A |
Age of first use of amphetamines for recreational purposes: 15–17 years (among people who had ever used amphetamines) |
Men |
1.09 ( 0.98 - 1.2) |
0.84 ( 0.27 - 1.41) |
N/A |
N/A |
Women |
1.02 ( 0.93 - 1.12) |
1.15 ( 0.65 - 1.65) |
N/A |
N/A |
Total |
1.06 ( 0.98 - 1.14) |
1 ( 0.64 - 1.36) |
0 ( 0 - 0) |
N/A |
Age of first use of amphetamines for recreational purposes: 18–20 years (among people who had ever used amphetamines) |
Men |
0.98 ( 0.91 - 1.04) |
1.02 ( 0.69 - 1.35) |
N/A |
N/A |
Women |
1.05 ( 1 - 1.1) |
0.56 ( 0.31 - 0.81) |
N/A |
N/A |
Total |
1 ( 0.95 - 1.05) |
0.85 ( 0.61 - 1.09) |
1.5 ( 0.93 - 2.07) |
N/A |
Age of first use of amphetamines for recreational purposes: 21 years or older (among people who had ever used amphetamines) |
Men |
0.99 ( 0.93 - 1.06) |
1.05 ( 0.7 - 1.39) |
N/A |
N/A |
Women |
0.93 ( 0.87 - 0.99) |
1.36 ( 1.01 - 1.71) |
N/A |
N/A |
Total |
0.97 ( 0.92 - 1.02) |
1.17 ( 0.9 - 1.43) |
1.02 ( 0.43 - 1.61) |
N/A |
Median age of first using amphetamines (among people who had ever used amphetamines) |
Men |
1 |
1 |
N/A |
N/A |
Women |
0.95 |
1 |
N/A |
N/A |
Total |
1 |
1 |
1 |
N/A |
Used amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
1.21 ( 1.11 - 1.3) |
1.32 ( 0.64 - 2.01) |
0.44 ( 0.05 - 0.82) |
0.22 ( 0 - 0.67) |
Women |
1.18 ( 1.07 - 1.28) |
1.25 ( 0.68 - 1.83) |
0.03 ( 0 - 0.1) |
0 ( 0 - 0) |
Total |
1.2 ( 1.12 - 1.27) |
1.28 ( 0.82 - 1.74) |
0.3 ( 0.04 - 0.55) |
0.15 ( 0 - 0.45) |
Used speed for recreational purposes in the past 12 months (among total population) |
Men |
1.27 ( 1.17 - 1.36) |
1.36 ( 0.48 - 2.24) |
0.07 ( 0 - 0.23) |
0 ( 0 - 0) |
Women |
1.14 ( 0.94 - 1.33) |
1.36 ( 0.36 - 2.35) |
0.07 ( 0 - 0.22) |
0 ( 0 - 0) |
Total |
1.23 ( 1.14 - 1.31) |
1.34 ( 0.67 - 2) |
0.07 ( 0 - 0.19) |
0 ( 0 - 0) |
Used P for recreational purposes in the past 12 months (among total population) |
Men |
1.08 ( 0.89 - 1.27) |
2.17 ( 0.96 - 3.38) |
0.7 ( 0 - 1.45) |
0 ( 0 - 0) |
Women |
1.15 ( 1.02 - 1.29) |
1.4 ( 0.58 - 2.21) |
0.05 ( 0 - 0.16) |
0 ( 0 - 0) |
Total |
1.11 ( 0.99 - 1.24) |
1.79 ( 1.04 - 2.55) |
0.41 ( 0 - 0.82) |
0 ( 0 - 0) |
Used ice for recreational purposes in the past 12 months (among total population) |
Men |
1.19 ( 1.04 - 1.33) |
1.43 ( 0.42 - 2.44) |
0.46 ( 0 - 0.94) |
0 ( 0 - 0) |
Women |
0.86 ( 0.45 - 1.28) |
3.23 ( 0.92 - 5.54) |
0.18 ( 0 - 0.55) |
0 ( 0 - 0) |
Total |
1.11 ( 0.97 - 1.25) |
1.81 ( 0.89 - 2.73) |
0.39 ( 0.01 - 0.78) |
0 ( 0 - 0) |
Used other types of amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
1.26 ( 1.06 - 1.46) |
1.1 ( 0 - 2.75) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Women |
1.17 ( 0.88 - 1.46) |
1.83 ( 0 - 3.85) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1.22 ( 1.07 - 1.37) |
1.4 ( 0.24 - 2.55) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Used speed for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
1.05 ( 0.99 - 1.12) |
N/A |
N/A |
N/A |
Women |
0.98 ( 0.86 - 1.09) |
N/A |
N/A |
N/A |
Total |
1.03 ( 0.98 - 1.08) |
0.97 ( 0.68 - 1.25) |
N/A |
N/A |
Used P for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
0.9 ( 0.79 - 1.01) |
N/A |
N/A |
N/A |
Women |
0.99 ( 0.92 - 1.06) |
N/A |
N/A |
N/A |
Total |
0.94 ( 0.87 - 1) |
1.31 ( 0.92 - 1.7) |
N/A |
N/A |
Used ice for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
0.99 ( 0.89 - 1.08) |
N/A |
N/A |
N/A |
Women |
0.74 ( 0.41 - 1.07) |
N/A |
N/A |
N/A |
Total |
0.94 ( 0.84 - 1.03) |
1.31 ( 0.77 - 1.84) |
N/A |
N/A |
Used other types of amphetamines for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
1.05 ( 0.88 - 1.21) |
N/A |
N/A |
N/A |
Women |
1 ( 0.78 - 1.23) |
N/A |
N/A |
N/A |
Total |
1.03 ( 0.9 - 1.15) |
1.01 ( 0.2 - 1.82) |
N/A |
N/A |
Used amphetamines at home in the past 12 months (among past-year amphetamines users) |
Men |
0.97 ( 0.9 - 1.05) |
N/A |
N/A |
N/A |
Women |
0.97 ( 0.85 - 1.08) |
N/A |
N/A |
N/A |
Total |
0.97 ( 0.91 - 1.03) |
1.03 ( 0.66 - 1.41) |
N/A |
N/A |
Used amphetamines at someone elses home in the past 12 months (among past-year amphetamines users) |
Men |
0.92 ( 0.83 - 1.01) |
N/A |
N/A |
N/A |
Women |
1 ( 0.93 - 1.06) |
N/A |
N/A |
N/A |
Total |
0.95 ( 0.89 - 1.01) |
1.13 ( 0.8 - 1.47) |
N/A |
N/A |
Used amphetamines at pubs, hotels, restaurants or cafes in the past 12 months (among past-year amphetamines users) |
Men |
0.97 ( 0.72 - 1.22) |
N/A |
N/A |
N/A |
Women |
0.88 ( 0.23 - 1.54) |
N/A |
N/A |
N/A |
Total |
0.95 ( 0.73 - 1.17) |
0.83 ( 0 - 1.85) |
N/A |
N/A |
Used amphetamines at special events in the past 12 months (among past year amphetamines users) |
Men |
1.14 ( 1.05 - 1.22) |
N/A |
N/A |
N/A |
Women |
0.98 ( 0.75 - 1.22) |
N/A |
N/A |
N/A |
Total |
1.1 ( 1.03 - 1.18) |
0.25 ( 0 - 0.54) |
N/A |
N/A |
Used amphetamines at groups, workplaces or meetings in the past 12 months (among past-year amphetamines users) |
Men |
0.68 ( 0 - 2.13) |
N/A |
N/A |
N/A |
Women |
0.48 ( 0 - 1.77) |
N/A |
N/A |
N/A |
Total |
0.61 ( 0 - 1.41) |
2.58 ( 0 - 6.32) |
N/A |
N/A |
Used amphetamines in outdoor public places in the past 12 months (among past-year amphetamines users) |
Men |
1.15 ( 1.04 - 1.26) |
N/A |
N/A |
N/A |
Women |
1.18 ( 1.06 - 1.29) |
N/A |
N/A |
N/A |
Total |
1.16 ( 1.07 - 1.24) |
0.77 ( 0 - 1.98) |
N/A |
N/A |
Used amphetamines at nightclubs or bars in the past 12 months (among past-year amphetamines users) |
Men |
1.05 ( 0.95 - 1.14) |
N/A |
N/A |
N/A |
Women |
0.98 ( 0.73 - 1.23) |
N/A |
N/A |
N/A |
Total |
1.03 ( 0.94 - 1.12) |
1.1 ( 0.54 - 1.67) |
N/A |
N/A |
Used amphetamines at sports clubs or events in the past 12 months (among past-year amphetamines users) |
Men |
1.12 ( 0.99 - 1.24) |
N/A |
N/A |
N/A |
Women |
1.18 ( 1.06 - 1.3) |
N/A |
N/A |
N/A |
Total |
1.14 ( 1.04 - 1.24) |
0 ( 0 - 0) |
N/A |
N/A |
Used amphetamines in theatres or cinemas in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Used amphetamines in private motor vehicles in the past 12 months (among past-year amphetamines users) |
Men |
0.88 ( 0.43 - 1.33) |
N/A |
N/A |
N/A |
Women |
0.8 ( 0 - 1.59) |
N/A |
N/A |
N/A |
Total |
0.88 ( 0.47 - 1.29) |
1.51 ( 0 - 3.61) |
N/A |
N/A |
Used amphetamines in school, university or polytechnic in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Age-standardised rates by gender and NZDep2006 quintile |
|
1
(Least deprived) |
2 |
3 |
4 |
5
(Most deprived) |
Total |
Ever used amphetamines for recreational purposes in lifetime (among total population) |
Men |
5.8 ( 3.3 - 9.5) |
11.9 ( 7.2 - 16.7) |
13 ( 9.3 - 16.7) |
9.5 ( 5.8 - 13.1) |
9 ( 6 - 12) |
10 ( 8.3 - 11.7) |
Women |
6.6 ( 3.7 - 10.8) |
3.7 ( 2.3 - 5.2) |
8.1 ( 5.5 - 10.6) |
7.4 ( 4.9 - 9.9) |
5.7 ( 3.7 - 7.6) |
6.3 ( 5.2 - 7.4) |
Total |
6.3 ( 3.9 - 8.6) |
7.7 ( 5.3 - 10.1) |
10.4 ( 8.4 - 12.5) |
8.4 ( 6.2 - 10.7) |
7.2 ( 5.3 - 9.1) |
8.1 ( 7 - 9.1) |
Age of first use of amphetamines for recreational purposes: 14 years or younger (among people who had ever used amphetamines) |
Men |
N/A |
2.1 ( 0 - 12.4) |
5.3 ( 0.3 - 21.5) |
1.8 ( 0 - 10.3) |
0 ( 0 - 6) |
2.4 ( 0.5 - 6.7) |
Women |
N/A |
2.6 ( 0.2 - 10.1) |
4.3 ( 0.5 - 15.3) |
1.4 ( 0.1 - 5.6) |
0 ( 0 - 5.5) |
3 ( 0.8 - 7.5) |
Total |
3.2 ( 0.1 - 18.3) |
2.2 ( 0.2 - 8.6) |
4.9 ( 1 - 13.7) |
1.6 ( 0.2 - 5.6) |
0 ( 0 - 2.9) |
2.6 ( 1 - 5.5) |
Age of first use of amphetamines for recreational purposes: 15–17 years (among people who had ever used amphetamines) |
Men |
N/A |
18.7 ( 6.2 - 38.9) |
4.1 ( 1.2 - 9.7) |
27.8 ( 9.3 - 54.3) |
12.1 ( 4.3 - 25.3) |
14.6 ( 8.6 - 20.6) |
Women |
N/A |
9 ( 1.7 - 25.3) |
24.3 ( 9.8 - 45.2) |
29.5 ( 12.7 - 51.8) |
30.2 ( 13.5 - 51.9) |
23.9 ( 15.5 - 32.2) |
Total |
16.8 ( 5 - 36.9) |
16.3 ( 6.8 - 30.8) |
12.1 ( 5.7 - 21.9) |
28.6 ( 16.3 - 43.7) |
19.6 ( 10.4 - 32) |
18.4 ( 13.9 - 22.8) |
Age of first use of amphetamines for recreational purposes: 18–20 years (among people who had ever used amphetamines) |
Men |
N/A |
46.2 ( 29.2 - 63.8) |
50.8 ( 33.8 - 67.6) |
34.3 ( 18.2 - 53.6) |
37.4 ( 20.5 - 56.9) |
42.9 ( 34.4 - 51.4) |
Women |
N/A |
35.1 ( 12.3 - 64.6) |
37.3 ( 20 - 57.4) |
37 ( 20.1 - 56.6) |
31.8 ( 19.1 - 46.9) |
36.9 ( 27.1 - 46.6) |
Total |
39.8 ( 20.5 - 61.8) |
43.4 ( 29.4 - 58.2) |
45.4 ( 33.6 - 57.2) |
35.5 ( 22.6 - 48.5) |
35.1 ( 23.3 - 46.8) |
40.4 ( 33.7 - 47.2) |
Age of first use of amphetamines for recreational purposes: 21 years or older (among people who had ever used amphetamines) |
Men |
N/A |
33 ( 18.3 - 50.7) |
39.9 ( 22.7 - 59.1) |
36.1 ( 19.6 - 52.6) |
50.5 ( 34.2 - 66.9) |
40.1 ( 31.3 - 48.9) |
Women |
N/A |
53.2 ( 27.6 - 77.7) |
34 ( 21.1 - 48.9) |
32.1 ( 18.4 - 45.7) |
37.9 ( 23.1 - 54.6) |
36.2 ( 29.7 - 42.8) |
Total |
40.2 ( 26.3 - 55.3) |
38 ( 25.9 - 50.1) |
37.5 ( 26.4 - 48.6) |
34.3 ( 25.2 - 43.3) |
45.3 ( 34.5 - 56.1) |
38.6 ( 32.9 - 44.2) |
Median age of first using amphetamines (among people who had ever used amphetamines) |
Men |
21 |
19 |
20 |
19 |
21 |
20 |
Women |
20 |
21 |
20 |
18 |
19 |
20 |
Total |
20 |
20 |
20 |
19 |
20 |
20 |
Used amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
1.8 ( 0.5 - 4.4) |
3.4 ( 1.4 - 6.8) |
4.1 ( 2.2 - 6.9) |
5.1 ( 2.8 - 8.6) |
2.8 ( 1.3 - 5.1) |
3.5 ( 2.4 - 4.6) |
Women |
1.7 ( 0.3 - 4.8) |
1.1 ( 0.4 - 2.2) |
1.6 ( 0.7 - 3.2) |
3.1 ( 1.5 - 5.6) |
1.2 ( 0.7 - 1.8) |
1.7 ( 1.1 - 2.4) |
Total |
1.7 ( 0.7 - 3.5) |
2.2 ( 1.1 - 3.8) |
2.8 ( 1.8 - 4.2) |
4.1 ( 2.6 - 5.6) |
2 ( 1 - 2.9) |
2.6 ( 2 - 3.2) |
Used speed for recreational purposes in the past 12 months (among total population) |
Men |
1.3 ( 0.2 - 4.1) |
2 ( 0.6 - 4.7) |
2.2 ( 1 - 4.3) |
3.2 ( 1.5 - 6) |
0.8 ( 0.3 - 1.8) |
2 ( 1.2 - 2.7) |
Women |
1 ( 0.1 - 4.4) |
0.4 ( 0.1 - 1.2) |
1.1 ( 0.3 - 2.6) |
1 ( 0.3 - 2.3) |
0.5 ( 0.2 - 1) |
0.8 ( 0.4 - 1.2) |
Total |
1.2 ( 0.3 - 2.9) |
1.2 ( 0.5 - 2.5) |
1.6 ( 0.9 - 2.7) |
2.1 ( 1.1 - 3.6) |
0.6 ( 0.3 - 1.1) |
1.4 ( 0.9 - 1.8) |
Used P for recreational purposes in the past 12 months (among total population) |
Men |
0.5 ( 0.1 - 1.4) |
0.8 ( 0.1 - 2.9) |
1.6 ( 0.7 - 3.2) |
2.7 ( 1.1 - 5.6) |
1.7 ( 0.8 - 3.2) |
1.4 ( 0.9 - 2) |
Women |
1 ( 0.1 - 4.4) |
0.8 ( 0.3 - 1.9) |
1.1 ( 0.3 - 2.6) |
1.6 ( 0.4 - 4.1) |
1 ( 0.5 - 1.6) |
1.1 ( 0.6 - 1.7) |
Total |
0.8 ( 0.1 - 2.3) |
0.8 ( 0.3 - 1.8) |
1.3 ( 0.7 - 2.3) |
2.1 ( 1.1 - 3.7) |
1.3 ( 0.7 - 1.9) |
1.3 ( 0.9 - 1.6) |
Used ice for recreational purposes in the past 12 months (among total population) |
Men |
0.2 ( 0 - 1) |
1.2 ( 0.2 - 4) |
1.5 ( 0.6 - 3.1) |
2.7 ( 1.2 - 5.1) |
0.5 ( 0.2 - 1.1) |
1.3 ( 0.7 - 1.8) |
Women |
0 ( 0 - 0.7) |
0.2 ( 0 - 0.6) |
0.7 ( 0.1 - 2) |
0.3 ( 0.1 - 0.9) |
0.5 ( 0.2 - 1) |
0.3 ( 0.2 - 0.6) |
Total |
0.1 ( 0 - 0.5) |
0.7 ( 0.1 - 2) |
1 ( 0.5 - 1.9) |
1.5 ( 0.7 - 2.6) |
0.5 ( 0.3 - 0.8) |
0.8 ( 0.5 - 1.1) |
Used other types of amphetamines for recreational purposes in the past 12 months (among total population) |
Men |
0.2 ( 0 - 1.4) |
0.6 ( 0.1 - 2.5) |
0.4 ( 0 - 1.5) |
1.1 ( 0.2 - 3.3) |
0 ( 0 - 0.5) |
0.5 ( 0.2 - 1) |
Women |
0.1 ( 0 - 0.7) |
0.1 ( 0 - 0.8) |
0.2 ( 0 - 0.7) |
1 ( 0.2 - 2.7) |
0.2 ( 0 - 0.5) |
0.3 ( 0.1 - 0.7) |
Total |
0.2 ( 0 - 0.7) |
0.4 ( 0.1 - 1.2) |
0.3 ( 0.1 - 0.8) |
1 ( 0.4 - 2.2) |
0.1 ( 0 - 0.3) |
0.4 ( 0.2 - 0.7) |
Used speed for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
62.9 ( 47.7 - 78) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
52.4 ( 33.6 - 71.3) |
Total |
N/A |
N/A |
N/A |
52.4 ( 27.4 - 76.5) |
41.7 ( 22.5 - 62.9) |
59.2 ( 47.7 - 70.6) |
Used P for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
46.4 ( 31.4 - 61.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
67.1 ( 49.4 - 84.9) |
Total |
N/A |
N/A |
N/A |
52.9 ( 29.6 - 75.3) |
84.5 ( 70.1 - 98.9) |
53.7 ( 42 - 65.5) |
Used ice for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
40.5 ( 26 - 55.1) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
21.1 ( 9.6 - 37.5) |
Total |
N/A |
N/A |
N/A |
37 ( 17 - 61) |
32.2 ( 16.3 - 51.7) |
33.7 ( 22.6 - 44.7) |
Used other types of amphetamines for recreational purposes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
15.9 ( 6.5 - 30.3) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
20.1 ( 6.5 - 41.8) |
Total |
N/A |
N/A |
N/A |
25.4 ( 8.6 - 50.3) |
5.9 ( 1.1 - 17.3) |
17.3 ( 9.2 - 28.6) |
Used amphetamines at home in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
48.4 ( 33.4 - 63.4) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
46 ( 25.8 - 66.2) |
Total |
N/A |
N/A |
N/A |
41.5 ( 19.7 - 65.9) |
50.6 ( 25.6 - 75.4) |
47.6 ( 36 - 59.2) |
Used amphetamines at someone elses home in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
53.2 ( 37.6 - 68.8) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
67.3 ( 52.1 - 82.6) |
Total |
N/A |
N/A |
N/A |
52.5 ( 26.8 - 77.2) |
80 ( 64.6 - 90.8) |
58.2 ( 46.1 - 70.3) |
Used amphetamines at pubs, hotels, restaurants or cafes in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
10.8 ( 4 - 22.1) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
7.1 ( 1.4 - 19.5) |
Total |
N/A |
N/A |
N/A |
10.9 ( 2.5 - 27.7) |
4.6 ( 0.1 - 25.5) |
9.5 ( 4.5 - 17.1) |
Used amphetamines at special events in the past 12 months (among past year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
22 ( 10.4 - 37.9) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
13.3 ( 5.3 - 26.1) |
Total |
N/A |
N/A |
N/A |
14.8 ( 4.9 - 31.4) |
19.6 ( 0.7 - 68.1) |
18.9 ( 11 - 29.2) |
Used amphetamines at groups, workplaces or meetings in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
3.2 ( 0.4 - 11.1) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
3 ( 0.4 - 10.1) |
Total |
N/A |
N/A |
N/A |
3.7 ( 0.1 - 21.4) |
3.2 ( 0.3 - 12.6) |
3.1 ( 0.8 - 7.9) |
Used amphetamines in outdoor public places in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
4.5 ( 0.6 - 15.2) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
4.4 ( 0.8 - 13.2) |
Total |
N/A |
N/A |
N/A |
0 ( 0 - 9.3) |
2.5 ( 0.2 - 10.7) |
4.5 ( 1.3 - 10.8) |
Used amphetamines at nightclubs or bars in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
34.2 ( 22.5 - 47.4) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
17.9 ( 7.2 - 34.1) |
Total |
N/A |
N/A |
N/A |
20.9 ( 8.2 - 40) |
10.3 ( 1.5 - 30.7) |
28.4 ( 19.9 - 36.9) |
Used amphetamines at sports clubs or events in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
5.4 ( 1.1 - 15.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
5.2 ( 0.1 - 27.7) |
Total |
N/A |
N/A |
N/A |
12.4 ( 2 - 35.1) |
0 ( 0 - 8.8) |
5.3 ( 1.4 - 13.5) |
Used amphetamines in theatres or cinemas in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 5.1) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 5.6) |
Total |
N/A |
N/A |
N/A |
0 ( 0 - 9.3) |
0 ( 0 - 8.8) |
0 ( 0 - 2.7) |
Used amphetamines in private motor vehicles in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
7 ( 1.8 - 17.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
1.5 ( 0.3 - 4.7) |
Total |
N/A |
N/A |
N/A |
4.9 ( 0.2 - 23.2) |
4.2 ( 0.2 - 17.5) |
5.1 ( 1.6 - 11.7) |
Used amphetamines in school, university or polytechnic in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 5.1) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 5.6) |
Total |
N/A |
N/A |
N/A |
0 ( 0 - 9.3) |
0 ( 0 - 8.8) |
0 ( 0 - 2.7) |
300
300
277
3
259
5
False
False
Chapter5a: Amphetamines |
Frequency |
|
Unadjusted prevalence by gender and age groups |
|
16-17 |
18-24 |
25-34 |
35-44 |
45-54 |
55-65 |
Total |
Used amphetamines at least weekly in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
11.4 ( 4.5 - 22.7) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
18.8 ( 5 - 42.7) |
Total |
N/A |
10.9 ( 2.6 - 27.4) |
20.3 ( 8.1 - 38.4) |
N/A |
N/A |
N/A |
13.9 ( 7 - 23.8) |
Used amphetamines at least monthly in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
22.9 ( 11.8 - 37.8) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
31.5 ( 13.4 - 54.8) |
Total |
N/A |
15.5 ( 5.2 - 32.7) |
41.8 ( 21.6 - 64.3) |
N/A |
N/A |
N/A |
25.8 ( 15.3 - 36.3) |
Used amphetamines 3–11 times in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
32.1 ( 16.9 - 50.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
11.6 ( 4 - 24.6) |
Total |
N/A |
31.8 ( 12.5 - 57.1) |
13.6 ( 3.8 - 31.3) |
N/A |
N/A |
N/A |
25.1 ( 13.8 - 36.5) |
Used amphetamines 1–2 times in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
45 ( 28.2 - 62.7) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
56.9 ( 33.9 - 78) |
Total |
N/A |
52.7 ( 27.5 - 76.9) |
44.6 ( 24.2 - 66.5) |
N/A |
N/A |
N/A |
49.1 ( 36.7 - 61.5) |
Used P at least weekly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
19.2 ( 6.4 - 39.6) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
18 ( 4.1 - 43.5) |
Total |
N/A |
N/A |
35.2 ( 12.8 - 63.8) |
N/A |
N/A |
N/A |
18.7 ( 8.6 - 33) |
Used P at least monthly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
31.5 ( 14.3 - 53.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
33.8 ( 11.7 - 62.8) |
Total |
N/A |
N/A |
63.3 ( 37.7 - 84.4) |
N/A |
N/A |
N/A |
32.5 ( 18.7 - 46.4) |
Used P 3–11 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
27.3 ( 9.5 - 52.7) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
14.5 ( 4.2 - 32.7) |
Total |
N/A |
N/A |
11.5 ( 3.2 - 26.7) |
N/A |
N/A |
N/A |
21.7 ( 10.2 - 37.6) |
Used P 1–2 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
41.2 ( 17.6 - 68.3) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
51.7 ( 22.2 - 80.3) |
Total |
N/A |
N/A |
25.2 ( 8.1 - 50.8) |
N/A |
N/A |
N/A |
45.8 ( 27.3 - 65.1) |
Used ice at least weekly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
18 ( 6.6 - 35.7) |
Used ice at least monthly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
41.8 ( 23.2 - 62.2) |
Used ice 3–11 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
14.1 ( 3.6 - 33.8) |
Used ice 1–2 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
44.1 ( 24.2 - 65.5) |
Used speed at least weekly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
5.5 ( 1.1 - 15.3) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
6.4 ( 1.8 - 15.6) |
Used speed at least monthly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
18.5 ( 7.2 - 35.9) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
21.9 ( 10.1 - 38.2) |
Used speed 3–11 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
37.3 ( 15.4 - 64) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
26.9 ( 11.1 - 48.6) |
Used speed 1–2 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
44.1 ( 20.8 - 69.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
51.3 ( 32.3 - 70.2) |
Unadjusted prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Used amphetamines at least weekly in the past 12 months (among past-year amphetamines users) |
Men |
8.8 ( 2.5 - 20.8) |
N/A |
N/A |
N/A |
11.4 ( 4.5 - 22.7) |
Women |
19.6 ( 4.1 - 47.8) |
N/A |
N/A |
N/A |
18.8 ( 5 - 42.7) |
Total |
12.4 ( 5.3 - 23.5) |
19.8 ( 7.8 - 38.1) |
N/A |
N/A |
13.9 ( 7 - 23.8) |
Used amphetamines at least monthly in the past 12 months (among past-year amphetamines users) |
Men |
18.4 ( 8 - 33.7) |
N/A |
N/A |
N/A |
22.9 ( 11.8 - 37.8) |
Women |
32.5 ( 11.9 - 59.8) |
N/A |
N/A |
N/A |
31.5 ( 13.4 - 54.8) |
Total |
23.1 ( 12.7 - 36.5) |
34.7 ( 18.1 - 54.5) |
N/A |
N/A |
25.8 ( 15.3 - 36.3) |
Used amphetamines 3–11 times in the past 12 months (among past-year amphetamines users) |
Men |
32.6 ( 15.9 - 53.2) |
N/A |
N/A |
N/A |
32.1 ( 16.9 - 50.5) |
Women |
9 ( 1.9 - 23.8) |
N/A |
N/A |
N/A |
11.6 ( 4 - 24.6) |
Total |
24.7 ( 12.9 - 40.1) |
26.6 ( 11.4 - 47.4) |
N/A |
N/A |
25.1 ( 13.8 - 36.5) |
Used amphetamines 1–2 times in the past 12 months (among past-year amphetamines users) |
Men |
49.1 ( 30.1 - 68.2) |
N/A |
N/A |
N/A |
45 ( 28.2 - 62.7) |
Women |
58.5 ( 31.9 - 82) |
N/A |
N/A |
N/A |
56.9 ( 33.9 - 78) |
Total |
52.2 ( 38.4 - 66) |
38.8 ( 21.3 - 58.6) |
N/A |
N/A |
49.1 ( 36.7 - 61.5) |
Used P at least weekly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
19.2 ( 6.4 - 39.6) |
Women |
N/A |
N/A |
N/A |
N/A |
18 ( 4.1 - 43.5) |
Total |
18.8 ( 7.5 - 36.1) |
18.5 ( 6.2 - 38.4) |
N/A |
N/A |
18.7 ( 8.6 - 33) |
Used P at least monthly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
31.5 ( 14.3 - 53.5) |
Women |
N/A |
N/A |
N/A |
N/A |
33.8 ( 11.7 - 62.8) |
Total |
30.8 ( 15.7 - 49.6) |
36.8 ( 17.9 - 59.3) |
N/A |
N/A |
32.5 ( 18.7 - 46.4) |
Used P 3–11 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
27.3 ( 9.5 - 52.7) |
Women |
N/A |
N/A |
N/A |
N/A |
14.5 ( 4.2 - 32.7) |
Total |
19 ( 6.8 - 38.1) |
25.2 ( 8 - 51.1) |
N/A |
N/A |
21.7 ( 10.2 - 37.6) |
Used P 1–2 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
41.2 ( 17.6 - 68.3) |
Women |
N/A |
N/A |
N/A |
N/A |
51.7 ( 22.2 - 80.3) |
Total |
50.2 ( 28.4 - 72) |
38 ( 14.2 - 67) |
N/A |
N/A |
45.8 ( 27.3 - 65.1) |
Used ice at least weekly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
12.9 ( 2.3 - 35.6) |
N/A |
N/A |
N/A |
18 ( 6.6 - 35.7) |
Used ice at least monthly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
36.4 ( 15.9 - 61.4) |
N/A |
N/A |
N/A |
41.8 ( 23.2 - 62.2) |
Used ice 3–11 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
13.5 ( 1.8 - 40) |
N/A |
N/A |
N/A |
14.1 ( 3.6 - 33.8) |
Used ice 1–2 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
50.1 ( 25.6 - 74.5) |
N/A |
N/A |
N/A |
44.1 ( 24.2 - 65.5) |
Used speed at least weekly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
5.5 ( 1.1 - 15.3) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
4.2 ( 0.5 - 13.9) |
N/A |
N/A |
N/A |
6.4 ( 1.8 - 15.6) |
Used speed at least monthly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
18.5 ( 7.2 - 35.9) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
19.8 ( 7.2 - 39.2) |
N/A |
N/A |
N/A |
21.9 ( 10.1 - 38.2) |
Used speed 3–11 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
37.3 ( 15.4 - 64) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
27.7 ( 9.9 - 52.9) |
N/A |
N/A |
N/A |
26.9 ( 11.1 - 48.6) |
Used speed 1–2 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
44.1 ( 20.8 - 69.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
52.5 ( 29.6 - 74.7) |
N/A |
N/A |
N/A |
51.3 ( 32.3 - 70.2) |
Age-standardised prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Used amphetamines at least weekly in the past 12 months (among past-year amphetamines users) |
Men |
9.4 ( 2.7 - 22.3) |
N/A |
N/A |
N/A |
11.6 ( 4.5 - 23.2) |
Women |
19 ( 3.4 - 49) |
N/A |
N/A |
N/A |
18.4 ( 4.4 - 43.6) |
Total |
12.7 ( 5.2 - 24.5) |
20.4 ( 8.1 - 38.9) |
N/A |
N/A |
14 ( 6.9 - 24.2) |
Used amphetamines at least monthly in the past 12 months (among past-year amphetamines users) |
Men |
18.6 ( 7.9 - 34.4) |
N/A |
N/A |
N/A |
22.9 ( 11.6 - 38.1) |
Women |
31.5 ( 10.4 - 60.4) |
N/A |
N/A |
N/A |
30.5 ( 12 - 55.1) |
Total |
23 ( 12.5 - 36.7) |
35.5 ( 18.7 - 55.5) |
N/A |
N/A |
25.5 ( 14.9 - 36.2) |
Used amphetamines 3–11 times in the past 12 months (among past-year amphetamines users) |
Men |
32.3 ( 15 - 54) |
N/A |
N/A |
N/A |
32 ( 16.4 - 51.1) |
Women |
6.9 ( 1.6 - 18.2) |
N/A |
N/A |
N/A |
9.9 ( 3.4 - 21.1) |
Total |
23.6 ( 11.6 - 39.8) |
25.9 ( 11.2 - 46.1) |
N/A |
N/A |
24.4 ( 12.7 - 36) |
Used amphetamines 1–2 times in the past 12 months (among past-year amphetamines users) |
Men |
49.1 ( 29.6 - 68.8) |
N/A |
N/A |
N/A |
45.1 ( 27.9 - 63.2) |
Women |
61.6 ( 33.2 - 85.1) |
N/A |
N/A |
N/A |
59.6 ( 35.1 - 81) |
Total |
53.4 ( 39 - 67.7) |
38.5 ( 21.5 - 57.9) |
N/A |
N/A |
50.1 ( 37.2 - 63) |
Used P at least weekly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
20.5 ( 6.9 - 42) |
Women |
N/A |
N/A |
N/A |
N/A |
17.2 ( 3.3 - 43.8) |
Total |
19.4 ( 7.4 - 37.8) |
19.2 ( 6.3 - 39.9) |
N/A |
N/A |
19 ( 8.6 - 34) |
Used P at least monthly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
32.9 ( 14.8 - 55.6) |
Women |
N/A |
N/A |
N/A |
N/A |
32.7 ( 10 - 63.7) |
Total |
31.2 ( 15.3 - 51.3) |
37.7 ( 18.3 - 60.5) |
N/A |
N/A |
32.8 ( 18.4 - 47.3) |
Used P 3–11 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
25.7 ( 8.4 - 51.4) |
Women |
N/A |
N/A |
N/A |
N/A |
12.4 ( 3.5 - 28.9) |
Total |
16.4 ( 5.1 - 35.5) |
24.5 ( 7.9 - 49.7) |
N/A |
N/A |
19.8 ( 8.8 - 35.7) |
Used P 1–2 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
41.4 ( 17.3 - 69) |
Women |
N/A |
N/A |
N/A |
N/A |
54.9 ( 22.8 - 84.2) |
Total |
52.4 ( 29.4 - 74.7) |
37.8 ( 14.1 - 66.8) |
N/A |
N/A |
47.4 ( 28 - 67.4) |
Used ice at least weekly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
12.4 ( 2 - 35.3) |
N/A |
N/A |
N/A |
17.2 ( 6.2 - 34.7) |
Used ice at least monthly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
35.8 ( 14.4 - 62.3) |
N/A |
N/A |
N/A |
41.1 ( 21.9 - 62.4) |
Used ice 3–11 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
12 ( 1.7 - 35.7) |
N/A |
N/A |
N/A |
13.2 ( 3.5 - 31.3) |
Used ice 1–2 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
52.2 ( 25.6 - 77.9) |
N/A |
N/A |
N/A |
45.7 ( 24.5 - 68.2) |
Used speed at least weekly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
4.9 ( 1 - 13.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
4.2 ( 0.5 - 14.8) |
N/A |
N/A |
N/A |
6.1 ( 1.6 - 15.3) |
Used speed at least monthly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
17.2 ( 6.4 - 34) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
18.4 ( 6.6 - 36.9) |
N/A |
N/A |
N/A |
20.5 ( 9.3 - 36.4) |
Used speed 3–11 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
38.7 ( 15.9 - 65.9) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
28.6 ( 10.2 - 54.2) |
N/A |
N/A |
N/A |
27.5 ( 11.2 - 49.8) |
Used speed 1–2 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
44.1 ( 20.4 - 70) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
53.1 ( 29.8 - 75.4) |
N/A |
N/A |
N/A |
52.1 ( 32.7 - 71.4) |
Standardised rate ratios by gender for each ethnic group compared to males and females in the total population |
|
European/Other |
Māori |
Pacific |
Asian |
Used amphetamines at least weekly in the past 12 months (among past-year amphetamines users) |
Men |
0.81 ( 0.52 - 1.11) |
N/A |
N/A |
N/A |
Women |
1.03 ( 0.74 - 1.32) |
N/A |
N/A |
N/A |
Total |
0.91 ( 0.71 - 1.11) |
1.46 ( 0.45 - 2.48) |
N/A |
N/A |
Used amphetamines at least monthly in the past 12 months (among past-year amphetamines users) |
Men |
0.81 ( 0.65 - 0.97) |
N/A |
N/A |
N/A |
Women |
1.03 ( 0.88 - 1.19) |
N/A |
N/A |
N/A |
Total |
0.9 ( 0.78 - 1.02) |
1.39 ( 0.69 - 2.09) |
N/A |
N/A |
Used amphetamines 3–11 times in the past 12 months (among past-year amphetamines users) |
Men |
1.01 ( 0.87 - 1.15) |
N/A |
N/A |
N/A |
Women |
0.7 ( 0.31 - 1.08) |
N/A |
N/A |
N/A |
Total |
0.97 ( 0.82 - 1.12) |
1.06 ( 0.3 - 1.83) |
N/A |
N/A |
Used amphetamines 1–2 times in the past 12 months (among past-year amphetamines users) |
Men |
1.09 ( 1.01 - 1.17) |
N/A |
N/A |
N/A |
Women |
1.03 ( 0.95 - 1.12) |
N/A |
N/A |
N/A |
Total |
1.07 ( 1.01 - 1.12) |
0.77 ( 0.41 - 1.13) |
N/A |
N/A |
Used P at least weekly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
1.02 ( 0.82 - 1.23) |
1.01 ( 0.21 - 1.8) |
N/A |
N/A |
Used P at least monthly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
0.95 ( 0.8 - 1.11) |
1.15 ( 0.54 - 1.76) |
N/A |
N/A |
Used P 3–11 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
0.83 ( 0.49 - 1.16) |
1.24 ( 0.2 - 2.28) |
N/A |
N/A |
Used P 1–2 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
1.1 ( 1.01 - 1.2) |
0.8 ( 0.27 - 1.33) |
N/A |
N/A |
Used ice at least weekly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
0.72 ( 0.21 - 1.23) |
N/A |
N/A |
N/A |
Used ice at least monthly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
0.87 ( 0.67 - 1.07) |
N/A |
N/A |
N/A |
Used ice 3–11 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
0.91 ( 0.49 - 1.34) |
N/A |
N/A |
N/A |
Used ice 1–2 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
1.14 ( 1.01 - 1.27) |
N/A |
N/A |
N/A |
Used speed at least weekly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
0.69 ( 0.03 - 1.35) |
N/A |
N/A |
N/A |
Used speed at least monthly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
0.9 ( 0.69 - 1.11) |
N/A |
N/A |
N/A |
Used speed 3–11 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
1.04 ( 0.91 - 1.16) |
N/A |
N/A |
N/A |
Used speed 1–2 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
1.02 ( 0.95 - 1.09) |
N/A |
N/A |
N/A |
Age-standardised rates by gender and NZDep2006 quintile |
|
1 |
2 |
3 |
4 |
5 |
Total |
Used amphetamines at least weekly in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
11.6 ( 4.5 - 23.2) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
18.4 ( 4.4 - 43.6) |
Total |
N/A |
N/A |
N/A |
14.9 ( 3 - 38.3) |
26.4 ( 8.2 - 53.4) |
14 ( 6.9 - 24.2) |
Used amphetamines at least monthly in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
22.9 ( 11.6 - 38.1) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
30.5 ( 12 - 55.1) |
Total |
N/A |
N/A |
N/A |
21.5 ( 5.8 - 47.4) |
50.1 ( 26.5 - 73.5) |
25.5 ( 14.9 - 36.2) |
Used amphetamines 3–11 times in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
32 ( 16.4 - 51.1) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
9.9 ( 3.4 - 21.1) |
Total |
N/A |
N/A |
N/A |
19.4 ( 5.2 - 43.6) |
30.9 ( 9.5 - 60.9) |
24.4 ( 12.7 - 36) |
Used amphetamines 1–2 times in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
45.1 ( 27.9 - 63.2) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
59.6 ( 35.1 - 81) |
Total |
N/A |
N/A |
N/A |
59.1 ( 33 - 81.9) |
19.1 ( 7.5 - 36.7) |
50.1 ( 37.2 - 63) |
Used P at least weekly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
20.5 ( 6.9 - 42) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
17.2 ( 3.3 - 43.8) |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
19 ( 8.6 - 34) |
Used P at least monthly in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
32.9 ( 14.8 - 55.6) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
32.7 ( 10 - 63.7) |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
32.8 ( 18.4 - 47.3) |
Used P 3–11 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
25.7 ( 8.4 - 51.4) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
12.4 ( 3.5 - 28.9) |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
19.8 ( 8.8 - 35.7) |
Used P 1–2 times in the past 12 months (among past-year P users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
41.4 ( 17.3 - 69) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
54.9 ( 22.8 - 84.2) |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
47.4 ( 28 - 67.4) |
Used ice at least weekly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
17.2 ( 6.2 - 34.7) |
Used ice at least monthly in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
41.1 ( 21.9 - 62.4) |
Used ice 3–11 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
13.2 ( 3.5 - 31.3) |
Used ice 1–2 times in the past 12 months (among past-year ice users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
45.7 ( 24.5 - 68.2) |
Used speed at least weekly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
4.9 ( 1 - 13.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
6.1 ( 1.6 - 15.3) |
Used speed at least monthly in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
17.2 ( 6.4 - 34) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
20.5 ( 9.3 - 36.4) |
Used speed 3–11 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
38.7 ( 15.9 - 65.9) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
27.5 ( 11.2 - 49.8) |
Used speed 1–2 times in the past 12 months (among past-year speed users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
44.1 ( 20.4 - 70) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
52.1 ( 32.7 - 71.4) |
300
300
3
3
57
4
R1:R65536
False
False
Chapter5a: Amphetamines |
Risky behaviours |
|
Unadjusted prevalence by gender and age groups |
|
16-17 |
18-24 |
25-34 |
35-44 |
45-54 |
55-64 |
Total |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
35.4 ( 20.3 - 50.5) |
Women |
N/A |
N/A |
42 ( 16.3 - 71.4) |
N/A |
N/A |
N/A |
36.8 ( 19.1 - 57.7) |
Total |
N/A |
35.5 ( 16.3 - 59) |
46.8 ( 26.6 - 67.8) |
N/A |
N/A |
N/A |
35.9 ( 24.1 - 47.6) |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0 ( 0 - 3.7) |
2.8 ( 1.3 - 5.2) |
2 ( 0.8 - 4.2) |
0.6 ( 0.2 - 1.3) |
0.3 ( 0 - 1.6) |
0 ( 0 - 0.9) |
1 ( 0.6 - 1.4) |
Women |
0 ( 0 - 2.9) |
1.3 ( 0.3 - 3.3) |
1 ( 0.5 - 1.9) |
0.4 ( 0.1 - 1) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0.5 ( 0.3 - 0.8) |
Total |
0 ( 0 - 1.6) |
2 ( 1.1 - 3.4) |
1.5 ( 0.8 - 2.5) |
0.5 ( 0.2 - 0.9) |
0.1 ( 0 - 0.8) |
0 ( 0 - 0.3) |
0.7 ( 0.5 - 1) |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
27.9 ( 15.1 - 44) |
Women |
N/A |
N/A |
21.7 ( 4.3 - 52.8) |
N/A |
N/A |
N/A |
17.7 ( 7 - 34) |
Total |
N/A |
16.6 ( 5.8 - 33.8) |
33.6 ( 15.6 - 55.8) |
N/A |
N/A |
N/A |
24.4 ( 14.9 - 34) |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0 ( 0 - 3.7) |
1.6 ( 0.6 - 3.2) |
1.7 ( 0.6 - 3.8) |
1 ( 0.3 - 2.3) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0.8 ( 0.4 - 1.3) |
Women |
0 ( 0 - 2.9) |
0.3 ( 0 - 1.5) |
0.5 ( 0.1 - 1.4) |
0.6 ( 0.2 - 1.5) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0.3 ( 0.1 - 0.5) |
Total |
0 ( 0 - 1.6) |
0.9 ( 0.4 - 1.8) |
1.1 ( 0.5 - 2) |
0.8 ( 0.3 - 1.5) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0.5 ( 0.3 - 0.7) |
Had operated machinery while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0 ( 0 - 3.7) |
1.1 ( 0.4 - 2.6) |
0.5 ( 0.2 - 1.3) |
0.4 ( 0.1 - 1) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0.4 ( 0.2 - 0.6) |
Women |
0 ( 0 - 2.9) |
0.3 ( 0 - 1.5) |
0.3 ( 0.1 - 1) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0.1 ( 0 - 0.3) |
Total |
0 ( 0 - 1.6) |
0.7 ( 0.3 - 1.5) |
0.4 ( 0.2 - 0.8) |
0.2 ( 0.1 - 0.5) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0.2 ( 0.1 - 0.4) |
Used amphetamines at the same time as using alcohol at least once in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
15.2 ( 6 - 29.7) |
Women |
N/A |
N/A |
8.8 ( 0.9 - 29.9) |
N/A |
N/A |
N/A |
4.4 ( 1 - 11.8) |
Total |
N/A |
8.7 ( 2.1 - 22.3) |
13.4 ( 3.4 - 32) |
N/A |
N/A |
N/A |
11.5 ( 5.2 - 21.2) |
Used amphetamines at the same time as using cannabis at least once in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
42.3 ( 24.5 - 60) |
Women |
N/A |
N/A |
15.2 ( 3.9 - 35.7) |
N/A |
N/A |
N/A |
29.2 ( 14.7 - 47.6) |
Total |
N/A |
49.3 ( 25.2 - 73.6) |
32.3 ( 16.9 - 51.1) |
N/A |
N/A |
N/A |
37.8 ( 25.2 - 50.4) |
Used amphetamines at the same time as using BZP party pills at least once in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
10 ( 3.7 - 20.7) |
Women |
N/A |
N/A |
14.8 ( 2.6 - 40) |
N/A |
N/A |
N/A |
12.1 ( 4.2 - 25.4) |
Total |
N/A |
15.8 ( 5.2 - 33.4) |
7.7 ( 2.2 - 18.3) |
N/A |
N/A |
N/A |
10.7 ( 5.7 - 18) |
Unadjusted prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
32.4 ( 17.2 - 50.9) |
N/A |
N/A |
N/A |
35.4 ( 20.3 - 50.5) |
Women |
38 ( 17.4 - 62.3) |
N/A |
N/A |
N/A |
36.8 ( 19.1 - 57.7) |
Total |
34.2 ( 21.6 - 46.9) |
47.9 ( 30 - 66.2) |
N/A |
N/A |
35.9 ( 24.1 - 47.6) |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
1 ( 0.6 - 1.7) |
2.5 ( 1.2 - 4.4) |
0.3 ( 0 - 1.2) |
0 ( 0 - 2.1) |
1 ( 0.6 - 1.4) |
Women |
0.5 ( 0.3 - 0.9) |
0.7 ( 0.3 - 1.3) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.5 ( 0.3 - 0.8) |
Total |
0.8 ( 0.5 - 1.1) |
1.5 ( 0.8 - 2.5) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.7 ( 0.5 - 1) |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
21.9 ( 9.5 - 39.5) |
N/A |
N/A |
N/A |
27.9 ( 15.1 - 44) |
Women |
17.4 ( 6 - 35.9) |
N/A |
N/A |
N/A |
17.7 ( 7 - 34) |
Total |
20.4 ( 11.3 - 32.3) |
39.2 ( 21 - 60) |
N/A |
N/A |
24.4 ( 14.9 - 34) |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0.7 ( 0.3 - 1.3) |
2.1 ( 1 - 3.9) |
0.5 ( 0.1 - 1.4) |
0 ( 0 - 2.1) |
0.8 ( 0.4 - 1.3) |
Women |
0.3 ( 0.1 - 0.6) |
0.3 ( 0.1 - 1) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.3 ( 0.1 - 0.5) |
Total |
0.5 ( 0.3 - 0.8) |
1.2 ( 0.6 - 2) |
0.2 ( 0 - 0.7) |
0 ( 0 - 0.8) |
0.5 ( 0.3 - 0.7) |
Had operated machinery while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0.2 ( 0.1 - 0.5) |
1.8 ( 0.8 - 3.5) |
0.3 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0.4 ( 0.2 - 0.6) |
Women |
0.2 ( 0 - 0.4) |
0 ( 0 - 0.2) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.1 ( 0 - 0.3) |
Total |
0.2 ( 0.1 - 0.3) |
0.8 ( 0.4 - 1.6) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.2 ( 0.1 - 0.4) |
Used amphetamines at the same time as using alcohol at least once in the past 12 months (among past-year amphetamines users) |
Men |
15.9 ( 5.7 - 32.3) |
N/A |
N/A |
N/A |
15.2 ( 6 - 29.7) |
Women |
1.8 ( 0.3 - 5.9) |
N/A |
N/A |
N/A |
4.4 ( 1 - 11.8) |
Total |
11.1 ( 4.4 - 22.2) |
14.2 ( 4.9 - 30) |
N/A |
N/A |
11.5 ( 5.2 - 21.2) |
Used amphetamines at the same time as using cannabis at least once in the past 12 months (among past-year amphetamines users) |
Men |
40.9 ( 21.2 - 63) |
N/A |
N/A |
N/A |
42.3 ( 24.5 - 60) |
Women |
28.3 ( 12.5 - 49.4) |
N/A |
N/A |
N/A |
29.2 ( 14.7 - 47.6) |
Total |
36.7 ( 22.5 - 50.9) |
45.6 ( 25.5 - 66.8) |
N/A |
N/A |
37.8 ( 25.2 - 50.4) |
Used amphetamines at the same time as using BZP party pills at least once in the past 12 months (among past-year amphetamines users) |
Men |
10.9 ( 3.8 - 23) |
N/A |
N/A |
N/A |
10 ( 3.7 - 20.7) |
Women |
10.9 ( 2.9 - 26.3) |
N/A |
N/A |
N/A |
12.1 ( 4.2 - 25.4) |
Total |
10.9 ( 5.3 - 19.2) |
9.7 ( 3 - 21.7) |
N/A |
N/A |
10.7 ( 5.7 - 18) |
Age-standardised prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
33.3 ( 17.4 - 52.7) |
N/A |
N/A |
N/A |
36.2 ( 20.5 - 51.8) |
Women |
37.6 ( 15.7 - 64.1) |
N/A |
N/A |
N/A |
36.8 ( 17.8 - 59.2) |
Total |
34.8 ( 21.4 - 48.1) |
48.1 ( 30.6 - 65.9) |
N/A |
N/A |
36.4 ( 24.1 - 48.7) |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
1.4 ( 0.8 - 2.3) |
2.6 ( 1.3 - 4.5) |
0.3 ( 0 - 1.2) |
0 ( 0 - 2.1) |
1.2 ( 0.7 - 1.8) |
Women |
0.7 ( 0.4 - 1.3) |
0.7 ( 0.3 - 1.3) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.6 ( 0.3 - 1) |
Total |
1 ( 0.6 - 1.5) |
1.5 ( 0.9 - 2.5) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.9 ( 0.6 - 1.2) |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
22.2 ( 9.5 - 40.3) |
N/A |
N/A |
N/A |
28 ( 15 - 44.6) |
Women |
15.4 ( 4.7 - 33.7) |
N/A |
N/A |
N/A |
16.2 ( 6 - 32.5) |
Total |
19.8 ( 10.7 - 32) |
39.1 ( 21 - 59.6) |
N/A |
N/A |
23.9 ( 14.2 - 33.7) |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0.9 ( 0.4 - 1.7) |
2.2 ( 1 - 4) |
0.5 ( 0.1 - 1.4) |
0 ( 0 - 2.1) |
0.9 ( 0.5 - 1.6) |
Women |
0.4 ( 0.1 - 0.7) |
0.3 ( 0.1 - 1) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.3 ( 0.1 - 0.6) |
Total |
0.6 ( 0.4 - 1) |
1.2 ( 0.6 - 2) |
0.2 ( 0 - 0.7) |
0 ( 0 - 0.8) |
0.6 ( 0.4 - 0.9) |
Had operated machinery while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0.3 ( 0.1 - 0.7) |
1.9 ( 0.8 - 3.6) |
0.3 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0.4 ( 0.2 - 0.8) |
Women |
0.2 ( 0.1 - 0.5) |
0 ( 0 - 0.3) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.2 ( 0 - 0.4) |
Total |
0.2 ( 0.1 - 0.5) |
0.9 ( 0.4 - 1.7) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.3 ( 0.2 - 0.5) |
Used amphetamines at the same time as using alcohol at least once in the past 12 months (among past-year amphetamines users) |
Men |
15.9 ( 6.1 - 31.4) |
N/A |
N/A |
N/A |
15 ( 6.2 - 28.8) |
Women |
1.3 ( 0.2 - 4.2) |
N/A |
N/A |
N/A |
4 ( 0.9 - 11.3) |
Total |
10.8 ( 4.5 - 21.1) |
14 ( 4.9 - 29.2) |
N/A |
N/A |
11.2 ( 5.2 - 20.3) |
Used amphetamines at the same time as using cannabis at least once in the past 12 months (among past-year amphetamines users) |
Men |
43.7 ( 22.5 - 66.7) |
N/A |
N/A |
N/A |
44 ( 25.5 - 62.5) |
Women |
26.4 ( 10.3 - 49.1) |
N/A |
N/A |
N/A |
28.1 ( 13.1 - 47.8) |
Total |
37.7 ( 22.6 - 52.8) |
46.1 ( 26.1 - 67.1) |
N/A |
N/A |
38.4 ( 25.2 - 51.6) |
Used amphetamines at the same time as using BZP party pills at least once in the past 12 months (among past-year amphetamines users) |
Men |
10.8 ( 3.6 - 23.4) |
N/A |
N/A |
N/A |
10.1 ( 3.7 - 21) |
Women |
11.6 ( 2.8 - 28.6) |
N/A |
N/A |
N/A |
12.6 ( 4.2 - 27.2) |
Total |
11.1 ( 5.3 - 19.8) |
9.7 ( 3.1 - 21.7) |
N/A |
N/A |
11 ( 5.7 - 18.5) |
Standardised rate ratios by gender for each ethnic group compared to males and females in the total population |
|
European/Other |
Māori |
Pacific |
Asian |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
0.92 ( 0.81 - 1.03) |
N/A |
N/A |
N/A |
Women |
1.02 ( 0.9 - 1.15) |
N/A |
N/A |
N/A |
Total |
0.96 ( 0.87 - 1.04) |
1.32 ( 0.82 - 1.83) |
N/A |
N/A |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
1.11 ( 0.93 - 1.3) |
2.04 ( 0.89 - 3.2) |
0.26 ( 0 - 0.64) |
0 ( 0 - 0) |
Women |
1.2 ( 1.02 - 1.38) |
1.12 ( 0.21 - 2.02) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1.14 ( 1 - 1.29) |
1.68 ( 0.85 - 2.51) |
0.17 ( 0 - 0.42) |
0 ( 0 - 0) |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
0.79 ( 0.6 - 0.98) |
N/A |
N/A |
N/A |
Women |
0.95 ( 0.69 - 1.2) |
N/A |
N/A |
N/A |
Total |
0.83 ( 0.68 - 0.97) |
1.63 ( 0.84 - 2.42) |
N/A |
N/A |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0.95 ( 0.69 - 1.22) |
2.29 ( 0.79 - 3.79) |
0.51 ( 0 - 1.12) |
0 ( 0 - 0) |
Women |
1.14 ( 0.86 - 1.41) |
1.09 ( 0 - 2.29) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1 ( 0.8 - 1.2) |
1.91 ( 0.86 - 2.95) |
0.38 ( 0 - 0.82) |
0 ( 0 - 0) |
Had operated machinery while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0.65 ( 0.25 - 1.05) |
4.17 ( 2.2 - 6.14) |
0.74 ( 0 - 1.87) |
0 ( 0 - 0) |
Women |
1.3 ( 1.14 - 1.46) |
0.27 ( 0 - 0.92) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
0.83 ( 0.52 - 1.14) |
2.94 ( 1.38 - 4.49) |
0.53 ( 0 - 1.32) |
0 ( 0 - 0) |
Used amphetamines at the same time as using alcohol at least once in the past 12 months (among past-year amphetamines users) |
Men |
1.06 ( 0.91 - 1.2) |
N/A |
N/A |
N/A |
Women |
0.32 ( 0 - 0.89) |
N/A |
N/A |
N/A |
Total |
0.97 ( 0.78 - 1.15) |
1.25 ( 0.14 - 2.36) |
N/A |
N/A |
Used amphetamines at the same time as using cannabis at least once in the past 12 months (among past-year amphetamines users) |
Men |
0.99 ( 0.9 - 1.09) |
N/A |
N/A |
N/A |
Women |
0.94 ( 0.76 - 1.12) |
N/A |
N/A |
N/A |
Total |
0.98 ( 0.9 - 1.07) |
1.2 ( 0.6 - 1.8) |
N/A |
N/A |
Used amphetamines at the same time as using BZP party pills at least once in the past 12 months (among past-year amphetamines users) |
Men |
1.08 ( 0.94 - 1.21) |
N/A |
N/A |
N/A |
Women |
0.91 ( 0.57 - 1.26) |
N/A |
N/A |
N/A |
Total |
1.01 ( 0.85 - 1.17) |
0.89 ( 0.05 - 1.72) |
N/A |
N/A |
Age-standardised rates by gender and NZDep2006 quintile |
|
1
(Least deprived) |
2 |
3 |
4 |
5
(Most deprived) |
Total |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
36.2 ( 20.5 - 51.8) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
36.8 ( 17.8 - 59.2) |
Total |
N/A |
N/A |
N/A |
33.8 ( 14.1 - 58.7) |
44.2 ( 16.2 - 75.2) |
36.4 ( 24.1 - 48.7) |
Had driven a car or another motor vehicle while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0.2 ( 0 - 1) |
1.1 ( 0.2 - 3.6) |
1.6 ( 0.6 - 3.3) |
2 ( 0.7 - 4.3) |
1.3 ( 0.5 - 2.8) |
1.2 ( 0.7 - 1.8) |
Women |
0.6 ( 0 - 2.7) |
0.5 ( 0.1 - 1.3) |
0.9 ( 0.2 - 2.2) |
0.7 ( 0.2 - 1.7) |
0.4 ( 0.2 - 0.9) |
0.6 ( 0.3 - 1) |
Total |
0.4 ( 0 - 1.5) |
0.8 ( 0.2 - 1.9) |
1.2 ( 0.6 - 2.1) |
1.3 ( 0.6 - 2.5) |
0.9 ( 0.4 - 1.6) |
0.9 ( 0.6 - 1.2) |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
28 ( 15 - 44.6) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
16.2 ( 6 - 32.5) |
Total |
N/A |
N/A |
N/A |
21.9 ( 7.6 - 43.8) |
42.4 ( 15.4 - 73.2) |
23.9 ( 14.2 - 33.7) |
Had worked while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0 ( 0 - 1.2) |
1 ( 0.1 - 3.8) |
0.9 ( 0.3 - 2.1) |
1.4 ( 0.4 - 3.3) |
1.4 ( 0.6 - 2.9) |
0.9 ( 0.5 - 1.6) |
Women |
0 ( 0 - 0.3) |
0.5 ( 0.1 - 1.5) |
0.4 ( 0 - 1.5) |
0.4 ( 0 - 1.3) |
0.2 ( 0 - 0.7) |
0.3 ( 0.1 - 0.6) |
Total |
0 ( 0 - 0.1) |
0.8 ( 0.2 - 2) |
0.6 ( 0.2 - 1.3) |
0.9 ( 0.3 - 1.8) |
0.8 ( 0.4 - 1.5) |
0.6 ( 0.4 - 0.9) |
Had operated machinery while feeling under the influence of amphetamines at least once in the past 12 months (among total population) |
Men |
0 ( 0 - 1.2) |
0 ( 0 - 0.9) |
0.4 ( 0.1 - 1.1) |
0.8 ( 0.2 - 1.9) |
1.1 ( 0.3 - 2.6) |
0.4 ( 0.2 - 0.8) |
Women |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.8) |
0.3 ( 0 - 1.5) |
0.2 ( 0 - 1.1) |
0.2 ( 0 - 0.5) |
0.2 ( 0 - 0.4) |
Total |
0 ( 0 - 0.1) |
0.1 ( 0 - 0.4) |
0.3 ( 0.1 - 0.9) |
0.5 ( 0.2 - 1.1) |
0.6 ( 0.2 - 1.3) |
0.3 ( 0.2 - 0.5) |
Used amphetamines at the same time as using alcohol at least once in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
15 ( 6.2 - 28.8) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
4 ( 0.9 - 11.3) |
Total |
N/A |
N/A |
N/A |
7.9 ( 1.2 - 24.4) |
11.5 ( 2 - 32.2) |
11.2 ( 5.2 - 20.3) |
Used amphetamines at the same time as using cannabis at least once in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
44 ( 25.5 - 62.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
28.1 ( 13.1 - 47.8) |
Total |
N/A |
N/A |
N/A |
35.6 ( 15.1 - 60.9) |
53.6 ( 29.4 - 76.6) |
38.4 ( 25.2 - 51.6) |
Used amphetamines at the same time as using BZP party pills at least once in the past 12 months (among past-year amphetamines users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
10.1 ( 3.7 - 21) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
12.6 ( 4.2 - 27.2) |
Total |
N/A |
N/A |
N/A |
9.1 ( 2.2 - 23.1) |
18.5 ( 0.4 - 69.2) |
11 ( 5.7 - 18.5) |
300
300
3
R1:R65536
False
False
Chapter5a: Amphetamines |
Received help |
|
Unadjusted prevalence by gender and age groups |
|
16-17 |
18-24 |
25-34 |
35-44 |
45-54 |
55-64 |
Total |
Ever received help to reduce the level of amphetamine use (among total population) |
Men |
0 ( 0 - 3.7) |
1 ( 0.1 - 4.3) |
0.5 ( 0.1 - 1.4) |
0.9 ( 0.2 - 2.6) |
0.8 ( 0.2 - 2.2) |
0.4 ( 0 - 1.6) |
0.7 ( 0.3 - 1.2) |
Women |
0 ( 0 - 2.9) |
0.4 ( 0.1 - 1.3) |
1.2 ( 0.5 - 2.5) |
0.2 ( 0.1 - 0.6) |
0 ( 0 - 0.1) |
0.6 ( 0 - 3.4) |
0.5 ( 0.2 - 0.8) |
Total |
0 ( 0 - 1.6) |
0.7 ( 0.1 - 2.1) |
0.9 ( 0.4 - 1.6) |
0.6 ( 0.2 - 1.3) |
0.4 ( 0.1 - 1.1) |
0.5 ( 0.1 - 1.8) |
0.6 ( 0.3 - 0.8) |
Ever received help to reduce the level of amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
11.7 ( 3.4 - 26.8) |
Women |
N/A |
N/A |
2.6 ( 0 - 15.1) |
N/A |
N/A |
N/A |
4.5 ( 1.3 - 10.9) |
Total |
N/A |
7.8 ( 0.3 - 34.3) |
4.6 ( 0.9 - 13.5) |
N/A |
N/A |
N/A |
9.2 ( 3.4 - 19) |
Ever received help to reduce the level of amphetamine use (among people who had ever used amphetamines) |
Men |
N/A |
8 ( 0.4 - 32.7) |
3.2 ( 0.7 - 9) |
11 ( 2.2 - 29.2) |
10.5 ( 1.7 - 30.6) |
N/A |
7.6 ( 3.8 - 13.2) |
Women |
N/A |
5.1 ( 0.7 - 16.6) |
11.7 ( 4.6 - 23.2) |
4.7 ( 1.4 - 11.1) |
N/A |
N/A |
8.6 ( 4.3 - 15) |
Total |
N/A |
6.9 ( 1.1 - 20.4) |
6.9 ( 3.3 - 12.4) |
8.4 ( 2.7 - 18.7) |
7.6 ( 1.4 - 21.5) |
N/A |
8 ( 4.6 - 11.3) |
Ever received help to reduce level of amphetamine use from a general practitioner (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
34.7 ( 13 - 62.3) |
Ever received help to reduce level of amphetamine use from a drug and alcohol counsellor (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
57.9 ( 33.2 - 80) |
Ever received help to reduce level of amphetamine use from a detoxification programme (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
39.2 ( 17.8 - 64.1) |
Ever received help to reduce level of amphetamine use from a psychiatrist, psychologist or mental health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
28.2 ( 10.6 - 52.6) |
Ever received help to reduce level of amphetamine use from a Māori or Pacific health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 9.5) |
Ever received help to reduce level of amphetamine use from an emergency department at a public hospital (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
2 ( 0.2 - 7.8) |
Ever received help to reduce level of amphetamine use from a friend or family member (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
37.1 ( 16.1 - 62.4) |
Ever received help to reduce level of amphetamine use from a natural or alternative therapist (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
10.2 ( 1.6 - 29.8) |
Ever received help to reduce level of amphetamine use from Narcotics Anonymous or other support group (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
35.1 ( 14.8 - 60.4) |
Received help to reduce the level of amphetamine use in the past 12 months (among total population) |
Men |
0 ( 0 - 3.7) |
0 ( 0 - 1.1) |
0 ( 0 - 0.7) |
0.1 ( 0 - 0.3) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0 ( 0 - 0.1) |
Women |
0 ( 0 - 2.9) |
0 ( 0 - 0.7) |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0 ( 0 - 0.1) |
Total |
0 ( 0 - 1.6) |
0 ( 0 - 0.4) |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.2) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0 ( 0 - 0.1) |
Received help to reduce the level of amphetamine use in the past 12 months (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
0.4 ( 0 - 2.4) |
Women |
N/A |
N/A |
2.6 ( 0 - 15.1) |
N/A |
N/A |
N/A |
3.2 ( 0.8 - 8.7) |
Total |
N/A |
0 ( 0 - 8.2) |
1 ( 0 - 5.9) |
N/A |
N/A |
N/A |
1.4 ( 0.4 - 3.3) |
Received help to reduce the level of amphetamine use in the past 12 months (among people who had ever used amphetamines) |
Men |
N/A |
0 ( 0 - 8.8) |
0 ( 0 - 3.8) |
0.6 ( 0 - 3.5) |
0 ( 0 - 9.3) |
N/A |
0.1 ( 0 - 0.7) |
Women |
N/A |
0 ( 0 - 7.4) |
0.6 ( 0 - 3.4) |
2.5 ( 0.4 - 7.6) |
N/A |
N/A |
0.8 ( 0.2 - 2.1) |
Total |
N/A |
0 ( 0 - 4.1) |
0.3 ( 0 - 1.4) |
1.4 ( 0.4 - 3.6) |
0 ( 0 - 5.6) |
N/A |
0.4 ( 0.1 - 0.9) |
Unadjusted prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Ever received help to reduce the level of amphetamine use (among total population) |
Men |
0.7 ( 0.3 - 1.4) |
0.9 ( 0.3 - 2) |
0.1 ( 0 - 0.8) |
0.5 ( 0 - 2.7) |
0.7 ( 0.3 - 1.2) |
Women |
0.5 ( 0.2 - 1) |
0.8 ( 0.3 - 1.6) |
0.1 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.5 ( 0.2 - 0.8) |
Total |
0.6 ( 0.4 - 1) |
0.8 ( 0.4 - 1.4) |
0.1 ( 0 - 0.5) |
0.2 ( 0 - 1.3) |
0.6 ( 0.3 - 0.8) |
Ever received help to reduce the level of amphetamine use (among past-year amphetamine users) |
Men |
11.4 ( 2.7 - 28.9) |
N/A |
N/A |
N/A |
11.7 ( 3.4 - 26.8) |
Women |
4.1 ( 0.9 - 11.3) |
N/A |
N/A |
N/A |
4.5 ( 1.3 - 10.9) |
Total |
9 ( 2.8 - 20.3) |
13.9 ( 4.7 - 29.4) |
N/A |
N/A |
9.2 ( 3.4 - 19) |
Ever received help to reduce the level of amphetamine use (among people who had ever used amphetamines) |
Men |
7.4 ( 3.3 - 14) |
6.7 ( 2.1 - 15.5) |
N/A |
N/A |
7.6 ( 3.8 - 13.2) |
Women |
8.6 ( 4 - 16) |
10.4 ( 4.1 - 20.6) |
N/A |
N/A |
8.6 ( 4.3 - 15) |
Total |
7.9 ( 4.6 - 12.5) |
8.2 ( 4.3 - 14) |
3.5 ( 0.3 - 13.3) |
N/A |
8 ( 4.6 - 11.3) |
Ever received help to reduce level of amphetamine use from a general practitioner (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
34.7 ( 13 - 62.3) |
Ever received help to reduce level of amphetamine use from a drug and alcohol counsellor (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
57.9 ( 33.2 - 80) |
Ever received help to reduce level of amphetamine use from a detoxification programme (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
39.2 ( 17.8 - 64.1) |
Ever received help to reduce level of amphetamine use from a psychiatrist, psychologist or mental health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
28.2 ( 10.6 - 52.6) |
Ever received help to reduce level of amphetamine use from a Māori or Pacific health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 9.5) |
Ever received help to reduce level of amphetamine use from an emergency department at a public hospital (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
2 ( 0.2 - 7.8) |
Ever received help to reduce level of amphetamine use from a friend or family member (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
37.1 ( 16.1 - 62.4) |
Ever received help to reduce level of amphetamine use from a natural or alternative therapist (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
10.2 ( 1.6 - 29.8) |
Ever received help to reduce level of amphetamine use from Narcotics Anonymous or other support group (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
35.1 ( 14.8 - 60.4) |
Received help to reduce the level of amphetamine use in the past 12 months (among total population) |
Men |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.6) |
0 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0 ( 0 - 0.1) |
Women |
0 ( 0 - 0.1) |
0.2 ( 0 - 0.7) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0 ( 0 - 0.1) |
Total |
0 ( 0 - 0.1) |
0.2 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0 ( 0 - 0.8) |
0 ( 0 - 0.1) |
Received help to reduce the level of amphetamine use in the past 12 months (among past-year amphetamine users) |
Men |
0 ( 0 - 6.7) |
N/A |
N/A |
N/A |
0.4 ( 0 - 2.4) |
Women |
2.7 ( 0.4 - 8.5) |
N/A |
N/A |
N/A |
3.2 ( 0.8 - 8.7) |
Total |
0.9 ( 0.2 - 2.7) |
5.3 ( 1.4 - 13.5) |
N/A |
N/A |
1.4 ( 0.4 - 3.3) |
Received help to reduce the level of amphetamine use in the past 12 months (among people who had ever used amphetamines) |
Men |
0 ( 0 - 2.2) |
0.8 ( 0 - 4.4) |
N/A |
N/A |
0.1 ( 0 - 0.7) |
Women |
0.7 ( 0.1 - 2) |
3.2 ( 0.6 - 9.3) |
N/A |
N/A |
0.8 ( 0.2 - 2.1) |
Total |
0.3 ( 0 - 0.8) |
1.7 ( 0.5 - 4.4) |
0 ( 0 - 11.2) |
N/A |
0.4 ( 0.1 - 0.9) |
Age-standardised prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Ever received help to reduce the level of amphetamine use (among total population) |
Men |
0.8 ( 0.3 - 1.6) |
0.8 ( 0.3 - 2) |
0.1 ( 0 - 0.8) |
0.4 ( 0 - 2.4) |
0.7 ( 0.3 - 1.3) |
Women |
0.6 ( 0.3 - 1.1) |
0.8 ( 0.3 - 1.6) |
0.1 ( 0 - 0.6) |
0 ( 0 - 1.4) |
0.5 ( 0.3 - 0.8) |
Total |
0.7 ( 0.4 - 1.1) |
0.8 ( 0.4 - 1.4) |
0.1 ( 0 - 0.5) |
0.2 ( 0 - 1.2) |
0.6 ( 0.3 - 0.8) |
Ever received help to reduce the level of amphetamine use (among past-year amphetamine users) |
Men |
10.6 ( 2.1 - 28.8) |
N/A |
N/A |
N/A |
10.8 ( 2.8 - 26.4) |
Women |
3.4 ( 0.6 - 10.3) |
N/A |
N/A |
N/A |
4 ( 1 - 10.3) |
Total |
8.2 ( 2.2 - 19.9) |
13.9 ( 4.8 - 29.3) |
N/A |
N/A |
8.5 ( 2.9 - 18.4) |
Ever received help to reduce the level of amphetamine use (among people who had ever used amphetamines) |
Men |
6.6 ( 2.6 - 13.5) |
6.4 ( 2 - 14.7) |
N/A |
N/A |
7 ( 3.3 - 12.8) |
Women |
7.9 ( 3.8 - 14.1) |
10.3 ( 4.1 - 20.6) |
N/A |
N/A |
7.9 ( 4.2 - 13.3) |
Total |
7.1 ( 4 - 11.6) |
7.9 ( 4.1 - 13.5) |
3.5 ( 0.3 - 13.4) |
N/A |
7.4 ( 4.2 - 10.5) |
Ever received help to reduce level of amphetamine use from a general practitioner (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
35.3 ( 11.9 - 65.5) |
Ever received help to reduce level of amphetamine use from a drug and alcohol counsellor (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
61.7 ( 37 - 82.6) |
Ever received help to reduce level of amphetamine use from a detoxification programme (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
34.5 ( 15.3 - 58.5) |
Ever received help to reduce level of amphetamine use from a psychiatrist, psychologist or mental health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
25.7 ( 9.3 - 49.3) |
Ever received help to reduce level of amphetamine use from a Māori or Pacific health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 9.5) |
Ever received help to reduce level of amphetamine use from an emergency department at a public hospital (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
1.9 ( 0.2 - 7.2) |
Ever received help to reduce level of amphetamine use from a friend or family member (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
35.8 ( 15.3 - 61.1) |
Ever received help to reduce level of amphetamine use from a natural or alternative therapist (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
11.9 ( 1.8 - 34.6) |
Ever received help to reduce level of amphetamine use from Narcotics Anonymous or other support group (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
40.2 ( 16.7 - 67.7) |
Received help to reduce the level of amphetamine use in the past 12 months (among total population) |
Men |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.5) |
0 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0 ( 0 - 0.1) |
Women |
0 ( 0 - 0.1) |
0.2 ( 0 - 0.7) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0 ( 0 - 0.1) |
Total |
0 ( 0 - 0.1) |
0.2 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0 ( 0 - 0.8) |
0 ( 0 - 0.1) |
Received help to reduce the level of amphetamine use in the past 12 months (among past-year amphetamine users) |
Men |
0 ( 0 - 6.7) |
N/A |
N/A |
N/A |
0.3 ( 0 - 1.9) |
Women |
1.8 ( 0.3 - 5.8) |
N/A |
N/A |
N/A |
2.6 ( 0.6 - 7.2) |
Total |
0.6 ( 0.1 - 1.9) |
5.2 ( 1.3 - 13.1) |
N/A |
N/A |
1.1 ( 0.3 - 2.7) |
Received help to reduce the level of amphetamine use in the past 12 months (among people who had ever used amphetamines) |
Men |
0 ( 0 - 2.2) |
0.7 ( 0 - 4.1) |
N/A |
N/A |
0.1 ( 0 - 0.7) |
Women |
0.5 ( 0.1 - 1.5) |
3.1 ( 0.6 - 9.1) |
N/A |
N/A |
0.7 ( 0.2 - 1.9) |
Total |
0.2 ( 0 - 0.6) |
1.7 ( 0.5 - 4.2) |
0 ( 0 - 11.2) |
N/A |
0.4 ( 0.1 - 0.9) |
Standardised rate ratios by gender for each ethnic group compared to males and females in the total population |
|
European/Other |
Māori |
Pacific |
Asian |
Ever received help to reduce the level of amphetamine use (among total population) |
Men |
1.07 ( 0.78 - 1.37) |
1.21 ( 0 - 2.55) |
0.21 ( 0 - 0.66) |
0.59 ( 0 - 1.84) |
Women |
1.18 ( 1.01 - 1.36) |
1.55 ( 0.23 - 2.87) |
0.23 ( 0 - 0.69) |
0 ( 0 - 0) |
Total |
1.12 ( 0.95 - 1.29) |
1.36 ( 0.44 - 2.28) |
0.22 ( 0 - 0.54) |
0.34 ( 0 - 1.05) |
Ever received help to reduce the level of amphetamine use (among past-year amphetamine users) |
Men |
0.98 ( 0.68 - 1.28) |
N/A |
N/A |
N/A |
Women |
0.85 ( 0.27 - 1.44) |
N/A |
N/A |
N/A |
Total |
0.96 ( 0.7 - 1.23) |
1.65 ( 0 - 3.7) |
N/A |
N/A |
Ever received help to reduce the level of amphetamine use (among people who had ever used amphetamines) |
Men |
0.94 ( 0.69 - 1.2) |
0.91 ( 0 - 1.89) |
N/A |
N/A |
Women |
1 ( 0.86 - 1.14) |
1.3 ( 0.26 - 2.35) |
N/A |
N/A |
Total |
0.97 ( 0.83 - 1.11) |
1.08 ( 0.41 - 1.75) |
0.47 ( 0 - 1.21) |
N/A |
Ever received help to reduce level of amphetamine use from a general practitioner (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Ever received help to reduce level of amphetamine use from a drug and alcohol counsellor (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Ever received help to reduce level of amphetamine use from a detoxification programme (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Ever received help to reduce level of amphetamine use from a psychiatrist, psychologist or mental health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Ever received help to reduce level of amphetamine use from a Māori or Pacific health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Ever received help to reduce level of amphetamine use from an emergency department at a public hospital (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Ever received help to reduce level of amphetamine use from a friend or family member (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Ever received help to reduce level of amphetamine use from a natural or alternative therapist (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Ever received help to reduce level of amphetamine use from Narcotics Anonymous or other support group (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Received help to reduce the level of amphetamine use in the past 12 months (among total population) |
Men |
0 ( 0 - 0) |
8.3 ( 7.12 - 9.49) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Women |
0.81 ( 0 - 1.77) |
5.16 ( 0.51 - 9.81) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
0.65 ( 0 - 1.4) |
5.85 ( 1.98 - 9.72) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Received help to reduce the level of amphetamine use in the past 12 months (among past-year amphetamine users) |
Men |
0 ( 0 - 0) |
N/A |
N/A |
N/A |
Women |
0.68 ( 0 - 1.48) |
N/A |
N/A |
N/A |
Total |
0.55 ( 0 - 1.16) |
4.58 ( 1.56 - 7.59) |
N/A |
N/A |
Received help to reduce the level of amphetamine use in the past 12 months (among people who had ever used amphetamines) |
Men |
0 ( 0 - 0) |
6.21 ( 4.47 - 7.95) |
N/A |
N/A |
Women |
0.68 ( 0 - 1.49) |
4.33 ( 0.51 - 8.15) |
N/A |
N/A |
Total |
0.56 ( 0 - 1.2) |
4.64 ( 1.69 - 7.59) |
0 ( 0 - 0) |
N/A |
Age-standardised rates by gender and NZDep2006 quintile |
|
1
(Least deprived) |
2 |
3 |
4 |
5
(Most deprived) |
Total |
Ever received help to reduce the level of amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0.4 ( 0 - 1.3) |
1.4 ( 0.5 - 3.2) |
1.4 ( 0.2 - 4.3) |
0.2 ( 0 - 0.5) |
0.7 ( 0.3 - 1.3) |
Women |
0.5 ( 0 - 2) |
0.3 ( 0 - 1.5) |
1 ( 0.4 - 2.3) |
0.1 ( 0 - 0.4) |
0.6 ( 0.2 - 1.1) |
0.5 ( 0.3 - 0.8) |
Total |
0.3 ( 0 - 1.1) |
0.3 ( 0.1 - 1) |
1.2 ( 0.6 - 2.3) |
0.7 ( 0.1 - 2.1) |
0.4 ( 0.2 - 0.7) |
0.6 ( 0.3 - 0.8) |
Ever received help to reduce the level of amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
10.8 ( 2.8 - 26.4) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
4 ( 1 - 10.3) |
Total |
N/A |
N/A |
N/A |
13.4 ( 1 - 45.7) |
5.4 ( 0.9 - 16.3) |
8.5 ( 2.9 - 18.4) |
Ever received help to reduce the level of amphetamine use (among people who had ever used amphetamines) |
Men |
N/A |
3.1 ( 0.3 - 11.5) |
11.2 ( 3.5 - 24.9) |
14.3 ( 2.2 - 40.2) |
1.9 ( 0.4 - 5.8) |
7 ( 3.3 - 12.8) |
Women |
N/A |
7.7 ( 0.2 - 37.3) |
12.7 ( 4.2 - 27.4) |
1.8 ( 0.3 - 5.9) |
9.9 ( 3.6 - 20.7) |
7.9 ( 4.2 - 13.3) |
Total |
4.1 ( 0.3 - 16.9) |
4.2 ( 0.8 - 12.2) |
11.8 ( 5.6 - 20.9) |
8.6 ( 1.7 - 23.4) |
5.2 ( 2.5 - 9.4) |
7.4 ( 4.2 - 10.5) |
Ever received help to reduce level of amphetamine use from a general practitioner (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
35.3 ( 11.9 - 65.5) |
Ever received help to reduce level of amphetamine use from a drug and alcohol counsellor (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
61.7 ( 37 - 82.6) |
Ever received help to reduce level of amphetamine use from a detoxification programme (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
34.5 ( 15.3 - 58.5) |
Ever received help to reduce level of amphetamine use from a psychiatrist, psychologist or mental health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
25.7 ( 9.3 - 49.3) |
Ever received help to reduce level of amphetamine use from a Māori or Pacific health service (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
0 ( 0 - 9.5) |
Ever received help to reduce level of amphetamine use from an emergency department at a public hospital (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
1.9 ( 0.2 - 7.2) |
Ever received help to reduce level of amphetamine use from a friend or family member (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
35.8 ( 15.3 - 61.1) |
Ever received help to reduce level of amphetamine use from a natural or alternative therapist (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
11.9 ( 1.8 - 34.6) |
Ever received help to reduce level of amphetamine use from Narcotics Anonymous or other support group (among people who had ever received help to reduce their level of amphetamine use) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
40.2 ( 16.7 - 67.7) |
Received help to reduce the level of amphetamine use in the past 12 months (among total population) |
Men |
0 ( 0 - 1.2) |
0 ( 0 - 0.9) |
0.1 ( 0 - 0.3) |
0 ( 0 - 0.7) |
0 ( 0 - 0.5) |
0 ( 0 - 0.1) |
Women |
0 ( 0 - 0.7) |
0 ( 0 - 0.5) |
0 ( 0 - 0.5) |
0 ( 0 - 0.3) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.1) |
Total |
0 ( 0 - 0.4) |
0 ( 0 - 0.3) |
0 ( 0 - 0.1) |
0 ( 0 - 0.1) |
0.1 ( 0 - 0.3) |
0 ( 0 - 0.1) |
Received help to reduce the level of amphetamine use in the past 12 months (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
0.3 ( 0 - 1.9) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
2.6 ( 0.6 - 7.2) |
Total |
N/A |
N/A |
N/A |
0.6 ( 0 - 3.5) |
5.4 ( 0.9 - 16.3) |
1.1 ( 0.3 - 2.7) |
Received help to reduce the level of amphetamine use in the past 12 months (among people who had ever used amphetamines) |
Men |
N/A |
0 ( 0 - 8.6) |
0.4 ( 0 - 2.4) |
0 ( 0 - 6.1) |
0 ( 0 - 5.9) |
0.1 ( 0 - 0.7) |
Women |
N/A |
0 ( 0 - 10.6) |
0 ( 0 - 5.6) |
0.6 ( 0 - 3.6) |
3.6 ( 0.5 - 11.3) |
0.7 ( 0.2 - 1.9) |
Total |
0 ( 0 - 7.1) |
0 ( 0 - 4.9) |
0.2 ( 0 - 1.4) |
0.3 ( 0 - 1.6) |
1.5 ( 0.3 - 4.5) |
0.4 ( 0.1 - 0.9) |
300
300
36
3
R1:R65536
False
False
Chapter5a: Amphetamines |
Wanted help |
|
Unadjusted prevalence by gender and age groups |
|
16-17 |
18-24 |
25-34 |
35-44 |
45-54 |
55-64 |
Total |
Ever wanted help to reduce the level of amphetamine use but did not get it (among total population) |
Men |
0 ( 0 - 3.7) |
0.2 ( 0 - 0.7) |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.8) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0.1 ( 0 - 0.2) |
Women |
0 ( 0 - 2.9) |
0.1 ( 0 - 0.4) |
0.4 ( 0 - 1.5) |
0.2 ( 0 - 1) |
0.2 ( 0 - 1) |
0 ( 0 - 0.5) |
0.2 ( 0 - 0.4) |
Total |
0 ( 0 - 1.6) |
0.1 ( 0 - 0.4) |
0.2 ( 0 - 0.8) |
0.2 ( 0 - 0.6) |
0.1 ( 0 - 0.5) |
0 ( 0 - 0.3) |
0.1 ( 0.1 - 0.3) |
Ever wanted help to reduce the level of amphetamine use but did not get it (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
2.6 ( 0.4 - 8.2) |
Women |
N/A |
N/A |
2.3 ( 0.2 - 8.8) |
N/A |
N/A |
N/A |
3.8 ( 0.2 - 15.7) |
Total |
N/A |
1.5 ( 0.1 - 6.1) |
2.1 ( 0.3 - 6.7) |
N/A |
N/A |
N/A |
3 ( 0.8 - 7.5) |
Ever wanted help to reduce the level of amphetamine use but did not get it (among people who had ever used amphetamines) |
Men |
N/A |
1.4 ( 0.1 - 5.7) |
0.7 ( 0.1 - 2.9) |
1.7 ( 0 - 9.4) |
0 ( 0 - 9.3) |
N/A |
0.9 ( 0.2 - 2.6) |
Women |
N/A |
1 ( 0 - 5.5) |
3.5 ( 0.3 - 13.7) |
3.7 ( 0.1 - 18.1) |
N/A |
N/A |
3.1 ( 0.9 - 7.5) |
Total |
N/A |
1.2 ( 0.2 - 3.9) |
1.9 ( 0.3 - 6.1) |
2.5 ( 0.4 - 8.3) |
1.9 ( 0 - 10.6) |
N/A |
1.8 ( 0.7 - 3.6) |
Reason for ever wanting help but not getting it: social pressure to keep using drugs (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: not knowing where to go (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of the law or police (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of what might happen once contact was made with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: service not being appropriate for type of use (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of losing friends (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not spare the time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get in touch with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no local service available (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no transport to get there (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get appointment soon enough or at a suitable time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: lack of child care (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: cost (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among total population) |
Men |
0 ( 0 - 3.7) |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.7) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0 ( 0 - 0.1) |
Women |
0.2 ( 0 - 1.2) |
0 ( 0 - 0.7) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.3) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0 ( 0 - 0.1) |
Total |
0.1 ( 0 - 0.6) |
0.1 ( 0 - 0.2) |
0.1 ( 0 - 0.3) |
0 ( 0 - 0.2) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0 ( 0 - 0.1) |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
1.1 ( 0.2 - 3.5) |
Women |
N/A |
N/A |
2.6 ( 0 - 15.1) |
N/A |
N/A |
N/A |
1 ( 0 - 5.5) |
Total |
N/A |
1 ( 0.1 - 3.9) |
2.2 ( 0.2 - 7.9) |
N/A |
N/A |
N/A |
1.1 ( 0.3 - 2.9) |
Had a relative, friend, doctor or other health worker show concern or suggest cutting down amphetamine use in the last 12 months (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
7.1 ( 2.7 - 14.9) |
Women |
N/A |
N/A |
8.3 ( 0.9 - 27.8) |
N/A |
N/A |
N/A |
9.7 ( 2.7 - 22.8) |
Total |
N/A |
7.6 ( 1.8 - 19.9) |
7.1 ( 1.7 - 18.4) |
N/A |
N/A |
N/A |
8 ( 3.8 - 14.3) |
Unadjusted prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Ever wanted help to reduce the level of amphetamine use but did not get it (among total population) |
Men |
0 ( 0 - 0.1) |
0.5 ( 0.1 - 1.9) |
0.3 ( 0 - 1) |
0 ( 0 - 2.1) |
0.1 ( 0 - 0.2) |
Women |
0.2 ( 0 - 0.5) |
0.2 ( 0.1 - 0.6) |
0.1 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.2 ( 0 - 0.4) |
Total |
0.1 ( 0 - 0.3) |
0.4 ( 0.1 - 0.9) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.1 ( 0.1 - 0.3) |
Ever wanted help to reduce the level of amphetamine use but did not get it (among past-year amphetamine users) |
Men |
0.6 ( 0 - 3.7) |
N/A |
N/A |
N/A |
2.6 ( 0.4 - 8.2) |
Women |
4 ( 0.2 - 18.6) |
N/A |
N/A |
N/A |
3.8 ( 0.2 - 15.7) |
Total |
1.7 ( 0.2 - 6.3) |
9.2 ( 1.5 - 27.2) |
N/A |
N/A |
3 ( 0.8 - 7.5) |
Ever wanted help to reduce the level of amphetamine use but did not get it (among people who had ever used amphetamines) |
Men |
0.2 ( 0 - 1.2) |
4.2 ( 0.5 - 14.8) |
N/A |
N/A |
0.9 ( 0.2 - 2.6) |
Women |
3.2 ( 0.8 - 8.3) |
3.4 ( 1 - 8.2) |
N/A |
N/A |
3.1 ( 0.9 - 7.5) |
Total |
1.4 ( 0.4 - 3.5) |
3.9 ( 1.1 - 9.4) |
5.2 ( 0.8 - 16.3) |
N/A |
1.8 ( 0.7 - 3.6) |
Reason for ever wanting help but not getting it: social pressure to keep using drugs (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: not knowing where to go (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of the law or police (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of what might happen once contact was made with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: service not being appropriate for type of use (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of losing friends (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not spare the time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get in touch with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no local service available (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no transport to get there (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get appointment soon enough or at a suitable time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: lack of child care (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: cost (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among total population) |
Men |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.7) |
0.3 ( 0 - 1.1) |
0 ( 0 - 2.1) |
0 ( 0 - 0.1) |
Women |
0 ( 0 - 0.1) |
0.2 ( 0 - 0.6) |
0.3 ( 0 - 1) |
0 ( 0 - 1.4) |
0 ( 0 - 0.1) |
Total |
0 ( 0 - 0.1) |
0.1 ( 0 - 0.4) |
0.3 ( 0.1 - 0.7) |
0 ( 0 - 0.8) |
0 ( 0 - 0.1) |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among past-year amphetamine users) |
Men |
0 ( 0 - 6.7) |
N/A |
N/A |
N/A |
1.1 ( 0.2 - 3.5) |
Women |
0 ( 0 - 8) |
N/A |
N/A |
N/A |
1 ( 0 - 5.5) |
Total |
0 ( 0 - 3.7) |
3.5 ( 0.4 - 12.2) |
N/A |
N/A |
1.1 ( 0.3 - 2.9) |
Had a relative, friend, doctor or other health worker show concern or suggest cutting down amphetamine use in the last 12 months (among past-year amphetamine users) |
Men |
2.3 ( 0.3 - 8) |
N/A |
N/A |
N/A |
7.1 ( 2.7 - 14.9) |
Women |
7.8 ( 1.3 - 23.1) |
N/A |
N/A |
N/A |
9.7 ( 2.7 - 22.8) |
Total |
4.1 ( 1.3 - 9.5) |
26.8 ( 11 - 48.5) |
N/A |
N/A |
8 ( 3.8 - 14.3) |
Age-standardised prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Ever wanted help to reduce the level of amphetamine use but did not get it (among total population) |
Men |
0 ( 0 - 0.2) |
0.5 ( 0.1 - 2) |
0.3 ( 0 - 1) |
0 ( 0 - 2.1) |
0.1 ( 0 - 0.3) |
Women |
0.2 ( 0.1 - 0.6) |
0.2 ( 0.1 - 0.6) |
0.1 ( 0 - 0.6) |
0 ( 0 - 1.4) |
0.2 ( 0.1 - 0.5) |
Total |
0.1 ( 0 - 0.3) |
0.4 ( 0.1 - 0.9) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.1 ( 0.1 - 0.3) |
Ever wanted help to reduce the level of amphetamine use but did not get it (among past-year amphetamine users) |
Men |
0.7 ( 0 - 4.2) |
N/A |
N/A |
N/A |
2.5 ( 0.4 - 7.9) |
Women |
2.6 ( 0.1 - 11.4) |
N/A |
N/A |
N/A |
2.8 ( 0.2 - 10.9) |
Total |
1.3 ( 0.2 - 4.4) |
9.1 ( 1.4 - 27) |
N/A |
N/A |
2.6 ( 0.7 - 6.4) |
Ever wanted help to reduce the level of amphetamine use but did not get it (among people who had ever used amphetamines) |
Men |
0.3 ( 0 - 1.6) |
4.1 ( 0.5 - 14.4) |
N/A |
N/A |
1 ( 0.2 - 2.8) |
Women |
3 ( 0.7 - 7.8) |
3.3 ( 1 - 8.2) |
N/A |
N/A |
3 ( 0.9 - 7.1) |
Total |
1.4 ( 0.4 - 3.4) |
3.8 ( 1.1 - 9.2) |
5.2 ( 0.8 - 16.2) |
N/A |
1.8 ( 0.7 - 3.5) |
Reason for ever wanting help but not getting it: social pressure to keep using drugs (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: not knowing where to go (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of the law or police (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of what might happen once contact was made with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: service not being appropriate for type of use (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of losing friends (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not spare the time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get in touch with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no local service available (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no transport to get there (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get appointment soon enough or at a suitable time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: lack of child care (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: cost (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among total population) |
Men |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.8) |
0.3 ( 0 - 1) |
0 ( 0 - 2.1) |
0 ( 0 - 0.1) |
Women |
0 ( 0 - 0.1) |
0.2 ( 0 - 0.6) |
0.3 ( 0 - 1) |
0 ( 0 - 1.4) |
0 ( 0 - 0.1) |
Total |
0 ( 0 - 0.1) |
0.1 ( 0 - 0.5) |
0.3 ( 0.1 - 0.7) |
0 ( 0 - 0.8) |
0 ( 0 - 0.1) |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among past-year amphetamine users) |
Men |
0 ( 0 - 6.7) |
N/A |
N/A |
N/A |
1.2 ( 0.2 - 3.8) |
Women |
0 ( 0 - 8) |
N/A |
N/A |
N/A |
0.9 ( 0 - 5.4) |
Total |
0 ( 0 - 3.7) |
3.6 ( 0.4 - 12.9) |
N/A |
N/A |
1.1 ( 0.3 - 3) |
Had a relative, friend, doctor or other health worker show concern or suggest cutting down amphetamine use in the last 12 months (among past-year amphetamine users) |
Men |
2.5 ( 0.3 - 8.8) |
N/A |
N/A |
N/A |
7.2 ( 2.7 - 15) |
Women |
6.8 ( 0.8 - 22.3) |
N/A |
N/A |
N/A |
9 ( 2.3 - 22.3) |
Total |
4 ( 1.2 - 9.6) |
26 ( 10.8 - 47.1) |
N/A |
N/A |
7.8 ( 3.6 - 14.2) |
Standardised rate ratios by gender for each ethnic group compared to males and females in the total population |
|
European/Other |
Māori |
Pacific |
Asian |
Ever wanted help to reduce the level of amphetamine use but did not get it (among total population) |
Men |
0.33 ( 0 - 1.04) |
5.68 ( 2.03 - 9.32) |
2.91 ( 0 - 9.28) |
0 ( 0 - 0) |
Women |
1.19 ( 0.9 - 1.47) |
1.34 ( 0 - 3.45) |
0.59 ( 0 - 2.04) |
0 ( 0 - 0) |
Total |
0.91 ( 0.47 - 1.35) |
2.7 ( 0 - 5.51) |
1.34 ( 0 - 3.27) |
0 ( 0 - 0) |
Ever wanted help to reduce the level of amphetamine use but did not get it (among past-year amphetamine users) |
Men |
0.3 ( 0 - 0.97) |
N/A |
N/A |
N/A |
Women |
0.91 ( 0.32 - 1.5) |
N/A |
N/A |
N/A |
Total |
0.52 ( 0.03 - 1.01) |
3.51 ( 0.09 - 6.93) |
N/A |
N/A |
Ever wanted help to reduce the level of amphetamine use but did not get it (among people who had ever used amphetamines) |
Men |
0.28 ( 0 - 0.91) |
4.25 ( 1.39 - 7.11) |
N/A |
N/A |
Women |
1 ( 0.77 - 1.23) |
1.13 ( 0 - 2.86) |
N/A |
N/A |
Total |
0.78 ( 0.4 - 1.16) |
2.15 ( 0 - 4.35) |
2.92 ( 0 - 7.19) |
N/A |
Reason for ever wanting help but not getting it: social pressure to keep using drugs (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: not knowing where to go (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of the law or police (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of what might happen once contact was made with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: service not being appropriate for type of use (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of losing friends (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not spare the time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get in touch with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no local service available (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no transport to get there (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get appointment soon enough or at a suitable time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: lack of child care (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: cost (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among total population) |
Men |
0 ( 0 - 0) |
3.38 ( 0 - 10.88) |
6.57 ( 0 - 18.89) |
0 ( 0 - 0) |
Women |
0 ( 0 - 0) |
3.95 ( 0 - 9.54) |
6.96 ( 0 - 18.32) |
0 ( 0 - 0) |
Total |
0 ( 0 - 0) |
3.66 ( 0.3 - 7.02) |
6.76 ( 0.53 - 12.99) |
0 ( 0 - 0) |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among past-year amphetamine users) |
Men |
0 ( 0 - 0) |
N/A |
N/A |
N/A |
Women |
0 ( 0 - 0) |
N/A |
N/A |
N/A |
Total |
0 ( 0 - 0) |
3.21 ( 0 - 6.61) |
N/A |
N/A |
Had a relative, friend, doctor or other health worker show concern or suggest cutting down amphetamine use in the last 12 months (among past-year amphetamine users) |
Men |
0.36 ( 0 - 0.81) |
N/A |
N/A |
N/A |
Women |
0.75 ( 0.16 - 1.34) |
N/A |
N/A |
N/A |
Total |
0.51 ( 0.13 - 0.89) |
3.34 ( 1.45 - 5.23) |
N/A |
N/A |
Age-standardised rates by gender and NZDep2006 quintile |
|
1
(Least deprived) |
2 |
3 |
4 |
5
(Most deprived) |
Total |
Ever wanted help to reduce the level of amphetamine use but did not get it (among total population) |
Men |
0 ( 0 - 1.2) |
0 ( 0 - 0.9) |
0.1 ( 0 - 0.8) |
0.2 ( 0 - 1.2) |
0.1 ( 0 - 0.5) |
0.1 ( 0 - 0.3) |
Women |
0.5 ( 0.1 - 2.1) |
0 ( 0 - 0.2) |
0 ( 0 - 0.2) |
0.3 ( 0 - 1.1) |
0 ( 0 - 0.1) |
0.2 ( 0.1 - 0.5) |
Total |
0.3 ( 0 - 1.1) |
0 ( 0 - 0.1) |
0.1 ( 0 - 0.4) |
0.3 ( 0.1 - 0.7) |
0.1 ( 0 - 0.2) |
0.1 ( 0.1 - 0.3) |
Ever wanted help to reduce the level of amphetamine use but did not get it (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
2.5 ( 0.4 - 7.9) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
2.8 ( 0.2 - 10.9) |
Total |
N/A |
N/A |
N/A |
2.5 ( 0 - 14.4) |
1.8 ( 0 - 10.6) |
2.6 ( 0.7 - 6.4) |
Ever wanted help to reduce the level of amphetamine use but did not get it (among people who had ever used amphetamines) |
Men |
N/A |
0 ( 0 - 8.6) |
1.2 ( 0 - 6.6) |
2.2 ( 0 - 12.3) |
1.4 ( 0.1 - 5.4) |
1 ( 0.2 - 2.8) |
Women |
N/A |
0.8 ( 0 - 4.6) |
0.4 ( 0 - 2.6) |
4.4 ( 0.5 - 15.4) |
0.3 ( 0 - 1.9) |
3 ( 0.9 - 7.1) |
Total |
4.5 ( 0.4 - 17.3) |
0.2 ( 0 - 1.1) |
0.9 ( 0.1 - 3.8) |
3.1 ( 0.6 - 9.1) |
1 ( 0.1 - 3.2) |
1.8 ( 0.7 - 3.5) |
Reason for ever wanting help but not getting it: social pressure to keep using drugs (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: not knowing where to go (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of the law or police (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of what might happen once contact was made with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: service not being appropriate for type of use (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: afraid of losing friends (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not spare the time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get in touch with the service (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no local service available (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: no transport to get there (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: could not get appointment soon enough or at a suitable time (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: lack of child care (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Reason for ever wanting help but not getting it: cost (among people who had ever wanted help to reduce the level of amphetamine use but not received it) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Total |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among total population) |
Men |
0 ( 0 - 1.2) |
0 ( 0 - 0.9) |
0 ( 0 - 0.8) |
0.1 ( 0 - 0.5) |
0.1 ( 0 - 0.5) |
0 ( 0 - 0.1) |
Women |
0 ( 0 - 0.7) |
0 ( 0 - 0.5) |
0 ( 0 - 0.5) |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.5) |
0 ( 0 - 0.1) |
Total |
0 ( 0 - 0.4) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.3) |
0.1 ( 0 - 0.3) |
0 ( 0 - 0.1) |
Wanted help to reduce level of amphetamine use in the past 12 months but did not get it (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
1.2 ( 0.2 - 3.8) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
0.9 ( 0 - 5.4) |
Total |
N/A |
N/A |
N/A |
1.2 ( 0 - 6.9) |
5.6 ( 1 - 16.8) |
1.1 ( 0.3 - 3) |
Had a relative, friend, doctor or other health worker show concern or suggest cutting down amphetamine use in the last 12 months (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
7.2 ( 2.7 - 15) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
9 ( 2.3 - 22.3) |
Total |
N/A |
N/A |
N/A |
6.5 ( 1.2 - 18.4) |
22.2 ( 4.1 - 54.6) |
7.8 ( 3.6 - 14.2) |
300
300
105
3
R1:R65536
False
False
Chapter5a: Amphetamines |
Harmful effects in past year |
|
Unadjusted prevalence by gender and age groups |
|
16-17 |
18-24 |
25-34 |
35-44 |
45-54 |
55-64 |
Total |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
20.7 ( 11.1 - 33.6) |
Women |
N/A |
N/A |
21.3 ( 5 - 49.3) |
N/A |
N/A |
N/A |
17 ( 7.6 - 30.7) |
Total |
N/A |
10.6 ( 2.4 - 27.3) |
22.4 ( 10.5 - 38.7) |
N/A |
N/A |
N/A |
19.4 ( 11.6 - 27.2) |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
12.7 ( 4.8 - 25.7) |
Women |
N/A |
N/A |
9 ( 0.7 - 32.9) |
N/A |
N/A |
N/A |
12 ( 4.4 - 24.7) |
Total |
N/A |
5.2 ( 1 - 15.1) |
12.3 ( 4.8 - 24.5) |
N/A |
N/A |
N/A |
12.5 ( 6.1 - 21.8) |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
12.7 ( 4.3 - 26.9) |
Women |
N/A |
N/A |
18.3 ( 4.2 - 43.9) |
N/A |
N/A |
N/A |
15.4 ( 6.6 - 28.6) |
Total |
N/A |
4.1 ( 0.5 - 14.4) |
12.9 ( 4.8 - 26.1) |
N/A |
N/A |
N/A |
13.6 ( 6.9 - 23.2) |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
7.8 ( 1.5 - 21.8) |
Women |
N/A |
N/A |
0 ( 0 - 11.6) |
N/A |
N/A |
N/A |
5.3 ( 1.1 - 14.9) |
Total |
N/A |
2.8 ( 0.6 - 8.2) |
1.5 ( 0 - 8.4) |
N/A |
N/A |
N/A |
6.9 ( 1.9 - 16.9) |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
10 ( 3.7 - 20.9) |
Women |
N/A |
N/A |
9.5 ( 1.7 - 26.9) |
N/A |
N/A |
N/A |
11 ( 3.8 - 23.5) |
Total |
N/A |
10.2 ( 2.1 - 27.2) |
10.2 ( 2.9 - 24.1) |
N/A |
N/A |
N/A |
10.4 ( 5.4 - 17.6) |
Experienced injuries in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
1.2 ( 0 - 6.5) |
Women |
N/A |
N/A |
0 ( 0 - 11.6) |
N/A |
N/A |
N/A |
4.7 ( 0.5 - 16.3) |
Total |
N/A |
2.4 ( 0 - 13.6) |
0 ( 0 - 6.4) |
N/A |
N/A |
N/A |
2.4 ( 0.5 - 6.7) |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
8.4 ( 1.7 - 23.2) |
Women |
N/A |
N/A |
0 ( 0 - 11.6) |
N/A |
N/A |
N/A |
1.5 ( 0.1 - 6) |
Total |
N/A |
0.6 ( 0 - 3.3) |
2.4 ( 0.2 - 8.9) |
N/A |
N/A |
N/A |
6 ( 1.2 - 16.9) |
Experienced legal problems in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
2.2 ( 0.3 - 7.3) |
Women |
N/A |
N/A |
3.3 ( 0.3 - 12.6) |
N/A |
N/A |
N/A |
5.3 ( 1 - 15.7) |
Total |
N/A |
3.9 ( 0.4 - 14) |
3.9 ( 0.9 - 10.4) |
N/A |
N/A |
N/A |
3.3 ( 1.1 - 7.4) |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
14.6 ( 5.6 - 28.8) |
Women |
N/A |
N/A |
28.3 ( 6 - 63.3) |
N/A |
N/A |
N/A |
13.2 ( 3.7 - 30.3) |
Total |
N/A |
10 ( 1.7 - 29) |
23 ( 9.3 - 42.8) |
N/A |
N/A |
N/A |
14.1 ( 7.1 - 24) |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among total population) |
Men |
0.3 ( 0 - 1.5) |
0.9 ( 0.1 - 3.1) |
0.9 ( 0.3 - 2.1) |
1.2 ( 0.3 - 3.2) |
0 ( 0 - 0.2) |
0 ( 0 - 0.9) |
0.6 ( 0.3 - 1.1) |
Women |
0 ( 0 - 2.9) |
0.4 ( 0.1 - 1.5) |
0.6 ( 0.2 - 1.3) |
0.4 ( 0.1 - 1) |
0 ( 0 - 0.2) |
0 ( 0 - 0.5) |
0.3 ( 0.1 - 0.5) |
Total |
0.1 ( 0 - 0.8) |
0.7 ( 0.2 - 1.7) |
0.7 ( 0.4 - 1.3) |
0.8 ( 0.3 - 1.7) |
0 ( 0 - 0.1) |
0 ( 0 - 0.3) |
0.4 ( 0.2 - 0.6) |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 3.7) |
0.3 ( 0.1 - 0.9) |
0.6 ( 0.2 - 1.4) |
0.8 ( 0.1 - 2.9) |
0 ( 0 - 0.2) |
0 ( 0 - 0.9) |
0.4 ( 0.1 - 0.8) |
Women |
0 ( 0 - 2.9) |
0.3 ( 0 - 1.5) |
0.3 ( 0.1 - 0.9) |
0.3 ( 0.1 - 0.8) |
0 ( 0 - 0.2) |
0 ( 0 - 0.5) |
0.2 ( 0.1 - 0.4) |
Total |
0 ( 0 - 1.6) |
0.3 ( 0.1 - 0.9) |
0.4 ( 0.2 - 0.8) |
0.6 ( 0.1 - 1.5) |
0 ( 0 - 0.1) |
0 ( 0 - 0.3) |
0.3 ( 0.1 - 0.5) |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 3.7) |
0.2 ( 0 - 0.7) |
0.4 ( 0.1 - 1.2) |
1.1 ( 0.2 - 3.2) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0.4 ( 0.1 - 0.8) |
Women |
0 ( 0 - 2.9) |
0.3 ( 0 - 1.5) |
0.5 ( 0.2 - 1.1) |
0.4 ( 0.1 - 1) |
0 ( 0 - 0.2) |
0 ( 0 - 0.5) |
0.3 ( 0.1 - 0.4) |
Total |
0 ( 0 - 1.6) |
0.3 ( 0 - 0.8) |
0.4 ( 0.2 - 0.9) |
0.7 ( 0.2 - 1.7) |
0 ( 0 - 0.1) |
0 ( 0 - 0.3) |
0.3 ( 0.2 - 0.5) |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 3.7) |
0.3 ( 0.1 - 0.9) |
0.1 ( 0 - 0.6) |
0.7 ( 0.1 - 2.8) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0.2 ( 0 - 0.6) |
Women |
0 ( 0 - 2.9) |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.3) |
0.3 ( 0.1 - 0.8) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0.1 ( 0 - 0.2) |
Total |
0 ( 0 - 1.6) |
0.2 ( 0 - 0.5) |
0.1 ( 0 - 0.3) |
0.5 ( 0.1 - 1.5) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.4) |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among total population) |
Men |
0.3 ( 0 - 1.5) |
0.9 ( 0.1 - 3.1) |
0.4 ( 0.1 - 1.5) |
0.3 ( 0 - 1.2) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0.3 ( 0.1 - 0.7) |
Women |
0 ( 0 - 2.9) |
0.4 ( 0 - 1.5) |
0.3 ( 0.1 - 0.7) |
0.2 ( 0 - 0.8) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0.2 ( 0.1 - 0.3) |
Total |
0.1 ( 0 - 0.8) |
0.6 ( 0.1 - 1.7) |
0.4 ( 0.1 - 0.8) |
0.3 ( 0.1 - 0.7) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0.2 ( 0.1 - 0.4) |
Experienced injuries in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 3.7) |
0 ( 0 - 1.1) |
0 ( 0 - 0.7) |
0.1 ( 0 - 0.8) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0 ( 0 - 0.2) |
Women |
0 ( 0 - 2.9) |
0.3 ( 0 - 1.5) |
0.1 ( 0 - 0.3) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0.1 ( 0 - 0.2) |
Total |
0 ( 0 - 1.6) |
0.1 ( 0 - 0.8) |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.1) |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 3.7) |
0.1 ( 0 - 0.4) |
0.2 ( 0 - 0.6) |
0.8 ( 0.1 - 3) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0.2 ( 0 - 0.7) |
Women |
0 ( 0 - 2.9) |
0 ( 0 - 0.7) |
0 ( 0 - 0.4) |
0.1 ( 0 - 0.3) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0 ( 0 - 0.1) |
Total |
0 ( 0 - 1.6) |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.3) |
0.4 ( 0.1 - 1.5) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.4) |
Experienced legal problems in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 3.7) |
0.2 ( 0 - 0.7) |
0.2 ( 0 - 0.7) |
0 ( 0 - 0.7) |
0 ( 0 - 0.8) |
0 ( 0 - 0.9) |
0.1 ( 0 - 0.2) |
Women |
0 ( 0 - 2.9) |
0.3 ( 0 - 1.5) |
0.1 ( 0 - 0.3) |
0.1 ( 0 - 0.3) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0.1 ( 0 - 0.2) |
Total |
0 ( 0 - 1.6) |
0.2 ( 0 - 0.8) |
0.1 ( 0 - 0.3) |
0 ( 0 - 0.1) |
0 ( 0 - 0.3) |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.2) |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 3.7) |
0.8 ( 0.1 - 3) |
0.8 ( 0.2 - 2.1) |
0.5 ( 0 - 2.1) |
0 ( 0 - 0.2) |
0 ( 0 - 0.9) |
0.4 ( 0.2 - 0.8) |
Women |
0 ( 0 - 2.9) |
0.3 ( 0 - 1.5) |
0.7 ( 0.2 - 1.9) |
0 ( 0 - 0.3) |
0 ( 0 - 0.4) |
0 ( 0 - 0.5) |
0.2 ( 0.1 - 0.4) |
Total |
0 ( 0 - 1.6) |
0.6 ( 0.1 - 1.6) |
0.7 ( 0.3 - 1.5) |
0.2 ( 0 - 1) |
0 ( 0 - 0.1) |
0 ( 0 - 0.3) |
0.3 ( 0.1 - 0.5) |
Unadjusted prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
19.1 ( 8.7 - 34.1) |
N/A |
N/A |
N/A |
20.7 ( 11.1 - 33.6) |
Women |
15.2 ( 5.4 - 31.3) |
N/A |
N/A |
N/A |
17 ( 7.6 - 30.7) |
Total |
17.8 ( 9.8 - 28.5) |
28.1 ( 14.9 - 44.8) |
N/A |
N/A |
19.4 ( 11.6 - 27.2) |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
10.6 ( 2.6 - 26.3) |
N/A |
N/A |
N/A |
12.7 ( 4.8 - 25.7) |
Women |
12.1 ( 3.6 - 27.5) |
N/A |
N/A |
N/A |
12 ( 4.4 - 24.7) |
Total |
11.1 ( 4.3 - 22.1) |
18.7 ( 8.3 - 33.9) |
N/A |
N/A |
12.5 ( 6.1 - 21.8) |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
12.1 ( 3.1 - 28.9) |
N/A |
N/A |
N/A |
12.7 ( 4.3 - 26.9) |
Women |
13.3 ( 4.3 - 28.7) |
N/A |
N/A |
N/A |
15.4 ( 6.6 - 28.6) |
Total |
12.5 ( 5.2 - 23.8) |
14.9 ( 5.5 - 29.9) |
N/A |
N/A |
13.6 ( 6.9 - 23.2) |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
6.1 ( 0.4 - 24.2) |
N/A |
N/A |
N/A |
7.8 ( 1.5 - 21.8) |
Women |
6.1 ( 1.2 - 17.6) |
N/A |
N/A |
N/A |
5.3 ( 1.1 - 14.9) |
Total |
6.1 ( 1 - 18.3) |
11.2 ( 3.4 - 25.6) |
N/A |
N/A |
6.9 ( 1.9 - 16.9) |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
8.6 ( 2.2 - 21.4) |
N/A |
N/A |
N/A |
10 ( 3.7 - 20.9) |
Women |
9.6 ( 2.4 - 23.9) |
N/A |
N/A |
N/A |
11 ( 3.8 - 23.5) |
Total |
9 ( 3.8 - 17.3) |
18.2 ( 7.9 - 33.3) |
N/A |
N/A |
10.4 ( 5.4 - 17.6) |
Experienced injuries in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0 ( 0 - 6.8) |
N/A |
N/A |
N/A |
1.2 ( 0 - 6.5) |
Women |
5.5 ( 0.6 - 19.2) |
N/A |
N/A |
N/A |
4.7 ( 0.5 - 16.3) |
Total |
1.8 ( 0.2 - 6.2) |
5.1 ( 0.3 - 20.8) |
N/A |
N/A |
2.4 ( 0.5 - 6.7) |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
8.1 ( 1.1 - 25.7) |
N/A |
N/A |
N/A |
8.4 ( 1.7 - 23.2) |
Women |
1.7 ( 0.1 - 7) |
N/A |
N/A |
N/A |
1.5 ( 0.1 - 6) |
Total |
5.9 ( 0.8 - 19) |
2.9 ( 0.3 - 11) |
N/A |
N/A |
6 ( 1.2 - 16.9) |
Experienced legal problems in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
2 ( 0.2 - 8.2) |
N/A |
N/A |
N/A |
2.2 ( 0.3 - 7.3) |
Women |
6.2 ( 1.1 - 18.4) |
N/A |
N/A |
N/A |
5.3 ( 1 - 15.7) |
Total |
3.5 ( 1 - 8.3) |
7.4 ( 2.1 - 17.8) |
N/A |
N/A |
3.3 ( 1.1 - 7.4) |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
14.4 ( 4.7 - 30.8) |
N/A |
N/A |
N/A |
14.6 ( 5.6 - 28.8) |
Women |
14.6 ( 3.7 - 34.6) |
N/A |
N/A |
N/A |
13.2 ( 3.7 - 30.3) |
Total |
14.4 ( 6.7 - 25.8) |
10.5 ( 2.6 - 26.1) |
N/A |
N/A |
14.1 ( 7.1 - 24) |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among total population) |
Men |
0.6 ( 0.3 - 1.3) |
1.3 ( 0.6 - 2.4) |
0.2 ( 0 - 1) |
0 ( 0 - 2.1) |
0.6 ( 0.3 - 1.1) |
Women |
0.3 ( 0.1 - 0.5) |
0.8 ( 0.4 - 1.4) |
0.1 ( 0 - 0.8) |
0 ( 0 - 1.4) |
0.3 ( 0.1 - 0.5) |
Total |
0.4 ( 0.2 - 0.8) |
1 ( 0.6 - 1.5) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.4 ( 0.2 - 0.6) |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among total population) |
Men |
0.3 ( 0.1 - 0.9) |
1 ( 0.4 - 2.1) |
0.2 ( 0 - 1) |
0 ( 0 - 2.1) |
0.4 ( 0.1 - 0.8) |
Women |
0.2 ( 0.1 - 0.4) |
0.4 ( 0.1 - 0.8) |
0.1 ( 0 - 0.8) |
0 ( 0 - 1.4) |
0.2 ( 0.1 - 0.4) |
Total |
0.3 ( 0.1 - 0.5) |
0.6 ( 0.3 - 1.1) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.3 ( 0.1 - 0.5) |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among total population) |
Men |
0.4 ( 0.1 - 1) |
0.4 ( 0 - 1.5) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.4 ( 0.1 - 0.8) |
Women |
0.2 ( 0.1 - 0.5) |
0.6 ( 0.2 - 1.3) |
0.1 ( 0 - 0.8) |
0 ( 0 - 1.4) |
0.3 ( 0.1 - 0.4) |
Total |
0.3 ( 0.1 - 0.6) |
0.5 ( 0.2 - 1) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.3 ( 0.2 - 0.5) |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among total population) |
Men |
0.2 ( 0 - 0.8) |
0.6 ( 0.2 - 1.7) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.2 ( 0 - 0.6) |
Women |
0.1 ( 0 - 0.3) |
0.1 ( 0 - 0.5) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.1 ( 0 - 0.2) |
Total |
0.1 ( 0 - 0.4) |
0.4 ( 0.1 - 0.8) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.1 ( 0 - 0.4) |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among total population) |
Men |
0.3 ( 0.1 - 0.8) |
0.7 ( 0.2 - 1.8) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.3 ( 0.1 - 0.7) |
Women |
0.2 ( 0.1 - 0.4) |
0.6 ( 0.2 - 1.3) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.2 ( 0.1 - 0.3) |
Total |
0.2 ( 0.1 - 0.4) |
0.7 ( 0.3 - 1.2) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.2 ( 0.1 - 0.4) |
Experienced injuries in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 0.2) |
0.3 ( 0 - 1.5) |
0 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0 ( 0 - 0.2) |
Women |
0.1 ( 0 - 0.3) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.1 ( 0 - 0.2) |
Total |
0 ( 0 - 0.1) |
0.2 ( 0 - 0.7) |
0 ( 0 - 0.5) |
0 ( 0 - 0.8) |
0.1 ( 0 - 0.1) |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among total population) |
Men |
0.3 ( 0 - 0.9) |
0.2 ( 0 - 0.7) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.2 ( 0 - 0.7) |
Women |
0 ( 0 - 0.1) |
0 ( 0 - 0.3) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0 ( 0 - 0.1) |
Total |
0.1 ( 0 - 0.5) |
0.1 ( 0 - 0.3) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.1 ( 0 - 0.4) |
Experienced legal problems in the past 12 months due to own amphetamine use (among total population) |
Men |
0.1 ( 0 - 0.3) |
0.3 ( 0 - 0.9) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.1 ( 0 - 0.2) |
Women |
0.1 ( 0 - 0.3) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.1 ( 0 - 0.2) |
Total |
0.1 ( 0 - 0.2) |
0.2 ( 0.1 - 0.6) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.1 ( 0 - 0.2) |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among total population) |
Men |
0.4 ( 0.2 - 1) |
0.5 ( 0.1 - 1.6) |
0 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0.4 ( 0.2 - 0.8) |
Women |
0.2 ( 0.1 - 0.5) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.2 ( 0.1 - 0.4) |
Total |
0.3 ( 0.2 - 0.6) |
0.3 ( 0.1 - 0.8) |
0 ( 0 - 0.5) |
0 ( 0 - 0.8) |
0.3 ( 0.1 - 0.5) |
Age-standardised prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
17.9 ( 8.4 - 31.5) |
N/A |
N/A |
N/A |
19.7 ( 10.8 - 31.5) |
Women |
13.7 ( 4.4 - 29.9) |
N/A |
N/A |
N/A |
15.7 ( 6.7 - 29.5) |
Total |
16.5 ( 9.3 - 26.1) |
28.3 ( 15.1 - 45) |
N/A |
N/A |
18.3 ( 11.1 - 25.5) |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
9.3 ( 2.6 - 22.2) |
N/A |
N/A |
N/A |
11.7 ( 4.7 - 22.9) |
Women |
10.6 ( 2.7 - 26) |
N/A |
N/A |
N/A |
10.8 ( 3.6 - 23.4) |
Total |
9.7 ( 4 - 19) |
18.8 ( 8.4 - 34) |
N/A |
N/A |
11.4 ( 5.8 - 19.5) |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
10 ( 2.8 - 23.8) |
N/A |
N/A |
N/A |
11.1 ( 4 - 23.2) |
Women |
11.7 ( 3.3 - 27.2) |
N/A |
N/A |
N/A |
14.1 ( 5.7 - 27.3) |
Total |
10.6 ( 4.6 - 20) |
14.5 ( 5.5 - 29.1) |
N/A |
N/A |
12.2 ( 6.4 - 20.4) |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
5 ( 0.4 - 19) |
N/A |
N/A |
N/A |
6.9 ( 1.5 - 18.4) |
Women |
4.4 ( 0.9 - 12.5) |
N/A |
N/A |
N/A |
4.1 ( 0.8 - 11.5) |
Total |
4.8 ( 0.9 - 14) |
10.8 ( 3.3 - 24.6) |
N/A |
N/A |
5.9 ( 1.8 - 13.9) |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
9 ( 2.2 - 22.7) |
N/A |
N/A |
N/A |
10.2 ( 3.6 - 21.5) |
Women |
8.6 ( 1.8 - 22.9) |
N/A |
N/A |
N/A |
10.3 ( 3.3 - 23) |
Total |
8.8 ( 3.5 - 17.7) |
17.9 ( 7.8 - 32.6) |
N/A |
N/A |
10.3 ( 5.2 - 17.7) |
Experienced injuries in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0 ( 0 - 6.8) |
N/A |
N/A |
N/A |
0.9 ( 0 - 5.2) |
Women |
5.3 ( 0.4 - 21.1) |
N/A |
N/A |
N/A |
4.6 ( 0.4 - 17.8) |
Total |
1.8 ( 0.2 - 7.1) |
4.9 ( 0.3 - 19.9) |
N/A |
N/A |
2.2 ( 0.4 - 6.8) |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
6.2 ( 0.9 - 19.7) |
N/A |
N/A |
N/A |
7.1 ( 1.5 - 19) |
Women |
1.1 ( 0.1 - 4.7) |
N/A |
N/A |
N/A |
1.1 ( 0.1 - 4.4) |
Total |
4.4 ( 0.7 - 14.1) |
3 ( 0.3 - 11.4) |
N/A |
N/A |
5 ( 1.1 - 13.6) |
Experienced legal problems in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
2.2 ( 0.2 - 8.9) |
N/A |
N/A |
N/A |
2.3 ( 0.3 - 7.9) |
Women |
6.2 ( 0.8 - 20.3) |
N/A |
N/A |
N/A |
5.4 ( 0.8 - 17.3) |
Total |
3.6 ( 1 - 9.1) |
7.5 ( 2.1 - 17.9) |
N/A |
N/A |
3.4 ( 1 - 8.1) |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
14.7 ( 4.9 - 31.2) |
N/A |
N/A |
N/A |
14.5 ( 5.6 - 28.7) |
Women |
15 ( 3.8 - 35.8) |
N/A |
N/A |
N/A |
13.4 ( 3.7 - 31) |
Total |
14.8 ( 6.9 - 26.3) |
10.4 ( 2.6 - 25.7) |
N/A |
N/A |
14.1 ( 7.2 - 24.1) |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among total population) |
Men |
0.8 ( 0.3 - 1.5) |
1.3 ( 0.6 - 2.5) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.7 ( 0.4 - 1.2) |
Women |
0.3 ( 0.1 - 0.7) |
0.8 ( 0.4 - 1.5) |
0.1 ( 0 - 0.8) |
0 ( 0 - 1.4) |
0.3 ( 0.2 - 0.6) |
Total |
0.5 ( 0.3 - 0.9) |
1 ( 0.7 - 1.6) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.5 ( 0.3 - 0.7) |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among total population) |
Men |
0.4 ( 0.1 - 1) |
1 ( 0.4 - 2.1) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.4 ( 0.2 - 0.8) |
Women |
0.2 ( 0.1 - 0.6) |
0.4 ( 0.1 - 0.8) |
0.1 ( 0 - 0.8) |
0 ( 0 - 1.4) |
0.2 ( 0.1 - 0.4) |
Total |
0.3 ( 0.1 - 0.6) |
0.7 ( 0.3 - 1.2) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.8) |
0.3 ( 0.2 - 0.5) |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among total population) |
Men |
0.4 ( 0.1 - 1) |
0.4 ( 0 - 1.4) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.4 ( 0.1 - 0.8) |
Women |
0.3 ( 0.1 - 0.6) |
0.6 ( 0.3 - 1.3) |
0.1 ( 0 - 0.8) |
0 ( 0 - 1.4) |
0.3 ( 0.1 - 0.5) |
Total |
0.3 ( 0.2 - 0.7) |
0.5 ( 0.2 - 1) |
0.1 ( 0 - 0.5) |
0 ( 0 - 0.8) |
0.3 ( 0.2 - 0.6) |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among total population) |
Men |
0.2 ( 0 - 0.8) |
0.6 ( 0.1 - 1.7) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.2 ( 0.1 - 0.7) |
Women |
0.1 ( 0 - 0.3) |
0.1 ( 0 - 0.5) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.1 ( 0 - 0.2) |
Total |
0.2 ( 0 - 0.4) |
0.4 ( 0.1 - 0.8) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.2 ( 0.1 - 0.4) |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among total population) |
Men |
0.4 ( 0.1 - 1.1) |
0.7 ( 0.2 - 1.8) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.4 ( 0.1 - 0.8) |
Women |
0.2 ( 0.1 - 0.5) |
0.6 ( 0.2 - 1.3) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.2 ( 0.1 - 0.4) |
Total |
0.3 ( 0.1 - 0.6) |
0.7 ( 0.3 - 1.2) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.3 ( 0.1 - 0.5) |
Experienced injuries in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 0.2) |
0.3 ( 0 - 1.5) |
0 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0 ( 0 - 0.2) |
Women |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.1 ( 0 - 0.3) |
Total |
0.1 ( 0 - 0.2) |
0.2 ( 0 - 0.7) |
0 ( 0 - 0.5) |
0 ( 0 - 0.8) |
0.1 ( 0 - 0.2) |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among total population) |
Men |
0.3 ( 0 - 0.9) |
0.2 ( 0 - 0.8) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.2 ( 0.1 - 0.7) |
Women |
0 ( 0 - 0.1) |
0 ( 0 - 0.3) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0 ( 0 - 0.1) |
Total |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.1 ( 0 - 0.4) |
Experienced legal problems in the past 12 months due to own amphetamine use (among total population) |
Men |
0.1 ( 0 - 0.4) |
0.3 ( 0 - 1) |
0.2 ( 0 - 0.9) |
0 ( 0 - 2.1) |
0.1 ( 0 - 0.3) |
Women |
0.1 ( 0 - 0.4) |
0.2 ( 0 - 0.6) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.1 ( 0 - 0.3) |
Total |
0.1 ( 0 - 0.3) |
0.2 ( 0.1 - 0.6) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.1 ( 0 - 0.2) |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among total population) |
Men |
0.6 ( 0.2 - 1.3) |
0.6 ( 0.1 - 1.7) |
0 ( 0 - 1.2) |
0 ( 0 - 2.1) |
0.5 ( 0.2 - 1) |
Women |
0.3 ( 0.1 - 0.8) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.2 ( 0.1 - 0.6) |
Total |
0.4 ( 0.2 - 0.8) |
0.3 ( 0.1 - 0.8) |
0 ( 0 - 0.5) |
0 ( 0 - 0.8) |
0.4 ( 0.2 - 0.6) |
Standardised rate ratios by gender for each ethnic group compared to males and females in the total population |
|
European/Other |
Māori |
Pacific |
Asian |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0.91 ( 0.74 - 1.08) |
N/A |
N/A |
N/A |
Women |
0.87 ( 0.59 - 1.15) |
N/A |
N/A |
N/A |
Total |
0.9 ( 0.76 - 1.04) |
1.55 ( 0.7 - 2.4) |
N/A |
N/A |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0.8 ( 0.48 - 1.11) |
N/A |
N/A |
N/A |
Women |
0.98 ( 0.76 - 1.2) |
N/A |
N/A |
N/A |
Total |
0.86 ( 0.65 - 1.06) |
1.66 ( 0.38 - 2.93) |
N/A |
N/A |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0.9 ( 0.62 - 1.17) |
N/A |
N/A |
N/A |
Women |
0.83 ( 0.51 - 1.16) |
N/A |
N/A |
N/A |
Total |
0.87 ( 0.67 - 1.07) |
1.19 ( 0.19 - 2.2) |
N/A |
N/A |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0.73 ( 0.07 - 1.4) |
N/A |
N/A |
N/A |
Women |
1.07 ( 0.97 - 1.17) |
N/A |
N/A |
N/A |
Total |
0.82 ( 0.4 - 1.23) |
1.83 ( 0 - 4.48) |
N/A |
N/A |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0.88 ( 0.53 - 1.22) |
N/A |
N/A |
N/A |
Women |
0.83 ( 0.4 - 1.26) |
N/A |
N/A |
N/A |
Total |
0.86 ( 0.62 - 1.11) |
1.74 ( 0.43 - 3.05) |
N/A |
N/A |
Experienced injuries in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0 ( 0 - 0) |
N/A |
N/A |
N/A |
Women |
1.14 ( 0.96 - 1.32) |
N/A |
N/A |
N/A |
Total |
0.82 ( 0 - 1.74) |
2.22 ( 0 - 7.65) |
N/A |
N/A |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0.88 ( 0.51 - 1.24) |
N/A |
N/A |
N/A |
Women |
1.05 ( 0.96 - 1.13) |
N/A |
N/A |
N/A |
Total |
0.9 ( 0.54 - 1.25) |
0.61 ( 0 - 2.03) |
N/A |
N/A |
Experienced legal problems in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
0.95 ( 0.3 - 1.61) |
N/A |
N/A |
N/A |
Women |
1.15 ( 1.04 - 1.26) |
N/A |
N/A |
N/A |
Total |
1.05 ( 0.85 - 1.26) |
2.19 ( 0 - 4.66) |
N/A |
N/A |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
1.01 ( 0.82 - 1.2) |
N/A |
N/A |
N/A |
Women |
1.12 ( 0.97 - 1.27) |
N/A |
N/A |
N/A |
Total |
1.05 ( 0.91 - 1.18) |
0.73 ( 0 - 1.5) |
N/A |
N/A |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among total population) |
Men |
1.11 ( 0.89 - 1.32) |
1.89 ( 0.34 - 3.44) |
0.35 ( 0 - 0.91) |
0 ( 0 - 0) |
Women |
0.99 ( 0.67 - 1.31) |
2.43 ( 0.85 - 4.01) |
0.41 ( 0 - 1.27) |
0 ( 0 - 0) |
Total |
1.07 ( 0.89 - 1.24) |
2.05 ( 0.92 - 3.18) |
0.37 ( 0 - 0.84) |
0 ( 0 - 0) |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among total population) |
Men |
0.96 ( 0.58 - 1.34) |
2.42 ( 0 - 4.9) |
0.6 ( 0 - 1.64) |
0 ( 0 - 0) |
Women |
1.11 ( 0.81 - 1.41) |
1.77 ( 0 - 3.72) |
0.64 ( 0 - 2.04) |
0 ( 0 - 0) |
Total |
1.01 ( 0.76 - 1.27) |
2.14 ( 0.53 - 3.75) |
0.61 ( 0 - 1.44) |
0 ( 0 - 0) |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among total population) |
Men |
1.08 ( 0.75 - 1.41) |
1 ( 0 - 2.75) |
0.42 ( 0 - 1.38) |
0 ( 0 - 0) |
Women |
0.98 ( 0.64 - 1.33) |
2.14 ( 0.34 - 3.94) |
0.47 ( 0 - 1.45) |
0 ( 0 - 0) |
Total |
1.03 ( 0.8 - 1.27) |
1.54 ( 0.27 - 2.8) |
0.44 ( 0 - 1.12) |
0 ( 0 - 0) |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among total population) |
Men |
0.89 ( 0.09 - 1.69) |
2.54 ( 0 - 7.51) |
0.66 ( 0 - 2.5) |
0 ( 0 - 0) |
Women |
1.28 ( 1.2 - 1.36) |
1.59 ( 0 - 4.45) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1 ( 0.55 - 1.45) |
2.21 ( 0 - 5.4) |
0.48 ( 0 - 1.63) |
0 ( 0 - 0) |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among total population) |
Men |
1.08 ( 0.68 - 1.48) |
1.96 ( 0 - 4.39) |
0.42 ( 0 - 1.37) |
0 ( 0 - 0) |
Women |
0.96 ( 0.48 - 1.44) |
3 ( 0.15 - 5.86) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1.03 ( 0.75 - 1.32) |
2.34 ( 0.64 - 4.04) |
0.27 ( 0 - 0.82) |
0 ( 0 - 0) |
Experienced injuries in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 0) |
8.29 ( 7.11 - 9.48) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Women |
1.35 ( 1.23 - 1.46) |
0.84 ( 0 - 3.84) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1.03 ( 0.16 - 1.89) |
2.56 ( 0 - 8.07) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among total population) |
Men |
1.07 ( 0.62 - 1.51) |
0.87 ( 0 - 2.9) |
0.66 ( 0 - 2.51) |
0 ( 0 - 0) |
Women |
1.24 ( 1.2 - 1.28) |
0 ( 0 - 0) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1.08 ( 0.65 - 1.51) |
0.77 ( 0 - 2.63) |
0.6 ( 0 - 2.36) |
0 ( 0 - 0) |
Experienced legal problems in the past 12 months due to own amphetamine use (among total population) |
Men |
1.16 ( 0.36 - 1.95) |
3.46 ( 0.16 - 6.77) |
1.98 ( 0 - 8.93) |
0 ( 0 - 0) |
Women |
1.36 ( 1.27 - 1.44) |
2.26 ( 0 - 9.23) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1.27 ( 1.02 - 1.51) |
2.77 ( 0 - 5.88) |
0.88 ( 0 - 2.95) |
0 ( 0 - 0) |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among total population) |
Men |
1.21 ( 0.98 - 1.45) |
1.13 ( 0 - 2.65) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Women |
1.32 ( 1.16 - 1.48) |
0.5 ( 0 - 1.44) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1.25 ( 1.09 - 1.41) |
0.89 ( 0 - 1.85) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Age-standardised rates by gender and NZDep2006 quintile |
|
1
(Least deprived) |
2 |
3 |
4 |
5
(Most deprived) |
Total |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
19.7 ( 10.8 - 31.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
15.7 ( 6.7 - 29.5) |
Total |
N/A |
N/A |
N/A |
12.1 ( 4.1 - 25.7) |
46 ( 19.9 - 73.8) |
18.3 ( 11.1 - 25.5) |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
11.7 ( 4.7 - 22.9) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
10.8 ( 3.6 - 23.4) |
Total |
N/A |
N/A |
N/A |
7.9 ( 2.3 - 18.8) |
21.4 ( 7.3 - 43.2) |
11.4 ( 5.8 - 19.5) |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
11.1 ( 4 - 23.2) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
14.1 ( 5.7 - 27.3) |
Total |
N/A |
N/A |
N/A |
10 ( 2.7 - 24.1) |
23.7 ( 9.1 - 45) |
12.2 ( 6.4 - 20.4) |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
6.9 ( 1.5 - 18.4) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
4.1 ( 0.8 - 11.5) |
Total |
N/A |
N/A |
N/A |
4.2 ( 0.7 - 12.8) |
14.7 ( 3.6 - 35.6) |
5.9 ( 1.8 - 13.9) |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
10.2 ( 3.6 - 21.5) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
10.3 ( 3.3 - 23) |
Total |
N/A |
N/A |
N/A |
4.9 ( 1.1 - 13.5) |
35.1 ( 9.9 - 68.7) |
10.3 ( 5.2 - 17.7) |
Experienced injuries in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
0.9 ( 0 - 5.2) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
4.6 ( 0.4 - 17.8) |
Total |
N/A |
N/A |
N/A |
0.6 ( 0 - 3.5) |
2 ( 0 - 11.4) |
2.2 ( 0.4 - 6.8) |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
7.1 ( 1.5 - 19) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
1.1 ( 0.1 - 4.4) |
Total |
N/A |
N/A |
N/A |
3.8 ( 0.1 - 19.1) |
9.4 ( 1.8 - 26.1) |
5 ( 1.1 - 13.6) |
Experienced legal problems in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
2.3 ( 0.3 - 7.9) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
5.4 ( 0.8 - 17.3) |
Total |
N/A |
N/A |
N/A |
1.9 ( 0.1 - 7.6) |
12.1 ( 3.2 - 29) |
3.4 ( 1 - 8.1) |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among past-year amphetamine users) |
Men |
N/A |
N/A |
N/A |
N/A |
N/A |
14.5 ( 5.6 - 28.7) |
Women |
N/A |
N/A |
N/A |
N/A |
N/A |
13.4 ( 3.7 - 31) |
Total |
N/A |
N/A |
N/A |
14 ( 2.6 - 37.5) |
15.4 ( 2.6 - 41.7) |
14.1 ( 7.2 - 24.1) |
Experienced any harmful effects on life in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0.3 ( 0 - 1.4) |
1.3 ( 0.3 - 3.4) |
0.5 ( 0.1 - 1.6) |
1.6 ( 0.5 - 3.8) |
0.7 ( 0.4 - 1.2) |
Women |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.3) |
0.5 ( 0.1 - 1.6) |
0.5 ( 0.1 - 1.3) |
0.5 ( 0.2 - 1.1) |
0.3 ( 0.2 - 0.6) |
Total |
0 ( 0 - 0.2) |
0.2 ( 0 - 0.7) |
0.9 ( 0.3 - 1.9) |
0.5 ( 0.2 - 1.1) |
1 ( 0.5 - 2) |
0.5 ( 0.3 - 0.7) |
Experienced harmful effects on friendships or social life in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0.3 ( 0 - 1.4) |
0.9 ( 0.1 - 2.9) |
0.2 ( 0 - 0.7) |
0.7 ( 0.3 - 1.5) |
0.4 ( 0.2 - 0.8) |
Women |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.2) |
0.3 ( 0 - 1.5) |
0.5 ( 0.1 - 1.3) |
0.2 ( 0 - 0.5) |
0.2 ( 0.1 - 0.4) |
Total |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.7) |
0.6 ( 0.2 - 1.6) |
0.3 ( 0.1 - 0.8) |
0.4 ( 0.2 - 0.8) |
0.3 ( 0.2 - 0.5) |
Experienced harmful effects on home life in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0.3 ( 0 - 1.4) |
0.8 ( 0.1 - 2.9) |
0.3 ( 0 - 1.6) |
0.5 ( 0.1 - 1.4) |
0.4 ( 0.1 - 0.8) |
Women |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.2) |
0.5 ( 0.1 - 1.6) |
0.5 ( 0.1 - 1.3) |
0.4 ( 0.1 - 0.9) |
0.3 ( 0.1 - 0.5) |
Total |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.7) |
0.6 ( 0.2 - 1.6) |
0.4 ( 0.1 - 1) |
0.4 ( 0.2 - 0.9) |
0.3 ( 0.2 - 0.6) |
Experienced harmful effects on work, study or employment in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0 ( 0 - 0.9) |
0.6 ( 0 - 2.9) |
0.1 ( 0 - 0.6) |
0.5 ( 0.1 - 1.4) |
0.2 ( 0.1 - 0.7) |
Women |
0 ( 0 - 0.7) |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.4) |
0.2 ( 0 - 0.9) |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.2) |
Total |
0 ( 0 - 0.4) |
0 ( 0 - 0.1) |
0.3 ( 0 - 1.4) |
0.2 ( 0 - 0.5) |
0.3 ( 0.1 - 0.7) |
0.2 ( 0.1 - 0.4) |
Experienced harmful effects on financial position in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0 ( 0 - 0.9) |
0.5 ( 0.1 - 1.9) |
0.1 ( 0 - 0.6) |
1.4 ( 0.3 - 3.8) |
0.4 ( 0.1 - 0.8) |
Women |
0 ( 0 - 0.7) |
0 ( 0 - 0.3) |
0.5 ( 0.1 - 1.6) |
0.3 ( 0.1 - 0.9) |
0.2 ( 0.1 - 0.5) |
0.2 ( 0.1 - 0.4) |
Total |
0 ( 0 - 0.4) |
0 ( 0 - 0.1) |
0.5 ( 0.1 - 1.2) |
0.2 ( 0.1 - 0.5) |
0.8 ( 0.2 - 1.8) |
0.3 ( 0.1 - 0.5) |
Experienced injuries in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0 ( 0 - 0.9) |
0.1 ( 0 - 0.8) |
0 ( 0 - 0.7) |
0 ( 0 - 0.5) |
0 ( 0 - 0.2) |
Women |
0 ( 0 - 0.7) |
0 ( 0 - 0.5) |
0.3 ( 0 - 1.5) |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.4) |
0.1 ( 0 - 0.3) |
Total |
0 ( 0 - 0.4) |
0 ( 0 - 0.3) |
0.2 ( 0 - 0.8) |
0 ( 0 - 0.1) |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.2) |
Experienced difficulty learning things in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0 ( 0 - 0.9) |
0.6 ( 0 - 2.9) |
0.3 ( 0 - 1.6) |
0.3 ( 0.1 - 0.9) |
0.2 ( 0.1 - 0.7) |
Women |
0 ( 0 - 0.7) |
0 ( 0 - 0.5) |
0 ( 0 - 0.5) |
0 ( 0 - 0.2) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.1) |
Total |
0 ( 0 - 0.4) |
0 ( 0 - 0.3) |
0.3 ( 0 - 1.4) |
0.2 ( 0 - 0.8) |
0.2 ( 0 - 0.5) |
0.1 ( 0 - 0.4) |
Experienced legal problems in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0 ( 0 - 0.9) |
0 ( 0 - 0.8) |
0.1 ( 0 - 0.6) |
0.3 ( 0.1 - 1) |
0.1 ( 0 - 0.3) |
Women |
0 ( 0 - 0.7) |
0 ( 0 - 0.5) |
0.3 ( 0 - 1.5) |
0 ( 0 - 0.3) |
0.2 ( 0 - 0.5) |
0.1 ( 0 - 0.3) |
Total |
0 ( 0 - 0.4) |
0 ( 0 - 0.3) |
0.1 ( 0 - 0.8) |
0.1 ( 0 - 0.3) |
0.2 ( 0.1 - 0.5) |
0.1 ( 0 - 0.2) |
Had one or more days off work or school in the past 12 months due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0.4 ( 0 - 2.3) |
0.5 ( 0.1 - 1.8) |
0.9 ( 0.1 - 3.2) |
0.6 ( 0.1 - 1.8) |
0.5 ( 0.2 - 1) |
Women |
0 ( 0 - 0.7) |
0.2 ( 0 - 1.1) |
0.7 ( 0.1 - 2.3) |
0.3 ( 0 - 1.1) |
0 ( 0 - 0.3) |
0.2 ( 0.1 - 0.6) |
Total |
0 ( 0 - 0.4) |
0.3 ( 0 - 1.1) |
0.6 ( 0.2 - 1.5) |
0.6 ( 0.1 - 1.6) |
0.3 ( 0.1 - 0.8) |
0.4 ( 0.2 - 0.6) |
300
300
3
R1:R65536
False
False
Chapter5a: Amphetamines |
Harmful effects in lifetime |
|
Unadjusted prevalence by gender and age groups |
|
16-17 |
18-24 |
25-34 |
35-44 |
45-54 |
55-64 |
Total |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
20.2 ( 6.5 - 42.1) |
28 ( 15.2 - 40.9) |
36 ( 18.2 - 57.3) |
22.3 ( 8.7 - 42.1) |
N/A |
26.4 ( 19.2 - 33.5) |
Women |
N/A |
49.3 ( 26.5 - 72.3) |
32.1 ( 19.2 - 44.9) |
24.1 ( 12.6 - 39.1) |
N/A |
N/A |
33.9 ( 26.1 - 41.7) |
Total |
N/A |
31.8 ( 19.7 - 43.9) |
29.8 ( 19.2 - 40.4) |
31.1 ( 18.9 - 43.3) |
25.5 ( 13.8 - 40.6) |
N/A |
29.3 ( 23.9 - 34.8) |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
17.4 ( 5.1 - 38.3) |
18 ( 8 - 32.7) |
23.6 ( 9.3 - 44.1) |
21.5 ( 8.1 - 41.6) |
N/A |
19.2 ( 12.7 - 25.7) |
Women |
N/A |
38.2 ( 18.5 - 61.4) |
27 ( 15.2 - 41.8) |
21.7 ( 10.9 - 36.4) |
N/A |
N/A |
27.5 ( 19.7 - 35.2) |
Total |
N/A |
25.7 ( 15.1 - 38.9) |
21.9 ( 11.8 - 32) |
22.8 ( 12.1 - 33.4) |
21.3 ( 10 - 37.1) |
N/A |
22.5 ( 17 - 28) |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
11.9 ( 1.8 - 34.5) |
11.3 ( 5 - 21) |
25 ( 10.3 - 45.8) |
21.8 ( 8.3 - 41.8) |
N/A |
16.2 ( 10.2 - 22.2) |
Women |
N/A |
37.3 ( 17.7 - 60.5) |
25.2 ( 13.3 - 40.7) |
17.7 ( 8.3 - 31.1) |
N/A |
N/A |
25.7 ( 17.6 - 33.8) |
Total |
N/A |
22.3 ( 12 - 35.9) |
17.3 ( 10.6 - 24) |
22 ( 12 - 35.1) |
21.7 ( 10.8 - 36.6) |
N/A |
20 ( 15.4 - 24.5) |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
12.2 ( 2.2 - 33.6) |
7.3 ( 2.8 - 15) |
21.9 ( 7.4 - 44.4) |
20.5 ( 7.3 - 41) |
N/A |
14 ( 8 - 20) |
Women |
N/A |
16.3 ( 4.4 - 37.1) |
18.8 ( 8.2 - 34.4) |
13.5 ( 5.1 - 27) |
N/A |
N/A |
17.1 ( 10.2 - 24) |
Total |
N/A |
13.8 ( 5.5 - 27) |
12.3 ( 7 - 19.5) |
18.4 ( 8.8 - 32.1) |
17.8 ( 7.4 - 33.4) |
N/A |
15.2 ( 10.9 - 19.5) |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
19.8 ( 6.2 - 41.9) |
12 ( 6.2 - 20.4) |
15.8 ( 6.4 - 30.3) |
20.1 ( 6.9 - 41) |
N/A |
15.3 ( 10.2 - 20.4) |
Women |
N/A |
33 ( 14.8 - 56) |
17.7 ( 8.9 - 30) |
14.6 ( 5.9 - 28.3) |
N/A |
N/A |
19.8 ( 13.1 - 26.5) |
Total |
N/A |
25.1 ( 13.7 - 39.6) |
14.4 ( 8.4 - 20.4) |
15.3 ( 8.7 - 24.2) |
16.8 ( 6.6 - 32.8) |
N/A |
17.1 ( 13.1 - 21.1) |
Experienced injuries in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
1.4 ( 0 - 8.1) |
0.7 ( 0.1 - 2.5) |
2.8 ( 0.3 - 10.4) |
9 ( 0.3 - 39.6) |
N/A |
2.8 ( 0.8 - 7.2) |
Women |
N/A |
6.2 ( 0.9 - 19.5) |
4.3 ( 0.8 - 12.5) |
3.6 ( 1 - 9.1) |
N/A |
N/A |
7.3 ( 3.5 - 13.2) |
Total |
N/A |
3.3 ( 0.8 - 8.8) |
2.2 ( 0.6 - 5.6) |
3.1 ( 1 - 7.1) |
10.9 ( 2.5 - 28) |
N/A |
4.6 ( 2.4 - 7.9) |
Experienced difficulty learning things in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
2 ( 0.1 - 8.1) |
5.7 ( 1.7 - 13.3) |
13.7 ( 3 - 34.7) |
14.9 ( 2.9 - 39) |
N/A |
8.6 ( 4.6 - 14.3) |
Women |
N/A |
12.3 ( 4 - 27) |
11.2 ( 2.6 - 28.3) |
10.2 ( 3.3 - 22.7) |
N/A |
N/A |
11.8 ( 6.3 - 19.6) |
Total |
N/A |
6.1 ( 2.5 - 12) |
8 ( 3.5 - 15.3) |
12.3 ( 4.6 - 25) |
12.4 ( 3.1 - 30) |
N/A |
9.9 ( 6.3 - 13.4) |
Experienced legal problems in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
2.9 ( 0.4 - 9.2) |
2.1 ( 0.5 - 5.7) |
2.2 ( 0.2 - 9.3) |
12.4 ( 1.7 - 37.1) |
N/A |
4.4 ( 1.8 - 8.7) |
Women |
N/A |
6.8 ( 0.9 - 22.1) |
3 ( 0.4 - 10) |
2.5 ( 0.4 - 7.4) |
N/A |
N/A |
5.3 ( 2 - 11.2) |
Total |
N/A |
4.5 ( 1.3 - 10.6) |
2.5 ( 0.9 - 5.5) |
2.3 ( 0.6 - 6.2) |
8.8 ( 1.3 - 27) |
N/A |
4.7 ( 2.3 - 7.2) |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among total population) |
Men |
0.4 ( 0 - 1.5) |
2.5 ( 0.8 - 5.8) |
4.4 ( 2.2 - 6.7) |
3.1 ( 1.4 - 5.8) |
1.6 ( 0.6 - 3.6) |
0.5 ( 0.1 - 1.8) |
2.4 ( 1.7 - 3.1) |
Women |
0 ( 0 - 2.9) |
3.9 ( 2 - 6.6) |
3.4 ( 1.8 - 5) |
1.3 ( 0.7 - 2.1) |
0.9 ( 0.3 - 2) |
0.7 ( 0 - 3.3) |
1.9 ( 1.3 - 2.4) |
Total |
0.2 ( 0 - 0.8) |
3.2 ( 1.7 - 4.7) |
3.9 ( 2.3 - 5.4) |
2.1 ( 1.1 - 3.1) |
1.3 ( 0.6 - 2.3) |
0.6 ( 0.1 - 1.8) |
2.1 ( 1.7 - 2.5) |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among total population) |
Men |
0.1 ( 0 - 0.7) |
2.1 ( 0.6 - 5.2) |
2.9 ( 1.3 - 5.5) |
2 ( 0.8 - 4.1) |
1.6 ( 0.5 - 3.6) |
0.4 ( 0 - 1.6) |
1.7 ( 1.1 - 2.4) |
Women |
0 ( 0 - 2.9) |
3 ( 1.4 - 5.5) |
2.9 ( 1.6 - 4.8) |
1.1 ( 0.6 - 2) |
0.6 ( 0.1 - 1.7) |
0.6 ( 0 - 3.4) |
1.5 ( 1 - 2) |
Total |
0.1 ( 0 - 0.4) |
2.6 ( 1.4 - 4.3) |
2.9 ( 1.4 - 4.3) |
1.6 ( 0.8 - 2.3) |
1.1 ( 0.5 - 2.1) |
0.5 ( 0.1 - 1.8) |
1.6 ( 1.2 - 2) |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among total population) |
Men |
0.1 ( 0 - 0.7) |
1.4 ( 0.2 - 4.3) |
1.8 ( 0.8 - 3.4) |
2.1 ( 0.8 - 4.4) |
1.6 ( 0.5 - 3.6) |
0.4 ( 0 - 1.6) |
1.4 ( 0.9 - 2) |
Women |
0 ( 0 - 2.9) |
2.9 ( 1.4 - 5.5) |
2.7 ( 1.4 - 4.6) |
0.9 ( 0.5 - 1.7) |
0.6 ( 0.2 - 1.5) |
0.6 ( 0 - 3.4) |
1.4 ( 0.9 - 1.9) |
Total |
0.1 ( 0 - 0.4) |
2.2 ( 1.1 - 3.8) |
2.3 ( 1.3 - 3.2) |
1.5 ( 0.8 - 2.6) |
1.1 ( 0.5 - 2) |
0.5 ( 0.1 - 1.8) |
1.4 ( 1.1 - 1.8) |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among total population) |
Men |
0.1 ( 0 - 0.7) |
1.5 ( 0.3 - 4.3) |
1.2 ( 0.5 - 2.3) |
1.9 ( 0.6 - 4.2) |
1.5 ( 0.5 - 3.5) |
0.4 ( 0 - 1.6) |
1.3 ( 0.7 - 1.8) |
Women |
0 ( 0 - 2.9) |
1.3 ( 0.4 - 3.1) |
2 ( 0.9 - 3.9) |
0.7 ( 0.3 - 1.5) |
0.3 ( 0.1 - 1) |
0.7 ( 0 - 3.3) |
0.9 ( 0.5 - 1.3) |
Total |
0.1 ( 0 - 0.4) |
1.4 ( 0.6 - 2.8) |
1.6 ( 0.9 - 2.6) |
1.3 ( 0.6 - 2.4) |
0.9 ( 0.3 - 1.9) |
0.6 ( 0.1 - 1.8) |
1.1 ( 0.8 - 1.4) |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among total population) |
Men |
0.4 ( 0 - 1.5) |
2.4 ( 0.7 - 5.8) |
1.9 ( 1 - 3.2) |
1.3 ( 0.6 - 2.7) |
1.5 ( 0.4 - 3.5) |
0.1 ( 0 - 0.5) |
1.4 ( 0.9 - 1.9) |
Women |
0 ( 0 - 2.9) |
2.6 ( 1.2 - 4.9) |
1.9 ( 1 - 3.2) |
0.8 ( 0.3 - 1.5) |
0.3 ( 0 - 1) |
0.6 ( 0 - 3.4) |
1.1 ( 0.7 - 1.5) |
Total |
0.2 ( 0 - 0.8) |
2.5 ( 1.4 - 4.2) |
1.9 ( 1.1 - 2.6) |
1 ( 0.6 - 1.7) |
0.8 ( 0.3 - 1.8) |
0.4 ( 0 - 1.7) |
1.2 ( 0.9 - 1.5) |
Experienced injuries in lifetime due to own amphetamine use (among total population) |
Men |
0.1 ( 0 - 0.7) |
0.2 ( 0 - 1) |
0.1 ( 0 - 0.4) |
0.2 ( 0 - 0.9) |
0.6 ( 0 - 2.9) |
0.1 ( 0 - 0.5) |
0.3 ( 0.1 - 0.7) |
Women |
0 ( 0 - 2.9) |
0.5 ( 0.1 - 1.6) |
0.5 ( 0.1 - 1.3) |
0.2 ( 0.1 - 0.5) |
0.4 ( 0.1 - 1.2) |
0.6 ( 0 - 3.4) |
0.4 ( 0.2 - 0.7) |
Total |
0.1 ( 0 - 0.4) |
0.3 ( 0.1 - 0.9) |
0.3 ( 0.1 - 0.7) |
0.2 ( 0.1 - 0.5) |
0.5 ( 0.1 - 1.5) |
0.4 ( 0 - 1.7) |
0.3 ( 0.2 - 0.6) |
Experienced difficulty learning things in lifetime due to own amphetamine use (among total population) |
Men |
0.1 ( 0 - 0.7) |
0.2 ( 0 - 1) |
0.9 ( 0.3 - 2.1) |
1.2 ( 0.3 - 3.3) |
1 ( 0.2 - 3.2) |
0.4 ( 0 - 1.6) |
0.8 ( 0.4 - 1.3) |
Women |
0 ( 0 - 2.9) |
1 ( 0.3 - 2.1) |
1.2 ( 0.3 - 3.1) |
0.5 ( 0.2 - 1.2) |
0.2 ( 0 - 1) |
0.6 ( 0 - 3.4) |
0.6 ( 0.3 - 1.1) |
Total |
0.1 ( 0 - 0.4) |
0.6 ( 0.3 - 1.2) |
1 ( 0.4 - 2.1) |
0.8 ( 0.3 - 1.8) |
0.6 ( 0.1 - 1.6) |
0.5 ( 0.1 - 1.8) |
0.7 ( 0.4 - 1) |
Experienced legal problems in lifetime due to own amphetamine use (among total population) |
Men |
0.1 ( 0 - 0.7) |
0.3 ( 0.1 - 1.1) |
0.3 ( 0.1 - 0.9) |
0.2 ( 0 - 0.8) |
0.9 ( 0.1 - 3) |
0.2 ( 0 - 0.9) |
0.4 ( 0.2 - 0.8) |
Women |
0 ( 0 - 2.9) |
0.5 ( 0.1 - 1.8) |
0.3 ( 0 - 1.1) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.1) |
0.7 ( 0 - 3.3) |
0.3 ( 0.1 - 0.6) |
Total |
0.1 ( 0 - 0.4) |
0.4 ( 0.1 - 1.1) |
0.3 ( 0.1 - 0.7) |
0.2 ( 0 - 0.4) |
0.4 ( 0.1 - 1.4) |
0.5 ( 0.1 - 1.7) |
0.3 ( 0.2 - 0.5) |
Unadjusted prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
26.6 ( 18.6 - 34.5) |
26.4 ( 16.4 - 38.6) |
N/A |
N/A |
26.4 ( 19.2 - 33.5) |
Women |
33.5 ( 25.1 - 41.9) |
34 ( 23.6 - 44.3) |
N/A |
N/A |
33.9 ( 26.1 - 41.7) |
Total |
29.4 ( 23.3 - 35.5) |
29.4 ( 22.1 - 36.7) |
45.1 ( 19.7 - 72.6) |
N/A |
29.3 ( 23.9 - 34.8) |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
19 ( 11.6 - 26.3) |
20.3 ( 11.7 - 31.3) |
N/A |
N/A |
19.2 ( 12.7 - 25.7) |
Women |
26.7 ( 18.3 - 35.1) |
24.9 ( 16.9 - 34.5) |
N/A |
N/A |
27.5 ( 19.7 - 35.2) |
Total |
22.1 ( 15.9 - 28.2) |
22.1 ( 16 - 28.3) |
28.9 ( 12.1 - 51.3) |
N/A |
22.5 ( 17 - 28) |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
16.1 ( 9.2 - 23) |
17.2 ( 9.2 - 28.2) |
N/A |
N/A |
16.2 ( 10.2 - 22.2) |
Women |
24.3 ( 15.4 - 33.1) |
28.1 ( 18.9 - 37.2) |
N/A |
N/A |
25.7 ( 17.6 - 33.8) |
Total |
19.4 ( 14.2 - 24.6) |
21.6 ( 15.2 - 28) |
21.6 ( 8.4 - 41.2) |
N/A |
20 ( 15.4 - 24.5) |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
13 ( 6.9 - 21.6) |
16.9 ( 9 - 27.7) |
N/A |
N/A |
14 ( 8 - 20) |
Women |
17.6 ( 9.8 - 25.4) |
16.4 ( 8.8 - 26.9) |
N/A |
N/A |
17.1 ( 10.2 - 24) |
Total |
14.9 ( 9.9 - 19.8) |
16.7 ( 10.7 - 22.7) |
19.2 ( 5.3 - 42.7) |
N/A |
15.2 ( 10.9 - 19.5) |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
14.7 ( 8.9 - 20.5) |
20.2 ( 11.4 - 31.6) |
N/A |
N/A |
15.3 ( 10.2 - 20.4) |
Women |
19.1 ( 11.8 - 26.4) |
23.5 ( 15.1 - 33.9) |
N/A |
N/A |
19.8 ( 13.1 - 26.5) |
Total |
16.5 ( 11.8 - 21.1) |
21.5 ( 15 - 28) |
18.6 ( 3.5 - 47.2) |
N/A |
17.1 ( 13.1 - 21.1) |
Experienced injuries in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
2.2 ( 0.2 - 8) |
7.1 ( 2.4 - 15.6) |
N/A |
N/A |
2.8 ( 0.8 - 7.2) |
Women |
7.7 ( 3.4 - 14.4) |
6.8 ( 2.5 - 14.4) |
N/A |
N/A |
7.3 ( 3.5 - 13.2) |
Total |
4.4 ( 2.1 - 8.2) |
7 ( 3.6 - 12.1) |
1.8 ( 0 - 10.6) |
N/A |
4.6 ( 2.4 - 7.9) |
Experienced difficulty learning things in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
8.1 ( 3.8 - 14.8) |
4.4 ( 1.1 - 11.2) |
N/A |
N/A |
8.6 ( 4.6 - 14.3) |
Women |
11.7 ( 5.7 - 20.8) |
8.7 ( 2.5 - 20.2) |
N/A |
N/A |
11.8 ( 6.3 - 19.6) |
Total |
9.6 ( 5.9 - 14.5) |
6.1 ( 2.6 - 11.8) |
14.2 ( 2.6 - 38) |
N/A |
9.9 ( 6.3 - 13.4) |
Experienced legal problems in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
4 ( 1.3 - 9.2) |
9.6 ( 4 - 18.8) |
N/A |
N/A |
4.4 ( 1.8 - 8.7) |
Women |
5.6 ( 2 - 12.4) |
7 ( 3 - 13.5) |
N/A |
N/A |
5.3 ( 2 - 11.2) |
Total |
4.7 ( 2.3 - 8.5) |
8.6 ( 4.7 - 14.1) |
6.3 ( 1 - 19.4) |
N/A |
4.7 ( 2.3 - 7.2) |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among total population) |
Men |
2.6 ( 1.7 - 3.5) |
3.4 ( 2.1 - 5.1) |
2.1 ( 0.8 - 4.3) |
0.5 ( 0 - 2.7) |
2.4 ( 1.7 - 3.1) |
Women |
2 ( 1.4 - 2.7) |
2.5 ( 1.6 - 3.4) |
1.3 ( 0.3 - 3.7) |
0 ( 0 - 1.4) |
1.9 ( 1.3 - 2.4) |
Total |
2.3 ( 1.8 - 2.9) |
2.9 ( 2.1 - 3.6) |
1.7 ( 0.8 - 3.1) |
0.2 ( 0 - 1.3) |
2.1 ( 1.7 - 2.5) |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among total population) |
Men |
1.9 ( 1.1 - 2.7) |
2.6 ( 1.5 - 4.1) |
1.5 ( 0.6 - 3.1) |
0.5 ( 0 - 2.7) |
1.7 ( 1.1 - 2.4) |
Women |
1.6 ( 1.1 - 2.2) |
1.8 ( 1.2 - 2.7) |
0.7 ( 0.2 - 1.5) |
0 ( 0 - 1.4) |
1.5 ( 1 - 2) |
Total |
1.7 ( 1.2 - 2.3) |
2.2 ( 1.6 - 2.8) |
1.1 ( 0.5 - 1.9) |
0.2 ( 0 - 1.3) |
1.6 ( 1.2 - 2) |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among total population) |
Men |
1.6 ( 0.8 - 2.3) |
2.2 ( 1.2 - 3.7) |
0.9 ( 0.3 - 2.3) |
0.5 ( 0 - 2.7) |
1.4 ( 0.9 - 2) |
Women |
1.5 ( 0.9 - 2.1) |
2 ( 1.2 - 2.8) |
0.7 ( 0.2 - 1.5) |
0 ( 0 - 1.4) |
1.4 ( 0.9 - 1.9) |
Total |
1.5 ( 1.1 - 2) |
2.1 ( 1.5 - 2.7) |
0.8 ( 0.4 - 1.5) |
0.2 ( 0 - 1.3) |
1.4 ( 1.1 - 1.8) |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among total population) |
Men |
1.3 ( 0.7 - 2.2) |
2.1 ( 1.1 - 3.7) |
1.2 ( 0.3 - 3.1) |
0.5 ( 0 - 2.7) |
1.3 ( 0.7 - 1.8) |
Women |
1.1 ( 0.6 - 1.6) |
1.2 ( 0.6 - 2.1) |
0.3 ( 0.1 - 0.9) |
0 ( 0 - 1.4) |
0.9 ( 0.5 - 1.3) |
Total |
1.2 ( 0.8 - 1.6) |
1.6 ( 1 - 2.3) |
0.7 ( 0.2 - 1.6) |
0.2 ( 0 - 1.3) |
1.1 ( 0.8 - 1.4) |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among total population) |
Men |
1.4 ( 0.8 - 2) |
2.6 ( 1.5 - 4.2) |
0.6 ( 0.2 - 1.5) |
0.5 ( 0 - 2.7) |
1.4 ( 0.9 - 1.9) |
Women |
1.2 ( 0.7 - 1.7) |
1.7 ( 1.1 - 2.6) |
0.8 ( 0 - 3.5) |
0 ( 0 - 1.4) |
1.1 ( 0.7 - 1.5) |
Total |
1.3 ( 0.9 - 1.7) |
2.1 ( 1.5 - 2.8) |
0.7 ( 0.2 - 1.9) |
0.2 ( 0 - 1.3) |
1.2 ( 0.9 - 1.5) |
Experienced injuries in lifetime due to own amphetamine use (among total population) |
Men |
0.2 ( 0 - 0.8) |
0.9 ( 0.3 - 2) |
0.1 ( 0 - 0.8) |
0 ( 0 - 2.1) |
0.3 ( 0.1 - 0.7) |
Women |
0.5 ( 0.2 - 0.9) |
0.5 ( 0.2 - 1.1) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.4 ( 0.2 - 0.7) |
Total |
0.3 ( 0.2 - 0.6) |
0.7 ( 0.3 - 1.2) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.3 ( 0.2 - 0.6) |
Experienced difficulty learning things in lifetime due to own amphetamine use (among total population) |
Men |
0.8 ( 0.4 - 1.5) |
0.5 ( 0.1 - 1.4) |
1 ( 0.2 - 3) |
0.5 ( 0 - 2.7) |
0.8 ( 0.4 - 1.3) |
Women |
0.7 ( 0.3 - 1.3) |
0.6 ( 0.2 - 1.5) |
0.1 ( 0 - 0.4) |
0 ( 0 - 1.4) |
0.6 ( 0.3 - 1.1) |
Total |
0.7 ( 0.5 - 1.2) |
0.6 ( 0.3 - 1.2) |
0.5 ( 0.1 - 1.5) |
0.2 ( 0 - 1.3) |
0.7 ( 0.4 - 1) |
Experienced legal problems in lifetime due to own amphetamine use (among total population) |
Men |
0.4 ( 0.1 - 0.9) |
1.2 ( 0.5 - 2.4) |
0.5 ( 0.1 - 1.4) |
0 ( 0 - 2.1) |
0.4 ( 0.2 - 0.8) |
Women |
0.3 ( 0.1 - 0.8) |
0.5 ( 0.2 - 1) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.3 ( 0.1 - 0.6) |
Total |
0.4 ( 0.2 - 0.7) |
0.8 ( 0.5 - 1.4) |
0.2 ( 0 - 0.7) |
0 ( 0 - 0.8) |
0.3 ( 0.2 - 0.5) |
Age-standardised prevalence by gender and ethnic groups |
|
European/Other |
Māori |
Pacific |
Asian |
Total |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
26.8 ( 18.5 - 35.2) |
26.3 ( 16.4 - 38.3) |
N/A |
N/A |
26.6 ( 19.3 - 34) |
Women |
33.7 ( 24.7 - 42.7) |
33.9 ( 23.5 - 44.3) |
N/A |
N/A |
34.2 ( 26.1 - 42.4) |
Total |
29.7 ( 23.2 - 36.2) |
29.3 ( 22.1 - 36.6) |
45.1 ( 19.6 - 72.7) |
N/A |
29.7 ( 23.9 - 35.5) |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
18.9 ( 11.2 - 26.7) |
19.7 ( 11.5 - 30.4) |
N/A |
N/A |
19.2 ( 12.5 - 25.9) |
Women |
26.9 ( 17.8 - 35.9) |
24.8 ( 16.7 - 34.4) |
N/A |
N/A |
27.7 ( 19.5 - 35.8) |
Total |
22.2 ( 15.6 - 28.9) |
21.7 ( 15.8 - 27.7) |
28.7 ( 12 - 51.3) |
N/A |
22.6 ( 16.8 - 28.5) |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
15.1 ( 8.2 - 22) |
16.7 ( 9.1 - 27.1) |
N/A |
N/A |
15.5 ( 9.6 - 21.4) |
Women |
24.4 ( 14.9 - 33.9) |
27.9 ( 18.7 - 37.1) |
N/A |
N/A |
26 ( 17.5 - 34.5) |
Total |
19 ( 13.6 - 24.4) |
21.1 ( 14.9 - 27.4) |
21.1 ( 8.1 - 40.5) |
N/A |
19.8 ( 15.1 - 24.5) |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
11.7 ( 5.9 - 20.3) |
16.3 ( 8.8 - 26.6) |
N/A |
N/A |
13.2 ( 7.3 - 19.1) |
Women |
16.7 ( 9.1 - 24.3) |
16.4 ( 8.8 - 27) |
N/A |
N/A |
16.4 ( 9.7 - 23.1) |
Total |
13.8 ( 9 - 18.6) |
16.4 ( 10.5 - 22.2) |
19.5 ( 5.2 - 43.7) |
N/A |
14.5 ( 10.3 - 18.7) |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
15.1 ( 8.9 - 21.3) |
19.9 ( 11.3 - 31.1) |
N/A |
N/A |
15.7 ( 10.4 - 21) |
Women |
19.2 ( 11.6 - 26.7) |
23.5 ( 15 - 33.9) |
N/A |
N/A |
20.1 ( 13.3 - 26.9) |
Total |
16.8 ( 11.9 - 21.7) |
21.3 ( 14.9 - 27.7) |
18.3 ( 3.5 - 46.6) |
N/A |
17.5 ( 13.3 - 21.7) |
Experienced injuries in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
1.7 ( 0.2 - 5.8) |
6.7 ( 2.3 - 14.5) |
N/A |
N/A |
2.4 ( 0.7 - 5.9) |
Women |
6 ( 2.9 - 10.8) |
6.8 ( 2.5 - 14.3) |
N/A |
N/A |
6.1 ( 3.2 - 10.4) |
Total |
3.5 ( 1.8 - 6.1) |
6.7 ( 3.5 - 11.5) |
1.9 ( 0 - 11.2) |
N/A |
3.9 ( 2.2 - 6.3) |
Experienced difficulty learning things in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
6.5 ( 2.9 - 12.2) |
4.1 ( 1.1 - 10) |
N/A |
N/A |
7.7 ( 4.2 - 12.7) |
Women |
10.7 ( 5 - 19.4) |
8.7 ( 2.5 - 20.2) |
N/A |
N/A |
11.1 ( 5.9 - 18.5) |
Total |
8.2 ( 5 - 12.6) |
5.9 ( 2.6 - 11.2) |
14.7 ( 2.6 - 39.5) |
N/A |
9 ( 5.8 - 12.3) |
Experienced legal problems in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
3.3 ( 1.1 - 7.4) |
9.3 ( 3.8 - 18.2) |
N/A |
N/A |
3.8 ( 1.7 - 7.4) |
Women |
4.4 ( 1.7 - 9.2) |
6.9 ( 3 - 13.3) |
N/A |
N/A |
4.3 ( 1.8 - 8.5) |
Total |
3.8 ( 1.9 - 6.6) |
8.3 ( 4.6 - 13.8) |
6.2 ( 1 - 19) |
N/A |
4 ( 2.1 - 6) |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among total population) |
Men |
3.1 ( 2 - 4.1) |
3.5 ( 2.2 - 5.3) |
2.1 ( 0.8 - 4.3) |
0.4 ( 0 - 2.4) |
2.7 ( 1.8 - 3.5) |
Women |
2.5 ( 1.7 - 3.4) |
2.5 ( 1.6 - 3.5) |
1.3 ( 0.3 - 3.6) |
0 ( 0 - 1.4) |
2.2 ( 1.5 - 2.8) |
Total |
2.8 ( 2.1 - 3.5) |
3 ( 2.2 - 3.8) |
1.7 ( 0.8 - 3.1) |
0.2 ( 0 - 1.2) |
2.4 ( 1.9 - 2.9) |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among total population) |
Men |
2.2 ( 1.2 - 3.1) |
2.6 ( 1.5 - 4.2) |
1.5 ( 0.6 - 3.1) |
0.4 ( 0 - 2.4) |
1.9 ( 1.2 - 2.6) |
Women |
2 ( 1.3 - 2.8) |
1.9 ( 1.2 - 2.7) |
0.7 ( 0.2 - 1.5) |
0 ( 0 - 1.4) |
1.7 ( 1.2 - 2.3) |
Total |
2.1 ( 1.4 - 2.8) |
2.2 ( 1.6 - 2.8) |
1.1 ( 0.5 - 1.9) |
0.2 ( 0 - 1.2) |
1.8 ( 1.3 - 2.3) |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among total population) |
Men |
1.7 ( 0.9 - 2.5) |
2.2 ( 1.2 - 3.7) |
0.9 ( 0.3 - 2.2) |
0.4 ( 0 - 2.4) |
1.5 ( 0.9 - 2.2) |
Women |
1.8 ( 1.1 - 2.6) |
2.1 ( 1.3 - 2.9) |
0.7 ( 0.2 - 1.5) |
0 ( 0 - 1.4) |
1.6 ( 1.1 - 2.2) |
Total |
1.8 ( 1.2 - 2.3) |
2.1 ( 1.5 - 2.8) |
0.8 ( 0.4 - 1.5) |
0.2 ( 0 - 1.2) |
1.6 ( 1.2 - 2) |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among total population) |
Men |
1.3 ( 0.7 - 2.3) |
2.2 ( 1.2 - 3.7) |
1.2 ( 0.3 - 3.2) |
0.4 ( 0 - 2.4) |
1.3 ( 0.7 - 1.9) |
Women |
1.2 ( 0.7 - 1.8) |
1.2 ( 0.6 - 2.2) |
0.3 ( 0.1 - 0.9) |
0 ( 0 - 1.4) |
1 ( 0.6 - 1.5) |
Total |
1.3 ( 0.8 - 1.7) |
1.7 ( 1 - 2.3) |
0.7 ( 0.2 - 1.7) |
0.2 ( 0 - 1.2) |
1.2 ( 0.8 - 1.5) |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among total population) |
Men |
1.7 ( 1 - 2.5) |
2.7 ( 1.5 - 4.3) |
0.6 ( 0.2 - 1.5) |
0.4 ( 0 - 2.4) |
1.6 ( 1 - 2.1) |
Women |
1.4 ( 0.8 - 2.1) |
1.8 ( 1.1 - 2.7) |
0.7 ( 0 - 3.5) |
0 ( 0 - 1.4) |
1.3 ( 0.8 - 1.7) |
Total |
1.6 ( 1.1 - 2) |
2.2 ( 1.5 - 2.8) |
0.7 ( 0.2 - 1.9) |
0.2 ( 0 - 1.2) |
1.4 ( 1.1 - 1.8) |
Experienced injuries in lifetime due to own amphetamine use (among total population) |
Men |
0.2 ( 0 - 0.7) |
0.9 ( 0.3 - 2) |
0.1 ( 0 - 0.8) |
0 ( 0 - 2.1) |
0.2 ( 0.1 - 0.6) |
Women |
0.4 ( 0.2 - 0.8) |
0.5 ( 0.2 - 1.1) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.4 ( 0.2 - 0.7) |
Total |
0.3 ( 0.2 - 0.6) |
0.7 ( 0.3 - 1.2) |
0.1 ( 0 - 0.4) |
0 ( 0 - 0.8) |
0.3 ( 0.2 - 0.5) |
Experienced difficulty learning things in lifetime due to own amphetamine use (among total population) |
Men |
0.7 ( 0.3 - 1.4) |
0.5 ( 0.2 - 1.3) |
1 ( 0.2 - 3.1) |
0.4 ( 0 - 2.4) |
0.8 ( 0.4 - 1.3) |
Women |
0.8 ( 0.4 - 1.4) |
0.6 ( 0.2 - 1.6) |
0.1 ( 0 - 0.5) |
0 ( 0 - 1.4) |
0.7 ( 0.4 - 1.2) |
Total |
0.8 ( 0.5 - 1.2) |
0.6 ( 0.3 - 1.1) |
0.5 ( 0.1 - 1.5) |
0.2 ( 0 - 1.2) |
0.7 ( 0.5 - 1) |
Experienced legal problems in lifetime due to own amphetamine use (among total population) |
Men |
0.4 ( 0.1 - 0.8) |
1.2 ( 0.5 - 2.5) |
0.5 ( 0.1 - 1.4) |
0 ( 0 - 2.1) |
0.4 ( 0.2 - 0.7) |
Women |
0.3 ( 0.1 - 0.7) |
0.5 ( 0.2 - 1) |
0 ( 0 - 0.7) |
0 ( 0 - 1.4) |
0.3 ( 0.1 - 0.5) |
Total |
0.4 ( 0.2 - 0.6) |
0.8 ( 0.5 - 1.4) |
0.2 ( 0 - 0.7) |
0 ( 0 - 0.8) |
0.3 ( 0.2 - 0.5) |
Standardised rate ratios by gender for each ethnic group compared to males and females in the total population |
|
European/Other |
Māori |
Pacific |
Asian |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
1.01 ( 0.92 - 1.1) |
0.99 ( 0.57 - 1.4) |
N/A |
N/A |
Women |
0.98 ( 0.93 - 1.04) |
0.99 ( 0.69 - 1.29) |
N/A |
N/A |
Total |
1 ( 0.94 - 1.05) |
0.99 ( 0.73 - 1.25) |
1.52 ( 0.65 - 2.39) |
N/A |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
0.99 ( 0.88 - 1.09) |
1.03 ( 0.49 - 1.57) |
N/A |
N/A |
Women |
0.97 ( 0.9 - 1.04) |
0.9 ( 0.56 - 1.23) |
N/A |
N/A |
Total |
0.98 ( 0.92 - 1.05) |
0.96 ( 0.64 - 1.28) |
1.27 ( 0.4 - 2.14) |
N/A |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
0.98 ( 0.85 - 1.1) |
1.08 ( 0.42 - 1.74) |
N/A |
N/A |
Women |
0.94 ( 0.85 - 1.03) |
1.07 ( 0.66 - 1.49) |
N/A |
N/A |
Total |
0.96 ( 0.89 - 1.04) |
1.07 ( 0.71 - 1.43) |
1.07 ( 0.27 - 1.86) |
N/A |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
0.89 ( 0.7 - 1.08) |
1.24 ( 0.45 - 2.02) |
N/A |
N/A |
Women |
1.02 ( 0.93 - 1.11) |
1 ( 0.43 - 1.58) |
N/A |
N/A |
Total |
0.95 ( 0.85 - 1.06) |
1.13 ( 0.66 - 1.6) |
1.34 ( 0.1 - 2.59) |
N/A |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
0.96 ( 0.83 - 1.09) |
1.27 ( 0.61 - 1.93) |
N/A |
N/A |
Women |
0.95 ( 0.85 - 1.06) |
1.17 ( 0.67 - 1.67) |
N/A |
N/A |
Total |
0.96 ( 0.88 - 1.05) |
1.22 ( 0.82 - 1.62) |
1.05 ( 0 - 2.17) |
N/A |
Experienced injuries in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
0.69 ( 0.1 - 1.28) |
2.74 ( 0 - 6.84) |
N/A |
N/A |
Women |
0.99 ( 0.82 - 1.16) |
1.12 ( 0.12 - 2.11) |
N/A |
N/A |
Total |
0.89 ( 0.71 - 1.07) |
1.71 ( 0.64 - 2.79) |
0.49 ( 0 - 1.52) |
N/A |
Experienced difficulty learning things in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
0.85 ( 0.63 - 1.07) |
0.53 ( 0 - 1.1) |
N/A |
N/A |
Women |
0.97 ( 0.8 - 1.13) |
0.78 ( 0.01 - 1.56) |
N/A |
N/A |
Total |
0.91 ( 0.77 - 1.05) |
0.65 ( 0.18 - 1.13) |
1.63 ( 0 - 3.52) |
N/A |
Experienced legal problems in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
0.87 ( 0.59 - 1.14) |
2.42 ( 0.28 - 4.55) |
N/A |
N/A |
Women |
1.02 ( 0.87 - 1.17) |
1.59 ( 0.22 - 2.96) |
N/A |
N/A |
Total |
0.94 ( 0.77 - 1.1) |
2.06 ( 0.86 - 3.26) |
1.54 ( 0 - 3.52) |
N/A |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among total population) |
Men |
1.15 ( 1.03 - 1.26) |
1.32 ( 0.68 - 1.96) |
0.77 ( 0.14 - 1.4) |
0.15 ( 0 - 0.47) |
Women |
1.17 ( 1.08 - 1.26) |
1.18 ( 0.67 - 1.69) |
0.6 ( 0 - 1.26) |
0 ( 0 - 0) |
Total |
1.16 ( 1.08 - 1.23) |
1.25 ( 0.83 - 1.66) |
0.69 ( 0.23 - 1.16) |
0.09 ( 0 - 0.26) |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among total population) |
Men |
1.12 ( 0.98 - 1.26) |
1.37 ( 0.57 - 2.17) |
0.77 ( 0.12 - 1.42) |
0.21 ( 0 - 0.65) |
Women |
1.15 ( 1.05 - 1.25) |
1.07 ( 0.58 - 1.56) |
0.38 ( 0.03 - 0.73) |
0 ( 0 - 0) |
Total |
1.14 ( 1.05 - 1.22) |
1.21 ( 0.75 - 1.68) |
0.58 ( 0.2 - 0.96) |
0.11 ( 0 - 0.34) |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among total population) |
Men |
1.11 ( 0.95 - 1.26) |
1.46 ( 0.51 - 2.4) |
0.58 ( 0 - 1.19) |
0.27 ( 0 - 0.82) |
Women |
1.11 ( 0.99 - 1.23) |
1.27 ( 0.66 - 1.88) |
0.41 ( 0.03 - 0.78) |
0 ( 0 - 0) |
Total |
1.11 ( 1.02 - 1.21) |
1.35 ( 0.84 - 1.87) |
0.49 ( 0.14 - 0.84) |
0.13 ( 0 - 0.39) |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among total population) |
Men |
1.01 ( 0.79 - 1.23) |
1.65 ( 0.55 - 2.75) |
0.89 ( 0 - 1.91) |
0.31 ( 0 - 0.95) |
Women |
1.21 ( 1.09 - 1.33) |
1.19 ( 0.4 - 1.97) |
0.29 ( 0 - 0.65) |
0 ( 0 - 0) |
Total |
1.1 ( 0.97 - 1.23) |
1.42 ( 0.75 - 2.09) |
0.61 ( 0.05 - 1.18) |
0.18 ( 0 - 0.53) |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among total population) |
Men |
1.1 ( 0.94 - 1.25) |
1.69 ( 0.74 - 2.64) |
0.38 ( 0 - 0.79) |
0.26 ( 0 - 0.8) |
Women |
1.13 ( 1 - 1.27) |
1.39 ( 0.66 - 2.12) |
0.59 ( 0 - 1.61) |
0 ( 0 - 0) |
Total |
1.11 ( 1.01 - 1.22) |
1.54 ( 0.98 - 2.1) |
0.48 ( 0 - 1) |
0.15 ( 0 - 0.44) |
Experienced injuries in lifetime due to own amphetamine use (among total population) |
Men |
0.78 ( 0.11 - 1.45) |
3.69 ( 0 - 9.34) |
0.61 ( 0 - 2.13) |
0 ( 0 - 0) |
Women |
1.17 ( 0.97 - 1.38) |
1.34 ( 0.11 - 2.56) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1.03 ( 0.82 - 1.24) |
2.18 ( 0.77 - 3.59) |
0.22 ( 0 - 0.69) |
0 ( 0 - 0) |
Experienced difficulty learning things in lifetime due to own amphetamine use (among total population) |
Men |
0.97 ( 0.7 - 1.23) |
0.7 ( 0 - 1.46) |
1.31 ( 0 - 3.08) |
0.54 ( 0 - 1.66) |
Women |
1.15 ( 0.95 - 1.35) |
0.94 ( 0 - 1.93) |
0.18 ( 0 - 0.46) |
0 ( 0 - 0) |
Total |
1.06 ( 0.89 - 1.22) |
0.82 ( 0.2 - 1.45) |
0.75 ( 0 - 1.62) |
0.28 ( 0 - 0.86) |
Experienced legal problems in lifetime due to own amphetamine use (among total population) |
Men |
0.99 ( 0.68 - 1.3) |
3.22 ( 0.33 - 6.12) |
1.26 ( 0 - 2.97) |
0 ( 0 - 0) |
Women |
1.21 ( 1.03 - 1.4) |
1.89 ( 0.2 - 3.59) |
0 ( 0 - 0) |
0 ( 0 - 0) |
Total |
1.09 ( 0.9 - 1.27) |
2.6 ( 1.03 - 4.16) |
0.71 ( 0 - 1.56) |
0 ( 0 - 0) |
Age-standardised rates by gender and NZDep2006 quintile |
|
1
(Least deprived) |
2 |
3 |
4 |
5
(Most deprived) |
Total |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
24.6 ( 9 - 47.5) |
32.3 ( 15.7 - 53) |
29.5 ( 13.6 - 50.2) |
31.3 ( 15.8 - 50.5) |
26.6 ( 19.3 - 34) |
Women |
N/A |
27.3 ( 9.3 - 53.3) |
49.5 ( 31.6 - 67.5) |
25.1 ( 10.2 - 46.3) |
34.1 ( 15.9 - 56.7) |
34.2 ( 26.1 - 42.4) |
Total |
18.5 ( 6.9 - 36.4) |
25.3 ( 12.5 - 42.2) |
39.1 ( 26.8 - 51.5) |
27.5 ( 16.1 - 39) |
32.4 ( 22.1 - 42.8) |
29.7 ( 23.9 - 35.5) |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
13 ( 2.9 - 33.1) |
27.3 ( 11.8 - 48.2) |
17.8 ( 5.3 - 38.9) |
26.5 ( 11.3 - 47.3) |
19.2 ( 12.5 - 25.9) |
Women |
N/A |
14.1 ( 2.5 - 38.4) |
46.3 ( 28.7 - 64.5) |
22 ( 6.9 - 45.7) |
23.4 ( 7.7 - 47.4) |
27.7 ( 19.5 - 35.8) |
Total |
14.2 ( 5.7 - 27.7) |
13.3 ( 4.6 - 27.9) |
34.8 ( 22.5 - 47.2) |
19.7 ( 9.6 - 33.8) |
25.2 ( 14.7 - 35.7) |
22.6 ( 16.8 - 28.5) |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
11.5 ( 2.8 - 28.5) |
22.6 ( 9.3 - 41.9) |
18.3 ( 5.2 - 40.5) |
16.7 ( 7.2 - 30.9) |
15.5 ( 9.6 - 21.4) |
Women |
N/A |
13.9 ( 2.5 - 37.5) |
39.1 ( 22.1 - 58.4) |
23.5 ( 8.8 - 45) |
28.9 ( 11.7 - 52.1) |
26 ( 17.5 - 34.5) |
Total |
9.3 ( 2.2 - 24) |
12.1 ( 4.5 - 24.7) |
29.2 ( 18.1 - 40.3) |
20.6 ( 10.6 - 34.2) |
21.9 ( 11.4 - 32.4) |
19.8 ( 15.1 - 24.5) |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
10.2 ( 1.7 - 29.6) |
17.7 ( 6 - 36.5) |
15.5 ( 3.5 - 38.2) |
14.4 ( 6.1 - 27) |
13.2 ( 7.3 - 19.1) |
Women |
N/A |
15.8 ( 3.5 - 39) |
26.7 ( 11.3 - 47.7) |
10.1 ( 3 - 23.2) |
17.1 ( 3.2 - 44.4) |
16.4 ( 9.7 - 23.1) |
Total |
6.9 ( 1.4 - 18.8) |
11.6 ( 4 - 24.5) |
21.3 ( 11.9 - 33.6) |
13.1 ( 5.1 - 25.8) |
15.5 ( 7.3 - 27.4) |
14.5 ( 10.3 - 18.7) |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
9.1 ( 2.1 - 23.3) |
15.8 ( 7 - 29) |
22.2 ( 7.1 - 45.9) |
26.9 ( 11.9 - 47.1) |
15.7 ( 10.4 - 21) |
Women |
N/A |
18.1 ( 3.1 - 47.5) |
27 ( 13.1 - 45.2) |
13.3 ( 4.5 - 28.3) |
25.7 ( 9.1 - 49.9) |
20.1 ( 13.3 - 26.9) |
Total |
10 ( 2.4 - 25.5) |
11.3 ( 4.4 - 22.7) |
20.3 ( 12.3 - 30.5) |
18.2 ( 8.4 - 32.3) |
26.4 ( 16.1 - 36.8) |
17.5 ( 13.3 - 21.7) |
Experienced injuries in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
4.3 ( 0.1 - 21.1) |
1.6 ( 0.1 - 6.5) |
2.3 ( 0.1 - 9.9) |
2.6 ( 0.6 - 7.2) |
2.4 ( 0.7 - 5.9) |
Women |
N/A |
7.7 ( 0.2 - 37.3) |
10.3 ( 3.1 - 23.5) |
3.2 ( 0.6 - 9.3) |
6.4 ( 1.3 - 17.7) |
6.1 ( 3.2 - 10.4) |
Total |
1.5 ( 0 - 8.4) |
5.1 ( 0.7 - 16.7) |
5.1 ( 1.8 - 11) |
2.7 ( 0.8 - 6.7) |
4.2 ( 1.5 - 9) |
3.9 ( 2.2 - 6.3) |
Experienced difficulty learning things in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
5.7 ( 0.5 - 21.3) |
12.4 ( 3.6 - 28.2) |
9.1 ( 2.1 - 23.3) |
6.3 ( 2.1 - 14) |
7.7 ( 4.2 - 12.7) |
Women |
N/A |
8 ( 0.2 - 38.5) |
23.2 ( 8.5 - 45.1) |
6.9 ( 1.4 - 19.4) |
8 ( 2 - 20.4) |
11.1 ( 5.9 - 18.5) |
Total |
2.5 ( 0.2 - 9.7) |
6.2 ( 1.2 - 17.6) |
16.7 ( 8.4 - 28.3) |
8.1 ( 3.2 - 16.2) |
7 ( 3.1 - 13.4) |
9 ( 5.8 - 12.3) |
Experienced legal problems in lifetime due to own amphetamine use (among people who had ever used amphetamine) |
Men |
N/A |
3.9 ( 0.1 - 21.8) |
3.8 ( 0.7 - 11.5) |
4.8 ( 1.3 - 11.9) |
5.3 ( 1.7 - 12.1) |
3.8 ( 1.7 - 7.4) |
Women |
N/A |
0.4 ( 0 - 2.7) |
9 ( 2 - 23.5) |
4.8 ( 0.8 - 14.7) |
4.4 ( 1.2 - 10.7) |
4.3 ( 1.8 - 8.5) |
Total |
0 ( 0 - 7.1) |
3 ( 0.1 - 15.8) |
5.9 ( 2.3 - 12.1) |
4.8 ( 1.9 - 10) |
4.9 ( 2.1 - 9.5) |
4 ( 2.1 - 6) |
Experienced any harmful effects on life in lifetime due to own amphetamine use (among total population) |
Men |
0.3 ( 0 - 1.1) |
2.9 ( 1.1 - 6.2) |
4.2 ( 2.1 - 7.4) |
2.8 ( 1.1 - 5.7) |
2.8 ( 1.4 - 5) |
2.7 ( 1.8 - 3.5) |
Women |
1.9 ( 0.6 - 4.6) |
1 ( 0.4 - 2.2) |
4 ( 2.3 - 6.3) |
1.9 ( 0.8 - 3.8) |
1.9 ( 0.9 - 3.6) |
2.2 ( 1.5 - 2.8) |
Total |
1.2 ( 0.4 - 2.5) |
2 ( 1 - 3.5) |
4.1 ( 2.6 - 5.5) |
2.3 ( 1.1 - 3.5) |
2.3 ( 1.4 - 3.3) |
2.4 ( 1.9 - 2.9) |
Experienced harmful effects on friendships or social life in lifetime due to own amphetamine use (among total population) |
Men |
0.3 ( 0 - 1.1) |
1.6 ( 0.4 - 4.2) |
3.5 ( 1.6 - 6.8) |
1.7 ( 0.5 - 4.3) |
2.4 ( 1 - 4.6) |
1.9 ( 1.2 - 2.6) |
Women |
1.4 ( 0.5 - 3.2) |
0.5 ( 0.1 - 1.5) |
3.7 ( 2.1 - 6) |
1.6 ( 0.6 - 3.7) |
1.3 ( 0.4 - 3) |
1.7 ( 1.2 - 2.3) |
Total |
0.9 ( 0.4 - 1.8) |
1 ( 0.4 - 2.3) |
3.6 ( 2.2 - 5.1) |
1.7 ( 0.8 - 3.1) |
1.8 ( 0.9 - 2.7) |
1.8 ( 1.3 - 2.3) |
Experienced harmful effects on home life in lifetime due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
1.4 ( 0.4 - 3.6) |
2.9 ( 1.3 - 5.7) |
1.7 ( 0.5 - 4.4) |
1.4 ( 0.7 - 2.6) |
1.5 ( 0.9 - 2.2) |
Women |
1.1 ( 0.3 - 2.9) |
0.5 ( 0.1 - 1.5) |
3.1 ( 1.6 - 5.4) |
1.7 ( 0.7 - 3.7) |
1.6 ( 0.7 - 3.3) |
1.6 ( 1.1 - 2.2) |
Total |
0.6 ( 0.2 - 1.5) |
0.9 ( 0.3 - 2) |
3 ( 1.8 - 4.3) |
1.7 ( 0.8 - 3.2) |
1.5 ( 0.8 - 2.2) |
1.6 ( 1.2 - 2) |
Experienced harmful effects on work, study or employment in lifetime due to own amphetamine use (among total population) |
Men |
0.2 ( 0 - 1) |
1.2 ( 0.2 - 3.7) |
2.3 ( 0.8 - 4.9) |
1.5 ( 0.3 - 4.2) |
1.3 ( 0.6 - 2.4) |
1.3 ( 0.7 - 1.9) |
Women |
0.7 ( 0.1 - 2.1) |
0.6 ( 0.2 - 1.5) |
2.1 ( 0.9 - 4.4) |
0.8 ( 0.3 - 1.7) |
1 ( 0.2 - 2.8) |
1 ( 0.6 - 1.5) |
Total |
0.4 ( 0.1 - 1.2) |
0.9 ( 0.3 - 2) |
2.2 ( 1.2 - 3.7) |
1.1 ( 0.4 - 2.3) |
1.1 ( 0.6 - 2) |
1.2 ( 0.8 - 1.5) |
Experienced harmful effects on financial position in lifetime due to own amphetamine use (among total population) |
Men |
0.2 ( 0 - 1) |
1.1 ( 0.3 - 2.9) |
2.1 ( 1 - 3.8) |
2.1 ( 0.6 - 5.1) |
2.4 ( 1.1 - 4.6) |
1.6 ( 1 - 2.1) |
Women |
1 ( 0.2 - 3.2) |
0.7 ( 0.1 - 2) |
2.2 ( 1.1 - 3.7) |
1 ( 0.4 - 2.1) |
1.5 ( 0.5 - 3.2) |
1.3 ( 0.8 - 1.7) |
Total |
0.6 ( 0.1 - 1.7) |
0.9 ( 0.3 - 1.8) |
2.1 ( 1.3 - 3.2) |
1.5 ( 0.7 - 2.9) |
1.9 ( 1 - 2.8) |
1.4 ( 1.1 - 1.8) |
Experienced injuries in lifetime due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0.5 ( 0 - 2.5) |
0.2 ( 0 - 0.8) |
0.2 ( 0 - 0.9) |
0.2 ( 0.1 - 0.6) |
0.2 ( 0.1 - 0.6) |
Women |
0.2 ( 0 - 1) |
0.3 ( 0 - 1.5) |
0.8 ( 0.3 - 2) |
0.2 ( 0 - 0.7) |
0.4 ( 0.1 - 1) |
0.4 ( 0.2 - 0.7) |
Total |
0.1 ( 0 - 0.5) |
0.4 ( 0.1 - 1.3) |
0.5 ( 0.2 - 1.2) |
0.2 ( 0.1 - 0.6) |
0.3 ( 0.1 - 0.6) |
0.3 ( 0.2 - 0.5) |
Experienced difficulty learning things in lifetime due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0.7 ( 0.1 - 2.6) |
1.6 ( 0.5 - 3.7) |
0.9 ( 0.2 - 2.3) |
0.6 ( 0.2 - 1.2) |
0.8 ( 0.4 - 1.3) |
Women |
0.3 ( 0 - 1.1) |
0.3 ( 0 - 1.5) |
1.8 ( 0.6 - 4) |
0.5 ( 0.1 - 1.4) |
0.4 ( 0.1 - 1.1) |
0.7 ( 0.4 - 1.2) |
Total |
0.2 ( 0 - 0.6) |
0.5 ( 0.1 - 1.4) |
1.7 ( 0.8 - 3) |
0.7 ( 0.3 - 1.4) |
0.5 ( 0.3 - 0.9) |
0.7 ( 0.5 - 1) |
Experienced legal problems in lifetime due to own amphetamine use (among total population) |
Men |
0 ( 0 - 1.2) |
0.5 ( 0 - 2.6) |
0.5 ( 0.1 - 1.4) |
0.5 ( 0.1 - 1.2) |
0.5 ( 0.2 - 1.1) |
0.4 ( 0.2 - 0.7) |
Women |
0 ( 0 - 0.7) |
0 ( 0 - 0.1) |
0.7 ( 0.2 - 2) |
0.4 ( 0.1 - 1.1) |
0.2 ( 0.1 - 0.6) |
0.3 ( 0.1 - 0.5) |
Total |
0 ( 0 - 0.4) |
0.2 ( 0 - 1.2) |
0.6 ( 0.2 - 1.3) |
0.4 ( 0.2 - 0.8) |
0.4 ( 0.2 - 0.7) |
0.3 ( 0.2 - 0.5) |
300
300
3
86
6
False
False
abhattac
abhattac
2010-06-01T16:16:34
2010-06-01T16:16:34
SAS Institute Inc. http://www.sas.com
9.01.01M3P02022006